Arnon Nagler
#92,898
Most Influential Person Now
Researcher
Arnon Nagler's AcademicInfluence.com Rankings
Arnon Naglercomputer-science Degrees
Computer Science
#3185
World Rank
#3337
Historical Rank
Computational Linguistics
#126
World Rank
#129
Historical Rank
Machine Learning
#316
World Rank
#320
Historical Rank
Artificial Intelligence
#502
World Rank
#511
Historical Rank
Download Badge
Computer Science
Arnon Nagler's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Arnon Nagler Influential?
(Suggest an Edit or Addition)Arnon Nagler's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. (1998) (2131)
- Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. (1999) (1758)
- G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4 (2002) (1360)
- The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. (2000) (807)
- Comparative studies of human FcRIII-positive and negative natural killer cells. (1989) (709)
- Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies (2008) (674)
- Autologous transplantation and maintenance therapy in multiple myeloma. (2014) (642)
- HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. (2003) (640)
- Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. (2000) (604)
- The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts. (2013) (548)
- Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression. (2007) (506)
- CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. (2004) (500)
- Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients (2010) (437)
- Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. (1996) (431)
- Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial. (2013) (430)
- Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) (2005) (428)
- Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. (2007) (416)
- Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. (2011) (392)
- Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib. (2011) (388)
- Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease. (2016) (379)
- Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. (2003) (368)
- Chemokine receptor CXCR4–dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells (2005) (349)
- CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice. (2004) (345)
- Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. (2009) (344)
- Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation (2016) (332)
- Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice. (2001) (329)
- Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually (2016) (329)
- Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling (2007) (318)
- Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. (2008) (312)
- Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity (2006) (289)
- Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report (2017) (288)
- Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015 (2015) (288)
- Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies (2013) (285)
- Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT) (2015) (277)
- A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. (2008) (272)
- Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. (2002) (270)
- Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide. (2012) (266)
- Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma. (2017) (263)
- Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins (1992) (262)
- Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation (1998) (259)
- Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial (2008) (258)
- Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. (2002) (256)
- Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation. (2012) (247)
- Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. (2004) (242)
- Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT. (2005) (235)
- A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12‐triggered integrin activation but not in chemokine‐triggered motility of human T lymphocytes and CD34+ cells (2008) (234)
- Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes. (1995) (233)
- Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. (1990) (231)
- Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo (1990) (230)
- Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation. (2010) (225)
- Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial. (1989) (222)
- Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis (2002) (220)
- Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice (2014) (219)
- Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies. (2013) (217)
- Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. (2003) (210)
- Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. (2020) (193)
- Human Eosinophils Regulate Human Lung- and Skin-Derived Fibroblast Properties in vitro: A Role for Transforming Growth Factor β (TGF-β) (1999) (192)
- Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma (2000) (191)
- Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality. (2002) (190)
- Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission (2016) (189)
- Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study. (2009) (189)
- Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants (2015) (189)
- Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. (1993) (188)
- Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (2018) (187)
- Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry. (2011) (183)
- Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia (2015) (181)
- Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019 (2019) (181)
- Early and late hematologic toxicity following CD19 CAR-T cells (2019) (180)
- LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. (2008) (178)
- Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia. (2011) (178)
- Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) (2019) (177)
- Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? (2006) (172)
- Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT. (2005) (171)
- High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia. (2013) (169)
- Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma. (2003) (162)
- T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapse (1995) (162)
- Human CD34(+)CXCR4(-) sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation. (2002) (159)
- The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. (2004) (159)
- Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. (1990) (159)
- Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling. (2004) (153)
- Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation (2012) (153)
- CXCL12 secretion by bone marrow stromal cells is dependent on cell contact and mediated by connexin-43 and connexin-45 gap junctions (2011) (151)
- Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma (2018) (149)
- Umbilical cord blood transplantation--how, when and for whom? (2004) (149)
- Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells (2006) (148)
- Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment. (2012) (145)
- Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT (2016) (144)
- The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation (2018) (141)
- Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors (2019) (141)
- Halofuginone to prevent and treat thioacetamide‐induced liver fibrosis in rats (2001) (141)
- Atypical PKC-ζ regulates SDF-1–mediated migration and development of human CD34+ progenitor cells (2005) (138)
- Invasive fungal sinusitis in patients undergoing bone marrow transplantation. (1993) (134)
- Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial. (2015) (133)
- Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma. (2015) (132)
- Human Umbilical Cord Blood–Derived CD133+ Cells Enhance Function and Repair of the Infarcted Myocardium (2006) (132)
- Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation (2014) (132)
- Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. (1993) (129)
- Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice. (2003) (128)
- Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report (2018) (128)
- Right atrial thrombi are related to indwelling central venous catheter position: insights into time course and possible mechanism of formation. (1998) (127)
- Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone (2008) (127)
- Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome–positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transpl (2016) (122)
- The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. (1988) (121)
- Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms. (2009) (121)
- Minimally Cultured or Selected Autologous Tumor-infiltrating Lymphocytes After a Lympho-depleting Chemotherapy Regimen in Metastatic Melanoma Patients (2009) (120)
- Transplantation of human bone marrow mesenchymal stem cells as a thin subretinal layer ameliorates retinal degeneration in a rat model of retinal dystrophy. (2014) (120)
- Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype (2014) (119)
- High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy. (2003) (119)
- Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide (2018) (117)
- Adoptive transfer of immunity to hepatitis B virus after T cell–depleted allogeneic bone marrow transplantation (1993) (115)
- Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR‐ligand mismatch after dose‐reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma (2005) (114)
- Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. (2004) (113)
- Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia (2016) (113)
- Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. (2000) (113)
- The effect of prior exposure to imatinib on transplant-related mortality. (2006) (112)
- Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT (2018) (110)
- MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization. (2009) (110)
- Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma. (2004) (110)
- Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. (2003) (110)
- Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation. (2001) (109)
- Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study. (2019) (109)
- Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation (2008) (108)
- Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC). (2013) (108)
- High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingd (2001) (107)
- Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis. (2019) (107)
- Utilization of Chimeric Antigen Receptor (CAR) T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B cell non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. (2019) (107)
- Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and (2013) (105)
- Weighing the risks of G‐CSF administration, leukopheresis, and standard marrow harvest: Ethical and safety considerations for normal pediatric hematopoietic cell donors (2006) (105)
- Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells. (2005) (105)
- A randomized study comparing yttrium‐90 ibritumomab tiuxetan (Zevalin) and high‐dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma (2012) (104)
- Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. (2004) (104)
- Halofuginone: a potent inhibitor of critical steps in angiogenesis progression (2000) (103)
- Enhanced Unique Pattern of Hematopoietic Cell Mobilization Induced by the CXCR4 Antagonist 4F‐Benzoyl‐TN14003 (2007) (103)
- Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma. (2004) (102)
- Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta). (1999) (101)
- Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant (2017) (98)
- A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS) (2016) (98)
- Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma (2006) (97)
- Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study. (2015) (97)
- Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation. (2004) (97)
- Case of crohn's disease in bone marrow transplantation (1993) (97)
- Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. (1995) (97)
- Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells. (2002) (96)
- Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells. (2004) (95)
- Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marr (2012) (95)
- Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning (2005) (93)
- Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients. (1996) (92)
- IFN-γ Acts on T Cells to Induce NK Cell Mobilization and Accumulation in Target Organs1 (2006) (92)
- The soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro maintenance and proliferation of human CD34(+)CD38(-/low) cells capable of repopulating severe combined immunodeficiency mice. (1999) (92)
- Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma. (2010) (91)
- A fludarabine-based protocol for bone marrow transplantation in Fanconi’s anemia (1997) (91)
- Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for (2018) (90)
- Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation. (2015) (90)
- cAMP-induced PKCzeta activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors. (2006) (90)
- CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth. (2011) (89)
- Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias (2003) (89)
- Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma. (2009) (89)
- Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fluda (2007) (88)
- Umbilical cord blood transplantation: pros, cons and beyond. (2009) (88)
- Immunotherapy with recombinant human interleukin-2 and recombinant interferon-alpha in lymphoma patients postautologous marrow or stem cell transplantation. (1997) (88)
- Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients. (2017) (88)
- Differences between graft product and donor side effects following bone marrow or stem cell donation (2003) (88)
- Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT (2014) (87)
- IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner. (2010) (87)
- Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS) (2006) (85)
- Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2017) (85)
- Graft-versus-tumour and graft-versus-leukaemia effect in patient with concurrent breast cancer and acute myelocytic leukaemia (1996) (85)
- Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD). (1996) (84)
- Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen (2001) (84)
- Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation (2001) (83)
- Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. (2012) (83)
- Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma. (2006) (83)
- Reduction in pulmonary fibrosis in vivo by halofuginone. (1996) (83)
- Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors (2009) (82)
- The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation (2019) (82)
- Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia (2018) (82)
- Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2017) (82)
- Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation. (2019) (80)
- Long‐term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2‐year follow‐up of the CHRONOS‐1 study (2019) (79)
- Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States. (2016) (79)
- Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy (2018) (79)
- Ovarian tissue cryopreservation in hematologic malignancy: Ten years' experience (2007) (77)
- Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells. (2005) (77)
- The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression (2017) (77)
- Interaction between CXCR4 and CCL20 Pathways Regulates Tumor Growth (2009) (76)
- Cytokine dysregulation in chronic graft versus host disease. (1995) (76)
- Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike (2012) (76)
- Post-Transplant Cyclophosphamide versus Antithymocyte Globulin in HLA-Mismatched unrelated Donors transplantation. (2019) (75)
- Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse (2018) (75)
- Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT) (2019) (74)
- Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries (2011) (74)
- The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma (2013) (74)
- Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high‐risk aggressive non‐Hodgkin's lymphoma (2003) (73)
- Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2020) (72)
- Yttrium-90-ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin's lymphoma. (2007) (72)
- A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia (2014) (72)
- Cytogenetics of extramedullary manifestations in multiple myeloma (2013) (72)
- Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2017) (71)
- Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT (2015) (71)
- Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT (2018) (71)
- A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia (2017) (71)
- Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study (2010) (71)
- Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial (2018) (71)
- Transplantation of Human Hematopoietic Stem Cells into Ischemic and Growing Kidneys Suggests a Role in Vasculogenesis but Not Tubulogenesis (2006) (71)
- European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching (1997) (71)
- Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings? (2016) (71)
- Heparanase expression in human leukemias is restricted to acute myeloid leukemias. (2002) (71)
- Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy (2008) (70)
- Inhibition of Transforming Growth Factor &bgr; Signaling by Halofuginone as a Modality for Pancreas Fibrosis Prevention (2009) (70)
- Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy (2008) (70)
- Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation. (2011) (69)
- Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1. (2017) (69)
- Reduced‐intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (2015) (69)
- Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective study. (1996) (69)
- Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial. (2018) (69)
- Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation. (2000) (68)
- Heparanase enhances myeloma progression via CXCL10 downregulation (2014) (67)
- Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-alpha. (2005) (67)
- Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: A survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (2014) (67)
- Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial. (2005) (67)
- Growth inhibition of prostate cancer xenografts by halofuginone * † (2002) (66)
- Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies (2015) (66)
- Management of Adults and Children receiving CAR T-cell therapy: 2021 Best Practice Recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) (2021) (65)
- Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells. (2006) (65)
- Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project. (2020) (65)
- Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remission (2014) (65)
- Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD. (2016) (63)
- Freeze-Drying of Mononuclear Cells Derived from Umbilical Cord Blood Followed by Colony Formation (2009) (63)
- Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML In Vitro and In Vivo (2012) (62)
- Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia major. (1998) (62)
- Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study (1999) (62)
- APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair. (2012) (62)
- Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced. (2004) (61)
- Philadelphia-Chromosome-Positive T-Lymphoblastic Leukemia: Acute Leukemia or Chronic Myelogenous Leukemia Blastic Crisis (2005) (61)
- Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia – a matched pair analysis by the Acute Leukaemia Working Party of EBMT (2018) (61)
- Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G‐CSF in a murine model of cyclophosphamide‐induced leukopenia † (2001) (61)
- Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience. (2012) (61)
- Topical treatment of cutaneous chronic graft versus host disease with halofuginone: a novel inhibitor of collagen type I synthesis. (1999) (61)
- Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP (2014) (61)
- Ascorbic acid inhibits apoptosis induced by X irradiation in HL60 myeloid leukemia cells. (1999) (60)
- High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma (2008) (60)
- Hematopoietic stem-cell transplantation using umbilical-cord blood. (2003) (59)
- Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT (2017) (59)
- Dexamethasone inhibits maturation, cytokine production and FcεRI expression of human cord blood‐derived mast cells (2002) (59)
- The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project (2018) (57)
- Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel (2020) (57)
- Effect of 1,25 dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E), and myeloid (CFU-C) progenitor cell growth and differentiation patterns. (1986) (57)
- MK-0457, an Aurora kinase and BCR–ABL inhibitor, is active in patients with BCR–ABL T315I leukemia (2013) (57)
- Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients (2000) (57)
- Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation. (1996) (57)
- Pegylated liposomal doxorubicin plus bortezomib in relapsed or refractory multiple myeloma: efficacy and safety in patients with renal function impairment. (2008) (57)
- Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties (2018) (57)
- Anti-T Lymphocyte Globulin (ATG) Induces Generation of Regulatory T Cells, at Least Part of Them Express Activated CD44 (2012) (57)
- HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia (2007) (57)
- IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organs. (2006) (57)
- Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation (2018) (56)
- Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients (2020) (56)
- Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced (2011) (56)
- Phase 1 study of INNO‐406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome‐positive leukemias after imatinib resistance or intolerance (2010) (56)
- Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective (2015) (56)
- Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT (2016) (55)
- Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma (2004) (55)
- Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease (1999) (55)
- Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study (2013) (55)
- Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT (2018) (55)
- CD 44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD 34 stem / progenitor cells to bone marrow (2004) (54)
- Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2018) (54)
- Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect (2007) (54)
- Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT (2016) (54)
- Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation (2010) (53)
- Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140 (2013) (53)
- Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy. (2019) (53)
- Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia. (1999) (52)
- Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium (2012) (52)
- Immunotherapy of minimal residual disease by immunocompetent lymphocytes and their activation by cytokines. (1992) (51)
- The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma (2014) (51)
- A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia (2014) (51)
- Multiple Myeloma Treatment in Real‐world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study (2018) (51)
- Staphylococcus aureus bacteremia and endocarditis: comparison of nosocomial and community-acquired infection. (1984) (51)
- Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia (2017) (51)
- Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study. (1995) (50)
- Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model--an MRI study. (2004) (50)
- Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors. (2010) (50)
- Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11. (2006) (50)
- Allogeneic cell-mediated immunotherapy for breast cancer after autologous stem cell transplantation: a clinical pilot study. (1998) (50)
- Rapid and efficient homing of human CD 34 1 CD 38 2 / lowCXCR 4 1 stem and progenitor cells to the bone marrow and spleen of NOD / SCID and NOD / SCID / B 2 m null mice (2001) (49)
- Linearity and stability of intravenous busulfan pharmacokinetics and the role of glutathione in busulfan elimination. (2011) (49)
- Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need. (2011) (49)
- Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma (2008) (49)
- Tissue regeneration potential in human umbilical cord blood. (2010) (49)
- Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood (2014) (49)
- Allogeneic stem cell transplantation in patients with Hodgkin's-Lymphoma. (2004) (48)
- An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients (2010) (48)
- Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Grou (2006) (48)
- Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma (2008) (48)
- Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factor. (1992) (48)
- External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation. (2019) (48)
- Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood. (2001) (48)
- Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive acute lymphoblastic leukemia (2009) (47)
- Bortezomib‐Cyclophosphamide‐Dexamethasone (VCD) versus Bortezomib‐Thalidomide‐Dexamethasone (VTD) ‐based regimens as induction therapies in newly diagnosed transplant eligible patients with multiple myeloma: a meta‐analysis (2014) (47)
- Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone. (2004) (47)
- Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy (2011) (47)
- Inhibition of Pancreatic Stellate Cell Activation by Halofuginone Prevents Pancreatic Xenograft Tumor Development (2010) (47)
- Allogenic hematopoietic stem‐cell transplantation with reduced‐intensity conditioning in patients with refractory and recurrent multiple myeloma (2010) (47)
- Vantage 095: Vorinostat in Combination with Bortezomib in Salvage Multiple Myeloma Patients: Final Study Results of a Global Phase 2b Trial (2011) (46)
- Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulations (2001) (46)
- Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study (2017) (46)
- Halofuginone: From veterinary use to human therapy (2000) (46)
- Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors (1994) (46)
- Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice (2000) (46)
- Use of Fiberoptic Bronchoscopy in Bone Marrow Transplant Recipients (1998) (46)
- Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes. (1990) (46)
- Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation (2018) (46)
- Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trial. (2014) (46)
- Epiretinal transplantation of human bone marrow mesenchymal stem cells rescues retinal and vision function in a rat model of retinal degeneration. (2015) (45)
- Effects of CSFs in preleukemia. (1990) (45)
- Hepatitis B virus infection associated with hematopoietic tumors. (1994) (45)
- Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT (2019) (45)
- Related cord blood transplants: the Eurocord experience from 78 transplants. Eurocord Transplant group. (1998) (45)
- Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects (2015) (45)
- Intravenous ribavirin therapy for adenovirus gastroenteritis after bone marrow transplantation. (1995) (45)
- Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma. (1999) (45)
- Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma (2008) (45)
- Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell Transplantation (2019) (45)
- Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome–positive acute lymphoblastic leukemia (2015) (45)
- Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group (2019) (44)
- Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet™) combined morphological and cytogenetical analysis (2002) (44)
- Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant Study (2019) (44)
- OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OVER 69 YEARS OF AGE WITH ACUTE MYELOID LEUKEMIA: ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT. (2019) (44)
- Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study (2019) (44)
- Fludarabine and treosulfan: A novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes (2007) (44)
- Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes (2016) (44)
- Ponatinib reduces viability, migration, and functionality of human endothelial cells (2017) (43)
- Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation (2014) (43)
- Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients. (2004) (43)
- Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities. (1997) (43)
- Isolated Extramedullary Relapse of Acute Leukemia after Allogeneic Stem Cell Transplantation: Different Kinetics and Better Prognosis than Systemic Relapse. (2009) (43)
- The response of cord blood megakaryocyte progenitors to IL‐3, IL‐6 and aplastic canine serum varies with gestational age (1995) (43)
- Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up (2010) (43)
- New developments in bone marrow transplantation. (1991) (43)
- Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis. (2015) (43)
- Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis (2017) (43)
- Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group–an observational analysis by the Acute Leukemia Working Party of the EBMT (2015) (42)
- Autologous transplant remains the preferred therapy for relapsed APL in CR2 (2016) (42)
- Alleviation of Acute and Chronic Graft-Versus-Host Disease in a Murine Model Is Associated with Glucocerebroside-Enhanced Natural Killer T Lymphocyte Plasticity (2007) (42)
- Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma (2003) (42)
- Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity (2012) (42)
- Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ⩾10 years (2015) (42)
- Biosimilar G-CSF Based Mobilization of Peripheral Blood Hematopoietic Stem Cells for Autologous and Allogeneic Stem Cell Transplantation (2013) (42)
- Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study. (2018) (42)
- Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT (2020) (41)
- Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT (2018) (41)
- CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives (2019) (41)
- Successful umbilical cord blood transplantation for Fanconi anemia using preimplantation genetic diagnosis for HLA‐matched donor (2004) (41)
- Imatinib plasma trough levels in chronic myeloid leukaemia: results of a multicentre study CSTI571AIL11TGLIVEC (2012) (41)
- The effect of pilocarpine on salivary constituents in patients with chronic graft-versus-host disease. (2001) (41)
- Peripheral T cell lymphoma, not otherwise specified (PTCL‐NOS). A new prognostic model developed by the International T cell Project Network (2018) (41)
- Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT (2019) (41)
- Results of the Myeloproliferative Neoplasms - Research Consortium (MPN-RC) 112 Randomized Trial of Pegylated Interferon Alfa-2a (PEG) Versus Hydroxyurea (HU) Therapy for the Treatment of High Risk Polycythemia Vera (PV) and High Risk Essential Thrombocythemia (ET) (2018) (41)
- Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party (2019) (40)
- Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study. (2019) (40)
- Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice. (2005) (40)
- High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation (2017) (40)
- Diffuse alveolar hemorrhage following allogeneic bone marrow transplantation in children. (2003) (40)
- Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party (2016) (40)
- Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database (2016) (40)
- Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT. (2017) (40)
- Impact of marrow cytogenetics and morphology on in vitro hematopoiesis in the myelodysplastic syndromes: comparison between recombinant human granulocyte colony-stimulating factor (CSF) and granulocyte-monocyte CSF. (1990) (39)
- Machine learning and artificial intelligence in haematology (2020) (39)
- Prognostic Significance of VEGF, VEGF Receptors, and Microvessel Density in Diffuse Large B Cell Lymphoma Treated with Anthracycline-Based Chemotherapy. (2007) (39)
- Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT (2016) (39)
- Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2015) (39)
- CORD BLOOD TRANSPLANTATION (CBT) IN HEMOGLOBINOPATHIES (1998) (39)
- Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response. (2009) (39)
- Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT) (2017) (39)
- Effects of recombinant human granulocyte and granulocyte-macrophage colony-stimulating factors on neutrophil function following autologous bone marrow transplantation. (1991) (38)
- Low molecular weight heparin for hickman catheter‐induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation (1992) (38)
- Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide (2018) (38)
- Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia (2016) (38)
- Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications (2018) (38)
- Total leucoderma: a rare manifestation of cutaneous chronic graft-versus-host disease. (1996) (37)
- Histamine enhances granulocyte‐macrophage colony‐stimulating factor and interleukin‐6 production by human peripheral blood mononuclear cells (1995) (37)
- Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. (2017) (37)
- The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT). (1995) (37)
- Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine (2018) (37)
- Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML) (2015) (37)
- Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment? (2008) (37)
- Halofuginone Has Anti-Proliferative Effects in Acute Promyelocytic Leukemia by Modulating the Transforming Growth Factor Beta Signaling Pathway (2011) (37)
- OCT1 genetic variants are associated with long term outcomes in imatinib treated chronic myeloid leukemia patients (2014) (37)
- The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis. (2017) (37)
- Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT (2019) (37)
- Programmed death-1 immune checkpoint blockade in the treatment of hematological malignancies (2016) (36)
- Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission (2018) (36)
- Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience (2010) (36)
- Rhinocerebral Aspergillosis in Patients Undergoing Bone Marrow Transplantation (1994) (36)
- The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation (2009) (36)
- Effects of CAMPATH-1 antibodies on the functional activity of monocytes and polymorphonuclear neutrophils. (1993) (36)
- Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT. (2018) (36)
- Bioactive magnetic near Infra-Red fluorescent core-shell iron oxide/human serum albumin nanoparticles for controlled release of growth factors for augmentation of human mesenchymal stem cell growth and differentiation (2015) (36)
- MAST CELLS INDUCE ACTIVATION OF HUMAN LUNG FIBROBLASTS IN VITRO (2004) (36)
- Novel Strategies for Immunotherapy in Multiple Myeloma: Previous Experience and Future Directions (2012) (35)
- Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor. (1991) (35)
- Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers (2017) (35)
- Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis (2019) (35)
- Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications (2016) (35)
- Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma (2016) (35)
- Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis. (2018) (35)
- Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party (2018) (35)
- European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation (2018) (35)
- Heparanase regulates retention and proliferation of primitive Sca-1+/c-Kit+/Lin- cells via modulation of the bone marrow microenvironment. (2008) (35)
- Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT (2017) (35)
- Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. (2021) (35)
- NK Cell Receptor NKp46 Regulates Graft-versus-Host Disease (2014) (35)
- Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation. (2017) (34)
- Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice (2014) (34)
- Efficacy and safety of pegylated liposomal Doxorubicin in combination with bortezomib for multiple myeloma: effects of adverse prognostic factors on outcome. (2011) (34)
- Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease (2018) (34)
- Salivary gland involvement in graft-versus-host disease: the underlying mechanism and implicated treatment. (2004) (34)
- Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo. (2003) (34)
- Sialometrical and Sialochemical Analysis of Patients with Chronic Graft-Versus-Host Disease—A Prolonged Study (2003) (34)
- Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse (2009) (34)
- Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disorders. (2001) (33)
- Heparanase upregulates Th2 cytokines, ameliorating experimental autoimmune encephalitis. (2010) (33)
- Analysis of beta-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantation. (1995) (33)
- Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (2014) (33)
- Assessment of the response to imatinib in chronic myeloid leukemia patients – comparison between the FISH, multiplex and RT‐PCR methods (2004) (33)
- Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study (2016) (33)
- Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes (2005) (33)
- European results of unrelated cord blood transplants (1998) (33)
- Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT (2016) (33)
- Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients (2020) (33)
- Impact of ABO incompatibility on patients’ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT (2017) (33)
- Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation. (2020) (32)
- Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT (2014) (32)
- Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study (2015) (32)
- Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission (2017) (32)
- Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT (2016) (32)
- Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy. (2020) (32)
- Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party (2017) (31)
- Long‐term outcome after a treosulfan‐based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2017) (31)
- A Phase I Study of INNO-406 in Patients with Advanced Philadelphia (Ph+) Chromosome-Positive Leukemias Who Are Resistant or Intolerant to Imatinib and Second Generation Tyrosine Kinase Inhibitors. (2007) (31)
- Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center (2018) (31)
- Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model (2000) (31)
- MAP kinase activation by mu opioid receptor in cord blood CD34(+)CD38(-) cells. (2002) (31)
- The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (2015) (31)
- The Effects of External Counter Pulsation Therapy on Circulating Endothelial Progenitor Cells in Patients with Angina Pectoris (2007) (31)
- Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (2020) (31)
- Immunogenicity and safety of the BNT162b2 mRNA COVID‐19 vaccine in haematopoietic stem cell transplantation recipients (2021) (30)
- The effects of recombinant interleukin 2-activated natural killer cells on autologous peripheral blood hematopoietic progenitors (1988) (30)
- Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced‐intensity allografting (2012) (30)
- Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study. (2018) (30)
- CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges (2020) (30)
- Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch? (2018) (30)
- Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents (2012) (30)
- Involvement of Host Stroma Cells and Tissue Fibrosis in Pancreatic Tumor Development in Transgenic Mice (2012) (30)
- Melphalan/Prednisone/Lenalidomide (MPR) Versus High-Dose Melphalan and Autologous Transplantation (MEL200) in Newly Diagnosed Multiple Myeloma (MM) Patients <65 Years: Results of a Randomized Phase III Study (2011) (30)
- Development of Allogeneic NK Cell Adoptive Transfer Therapy in Metastatic Melanoma Patients: In Vitro Preclinical Optimization Studies (2013) (30)
- Ccr5 deficiency regulates the proliferation and trafficking of natural killer cells under physiological conditions. (2011) (30)
- Allogeneic Cell‐Mediated and Cytokine‐Activated Immunotherapy for Malignant Lymphoma at the Stage of Minimal Residual Disease After Autologous Stem Cell Transplantation (1998) (30)
- Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors (2020) (30)
- VANTAGE 095: An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma. (2016) (29)
- Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6. (2009) (29)
- Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT (2019) (29)
- Selective generation of erythroid burst-promoting activity by recombinant interleukin 2-stimulated human T lymphocytes and natural killer cells. (1988) (29)
- Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study (2019) (29)
- Natural killer (NK) cells prevent virus production in cell culture (1999) (29)
- Transplantation and other uses of human umbilical cord blood and stem cells. (2007) (29)
- A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD). (2008) (29)
- RNA Inhibition Highlights Cyclin D1 as a Potential Therapeutic Target for Mantle Cell Lymphoma (2012) (29)
- The Molecular Basis of Salivary Gland Involvement in Graft-vs.-Host Disease (2004) (29)
- Thrombin generation as a predictor of thromboembolic events in multiple myeloma patients. (2017) (29)
- Double umbilical cord blood transplant: more than a cell dose? (2010) (29)
- Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT (2017) (29)
- Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation (2018) (29)
- Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis (2018) (28)
- Red blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection. (1994) (28)
- Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells (2009) (28)
- CXCR 4 Regulates Migration and Development of Human Acute Myelogenous Leukemia Stem Cells in Transplanted NOD / SCID Mice (2004) (28)
- Platelets but not monocytes contribute to the plasma levels of factor XIII subunit A in patients undergoing autologous peripheral blood stem cell transplantation (2004) (28)
- Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT (2020) (28)
- T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis (2015) (28)
- High-throughput, sensitive and quantitative assay for the detection of BCR-ABL kinase domain mutations (2007) (28)
- Parotid salivary gland dysfunction in chronic graft-versus-host disease (cGVHD): a longitudinal study in a mouse model (2000) (28)
- Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2021) (28)
- Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in haematological malignancies using biosimilar G‐CSF (2016) (28)
- Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia (2020) (28)
- Separation of hematopoietic progenitor cells from human umbilical cord blood. (1993) (28)
- RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT (2016) (28)
- Inhibition of Wilms tumor xenograft progression by halofuginone is accompanied by activation of WT-1 gene expression. (2005) (28)
- The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway (2016) (28)
- CT in the clinical and prognostic evaluation of acute graft-vs-host disease of the gastrointestinal tract. (2012) (27)
- Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination. (1995) (27)
- Expansion of megakaryocyte progenitors from human umbilical cord blood using a new two‐step separation procedure (1998) (27)
- Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas (2019) (27)
- Regulatory T Cells in Allogeneic Stem Cell Transplantation (2013) (27)
- Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen (2018) (27)
- Clofarabine‐containing conditioning regimen for allo‐SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT (2012) (27)
- ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors. (2018) (27)
- Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation (2016) (27)
- Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies. (1999) (27)
- Results from HARMONY: an open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis (2019) (27)
- Tumor Necrosis Factor Promotes Human T‐Cell Development in Nonobese Diabetic/Severe Combined Immunodeficient Mice (2004) (27)
- Massive pericardial effusion complicating the course of chronic graft-versus-host disease (cGVHD) in a child with acute lymphoblastic leukemia following allogeneic bone marrow transplantation (1997) (27)
- Intra‐arterial catheter directed therapy for severe graft‐versus‐host disease (2002) (26)
- Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT (2019) (26)
- Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years (2020) (26)
- Thiotepa‐based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched‐pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2017) (26)
- Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study (2016) (26)
- Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs (2019) (26)
- Efficacy of Dasatinib in Patients with Chronic Phase Philadelphia Chromosome-Positive CML Resistant or Intolerant to Imatinib: First Results of the CA180013 ‘START-C’ Phase II Study. (2005) (26)
- Differential usage of VLA‐4 and CXCR4 by CD3+CD56+ NKT cells and CD56+CD16+ NK cells regulates their interaction with endothelial cells (2004) (26)
- Neuronal Conditioning Medium and Nerve Growth Factor Induce Neuronal Differentiation of Collagen-Adherent Progenitors Derived from Human Umbilical Cord Blood (2007) (26)
- Cord blood transplantation (CBT) in hemoglobinopathies. Eurocord. (1998) (26)
- Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation. (2020) (26)
- Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT (2017) (26)
- Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation (2019) (26)
- A phase I study of INNO-406 in patients with advanced Philadelphia chromosome-positive (Ph+) leukemias who are resistant or intolerant to imatinib and may have also failed second-generation tyrosine kinase inhibitors. (2008) (26)
- Viewpoint: What is the role of allogeneic haematopoietic cell transplantation in the era of reduced-intensity conditioning – is there still an upper age limit? A focus on myeloid neoplasia (2007) (26)
- Changes in Gene Expression Pattern following Granulocyte Colony-Stimulating Factor Administration to Normal Stem Cell Sibling Donors (2006) (26)
- The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation (2018) (26)
- Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma (2019) (26)
- Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-d-glucose–positron emission tomography/computed tomography in mantle cell lymphoma? (2014) (25)
- The Role of Measurable Residual Disease (MRD) in Hematopoietic Stem Cell Transplantation for Hematological Malignancies Focusing on Acute Leukemia (2019) (25)
- Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model. (2000) (25)
- An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia (2017) (25)
- The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT (2013) (25)
- Dexamethasone inhibits maturation, cytokine production and Fc epsilon RI expression of human cord blood-derived mast cells. (2002) (25)
- Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T‐cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2018) (25)
- Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. (2015) (25)
- Endogenous basic fibroblast growth factor displaced by heparin from the lumenal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall. (1997) (25)
- Prognostic Scoring Systems in Allogeneic Hematopoietic Stem Cell Transplantation: Where Do We Stand? (2017) (25)
- Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation (2019) (25)
- Validation of the acute leukemia‐EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi‐center GITMO cohort (2017) (25)
- Sequential chemotherapy followed by reduced‐intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT (2017) (25)
- Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation. (2018) (25)
- Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC) (1999) (25)
- Aspergillus quadrilineatus, a new causative agent of fungal sinusitis (1992) (25)
- Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT (2016) (24)
- CAR-T cells: the narrow path between hope and bankruptcy? (2017) (24)
- Characterization of HPSE Gene Single Nucleotide Polymorphisms in Jewish Populations of Israel (2006) (24)
- Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study (2016) (24)
- Allogeneic Hematopoietic Stem-Cell Transplantation in AML and MDS Using Myeloablative Versus Reduced Intensity Conditioning: The Role of Dose-Intensity. (2005) (24)
- An improved index for diagnosis and mortality prediction in malignancy associated hemophagocytic lymphohistiocytosis. (2021) (24)
- Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT. (1996) (24)
- HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis. (2019) (24)
- Nonmyeloablative Conditioning Does Not Prevent Telomere Shortening after Allogeneic Stem Cell Transplantation (2005) (24)
- Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications. (1996) (24)
- Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties (2016) (24)
- Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia (2020) (24)
- Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy (2004) (24)
- Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation (2018) (24)
- Activity and tolerability of nilotinib (2010) (23)
- Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2019) (23)
- Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation (BMT). (1992) (23)
- Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study (2018) (23)
- Alloreactivity: the Janus-face of hematopoietic stem cell transplantation (2017) (23)
- Halofuginone, an inhibitor of collagen synthesis by rat stellate cells, stimulates insulin-like growth factor binding protein-1 synthesis by hepatocytes. (2004) (23)
- Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. (2016) (23)
- Selective CD4+ T-cell depletion does not prevent graft-versus-host disease. (1998) (23)
- Systemic chimerism in sex-mismatched liver transplant recipients detected by fluorescence in situ hybridization. (1994) (23)
- Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. (1990) (23)
- Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT (2017) (23)
- Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity. (2003) (23)
- Treatment of refractory autoimmune diseases with ablative immunotherapy using monoclonal antibodies and/or high dose chemotherapy with hematopoietic stem cell support. (2003) (22)
- Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT (2019) (22)
- CD45 regulates homing and engraftment of immature normal and leukemic human cells in transplanted immunodeficient mice. (2011) (22)
- Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases. (1988) (22)
- Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia (2020) (22)
- Human umbilical cord blood biology, transplantation and plasticity. (2006) (22)
- Involvement of the tyrosine phosphatase early gene of liver regeneration (PRL–1) in cell cycle and in liver regeneration and fibrosis effect of halofuginone (2006) (22)
- Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable? (2016) (22)
- Inhibition of matrix metalloproteinase-2 by halofuginone is mediated by the Egr1 transcription factor (2012) (22)
- Genotype and Allele Frequencies of C3435T Polymorphism of the MDR1 Gene in Various Jewish Populations of Israel (2004) (22)
- Ex vivo expansion of megakaryocyte precursors by preincubation of marrow allografts with interleukin-3 and granulocyte-macrophage colony-stimulating factor in vitro. (1995) (22)
- Prevention of Esophageal Strictures in a Caustic Burn Model Using Halofuginone, an Inhibitor of Collagen Type I Synthesis (2005) (22)
- Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia (2019) (22)
- CAR T cells induce a complete response in refractory Burkitt Lymphoma (2018) (22)
- Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation (2018) (22)
- Attenuated DNA damage responses and increased apoptosis characterize human hematopoietic stem cells exposed to irradiation (2018) (22)
- Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2019) (22)
- Granulocyte-colony stimulating factor for hematopoietic stem cell donation from healthy female donors during pregnancy and lactation: what do we know? (2013) (22)
- Typhlitis occurring in autologous bone marrow transplantation. (1992) (22)
- Invasive fungal infections in lymphoma patients receiving immunotherapy following autologous bone marrow transplantation (ABMT) (1997) (22)
- Eradication of B-CLL by autologous and allogeneic host nonreactive anti-third-party CTLs. (2005) (22)
- Allogeneic cell therapy of severe beta thalassemia major by displacement of host stem cells in mixed chimera by donor blood lymphocytes (1997) (22)
- Regulatory abnormalities in the marrow of patients with myelodysplastic syndromes (1989) (21)
- Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT (2016) (21)
- A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia (2022) (21)
- EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL) (2019) (21)
- Adoptive transfer of NK 1.1+ lymphocytes in immune-mediated colitis: a pro-inflammatory or a tolerizing subgroup of cells? (2005) (21)
- Effects of human interleukin 3, macrophage and granulocyte-macrophage colony-stimulating factor on monocyte function following autologous bone marrow transplantation. (1992) (21)
- Allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia in first complete remission: new answers for an old question (2005) (21)
- High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group (2002) (21)
- Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia (2020) (21)
- Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT (2018) (21)
- Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. (2020) (21)
- The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years—a report from the EBMT acute leukemia working party (2016) (21)
- Treatment of refractory autoimmune diseases with ablative immunotherapy. (2004) (21)
- Mobilized peripheral blood stem cells compared with bone marrow from HLA‐identical siblings for reduced‐intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMT (2012) (21)
- Treatment with anti CD19 chimeric antigen receptor T cells after antibody-based immunotherapy in adults with acute lymphoblastic leukemia. (2019) (21)
- T‐cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3‐ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2018) (21)
- Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT (2019) (21)
- Cord Blood Stem Cells for Hematopoietic Transplantation (2011) (20)
- Optimizing the Pretransplant Regimen for Autologous Stem Cell Transplantation in Acute Myelogenous Leukemia : Better Outcomes with Busulfan and Melphalan Compared with Busulfan and Cyclophosphamide in High Risk Patients Autografted in First Complete Remission (2017) (20)
- Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man (2000) (20)
- Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation. (1996) (20)
- In vitro and in vivo reversal of MDR1-mediated multidrug resistance by KT-5720: implications on hematological malignancies. (2006) (20)
- Myeloid progenitors from the bone marrow of patients with vitamin D resistant rickets (type II) fail to respond to 1,25(OH)2D3 (1987) (20)
- Oral tuberculosis following autologous bone marrow transplantation for Hodgkin's disease with interleukin-2 and alpha-interferon immunotherapy. (1996) (20)
- Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT (2017) (20)
- An Open-Label, Multicenter, 2-Arm, Dose-Finding, Phase 1b Study of the Combination of Ruxolitinib and Buparlisib (BKM120) in Patients with Myelofibrosis: Results from HARMONY Study (2015) (20)
- Maintenance Therapy With Lenalidomide Significantly Improved Survival Of Yong Newly Diagnosed Multiple Myeloma Patients (2013) (20)
- Parotid gland dysfunction in an animal model of chronic graft-vs-host disease. (1996) (20)
- Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation. (2000) (20)
- Immunotherapy in conjunction with autologous and allogeneic blood or marrow transplantation in lymphoma. (1998) (20)
- Melphalan/prednisone/lenalidomide (MPR) versus high-dose melphalan and autologous transplantation (MEL200) plus lenalidomide maintenance or no maintenance in newly diagnosed multiple myeloma (MM) patients. (2013) (20)
- Randomized trial showing equivalent efficacy of filgrastim 5 micrograms/kg/d and 10 micrograms/kg/d following high-dose chemotherapy and autologous bone marrow transplantation in high-risk lymphomas. (1997) (20)
- Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia (2018) (20)
- Partial protection of rat parotid glands from irradiation-induced hyposalivation by manganese superoxide dismutase. (2000) (20)
- Reprint of: Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States. (2016) (20)
- Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia (2020) (20)
- Single-Dose Daily Fractionation Is Not Inferior to Twice-a-Day Fractionated Total-Body Irradiation Before Allogeneic Stem Cell Transplantation for Acute Leukemia: A Useful Practice Simplification Resulting From the SARASIN Study. (2018) (20)
- OUTCOMES OF UCB TRANSPLANTATION ARE COMPARABLE IN FLT3+ AML: RESULTS OF CIBMTR, EUROCORD AND EBMT COLLABORATIVE ANALYSIS (2016) (20)
- JAK2V617F allele burden is associated with transformation to myelofibrosis (2012) (20)
- Venous thromboembolism in hematopoietic stem cell transplant recipients (2016) (20)
- The role of thiotepa in allogeneic stem cell transplantation in patients with leukemia. (1999) (20)
- Nonmyeloablative stem cell transplantation: lessons from the first decade of clinical experience. (2004) (19)
- Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma. (2012) (19)
- Human umbilical cord blood for hematopoietic progenitor cells transplantation. (1995) (19)
- The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases (1999) (19)
- Occurrence of graft‐versus‐host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT (2018) (19)
- Human Umbilical Cord Blood Stem Cells: Rational for Use as a Neuroprotectant in Ischemic Brain Disease (2010) (19)
- Dose-Reduced Conditioning Followed by Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis. Results from a Multicenter Prospective Trial of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). (2007) (19)
- Melphalan/prednisone/lenalidomide (MPR) versus high-dose melphalan and autologous transplantation (MEL200) in newly diagnosed multiple myeloma (MM) patients: A phase III trial. (2011) (19)
- Current status and future perspectives for yttrium-90 (90Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphoma (2007) (19)
- Ciprofloxacin enhances hematopoiesis and the peritoneal neutrophil function in lethally irradiated, bone marrow-transplanted mice. (1994) (19)
- Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation (2009) (19)
- Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals (2001) (19)
- Second transplantation using allogeneic peripheral blood stem cells in a β‐thalassaemia major patient featuring stable mixed chimaerism (1996) (19)
- P-glycoprotein-dependent resistance of cancer cells toward the extrinsic TRAIL apoptosis signaling pathway. (2013) (19)
- Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia (2018) (18)
- Post‐transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA‐identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow T (2020) (18)
- Secondary refractory anemia with excess of blasts in transformation terminating as acute lymphoblastic leukemia. (1986) (18)
- Human umbilical cord blood cells: a new alternative for myocardial repair? (2005) (18)
- Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remission (2017) (18)
- Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT (2017) (18)
- Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia (2021) (18)
- Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph‐negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation (2018) (18)
- Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation (2008) (18)
- Neurotherapeutic effect of cord blood derived CD45+ hematopoietic cells in mice after traumatic brain injury. (2014) (18)
- Differentiation of bone marrow cells from myelodysplastic patients in the presence of 1,25 dihydroxyvitamin D3 or 13‐cis retinoic acid (1986) (18)
- A Randomized Controlled Multicenter Study Comparing Recombinant Interleukin 2 (rIL-2) in Conjunction With Recombinant Interferon Alpha (IFN-α) Versus no Immunotherapy for Patients With Malignant Lymphoma Postautologous Stem Cell Transplantation (2010) (18)
- Detection of minimal residual disease after sex-mismatch bone marrow transplantation in chronic myelogenous leukemia by fluorescence in situ hybridization. (1994) (18)
- Adoptive cell therapy for metastatic melanoma patients: pre-clinical development at the Sheba Medical Center. (2006) (18)
- Treatment of Leukemia by Alloreactive Lymphocytes and Nonmyeloablative Stem Cell Transplantation (2002) (18)
- Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation (2019) (18)
- The Peptidic CXCR4 Antagonist, BL-8040, Significantly Reduces Bone Marrow Immature Leukemia Progenitors By Inducing Differentiation, Apoptosis and Mobilization: Results of the Dose Escalation Clinical Trial in Acute Myeloid Leukemia (2015) (18)
- Relapse of postpolycythemia myelofibrosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation (2008) (18)
- Anti‐thymocyte globulin improves survival free from relapse and graft‐versus‐host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia‐negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMT (2018) (18)
- Transient osteoporosis of hip joint with liver cirrhosis. (1984) (17)
- Cord blood biology and transplantation. (2004) (17)
- Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin (2019) (17)
- Ketotifen therapy in chronic graft‐versus‐host disease (cGVHD): effect on mast cells and fibroblasts (1995) (17)
- Individualized prediction of leukemia‐free survival after autologous stem cell transplantation in acute myeloid leukemia (2019) (17)
- Umbilical cord blood for use in transplantation. (1995) (17)
- Oral integrity and salivary profile in myeloma patients undergoing high-dose therapy followed by autologous SCT (2009) (17)
- Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma (2014) (17)
- Characterization of Cyclin E Expression in Multiple Myeloma and Its Functional Role in Seliciclib-Induced Apoptotic Cell Death (2012) (17)
- Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome (2014) (17)
- Cytogenetic and Molecular Response to Imatinib in High Risk (Sokal) Chronic Myeloid Leukemia (CML): Results of An European Leukemianet Prospective Study Comparing 400 Mg and 800 Mg Front-Line (2008) (17)
- Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party. (2018) (17)
- Halofuginone Prevents Subglottic Stenosis in a Canine Model (2006) (17)
- Higher infection rate after 7- compared with 5-day cycle of azacitidine in patients with higher-risk myelodysplastic syndrome. (2015) (17)
- Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose? (2019) (17)
- Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party (2019) (17)
- Treatment of chronic myelogenous leukemia with recombinant human interleukin-2 and interferon-alpha 2a. (1994) (17)
- Nicotinamide, a Form of Vitamin B3, Promotes Expansion of Natural Killer Cells That Display Increased In Vivo Survival and Cytotoxic Activity, (2011) (17)
- Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells. (2006) (17)
- Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma (2010) (17)
- Major salivary gland involvement in graft-versus-host disease: considerations related to pathogenesis, the role of cytokines and therapy. (1999) (17)
- Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT (2021) (17)
- Treatment with interferon alpha prior to discontinuation of imatinib in patients with chronic myeloid leukemia. (2012) (17)
- Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response (2020) (17)
- Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies (2015) (17)
- Timing of Post-Transplantation Cyclophosphamide Administration in Haploidentical Transplantation: A Comparative Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2020) (17)
- Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT (2017) (17)
- Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia (2018) (17)
- Major salivary gland dysfunction in patients with hematological malignancies receiving interleukin-2-based immunotherapy post-autologous blood stem cell transplantation (ABSCT) (1997) (16)
- CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy Study (2021) (16)
- Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMT (2021) (16)
- Role of interleukin-2 in human hematological malignancies (1995) (16)
- BL‐8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open‐label safety and efficacy phase 2a study (2020) (16)
- Safety and Efficacy of CD19-CAR T Cells in Richter's Transformation after Targeted Therapy for Chronic Lymphocytic Leukemia (2020) (16)
- Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial (2016) (16)
- LBA28CARFILZOMIB (K) VS LOW-DOSE CORTICOSTEROIDS AND OPTIONAL CYCLOPHOSPHAMIDE (CY) IN PATIENTS (PTS) WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 3 STUDY (FOCUS) (2014) (16)
- Heparanase Promotes Engraftment and Prevents Graft versus Host Disease in Stem Cell Transplantation (2010) (16)
- Incidence of HLA Loss in a Global Multicentric Cohort of Post-Transplantation Relapses: Results from the Hlaloss Collaborative Study (2018) (16)
- SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F (2013) (16)
- AMPLIFICATION OF IMMUNOLOGICAL FUNCTIONS BY SUBCUTANEOUS INJECTION OF INTERMEDIATE-HIGH DOSE INTERLEUKIN-2 FOR 2 YEARS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN CHILDREN WITH STAGE IV NEUROBLASTOMA (2000) (16)
- Effect of the combination of pegylated liposomal doxorubicin and bortezomib on time to progression (TTP) and overall survival of patients with relapsed/refractory multiple myeloma compared with bortezomib alone (2007) (16)
- Roneparstat (SST0001), an Innovative Heparanase (HPSE) Inhibitor for Multiple Myeloma (MM) Therapy: First in Man Study (2015) (16)
- Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and non-malignant diseases. (2001) (16)
- Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis. (2004) (16)
- Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT (2016) (16)
- Identification of strong intron enhancer in the heparanase gene: effect of functional rs4693608 variant on HPSE enhancer activity in hematological and solid malignancies (2018) (15)
- Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP (2014) (15)
- Successful administration of low molecular weight heparin in a patient with heparin-induced thrombocytopenia and coumarin-induced skin necrosis. (1993) (15)
- Histopathological study of the human submandibular gland in graft versus host disease. (1999) (15)
- Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysis (2018) (15)
- Involved field radiation post autologous stem cell transplantation in lymphoma patients is associated with major haematological toxicities (1998) (15)
- Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over (2019) (15)
- Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related Mortality. (2018) (15)
- Ontogeny of Human Natural Killer (NK) Cells: Fetal NK Cells Mediate Cytolytic Function and Express Cytoplasmic CD3e,~ Proteins (2003) (15)
- Novel strategies for improving hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation or intensive chemotherapy (2017) (15)
- Enhanced Survival and Neurite Network Formation of Human Umbilical Cord Blood Neuronal Progenitors in Three-Dimensional Collagen Constructs (2013) (15)
- Inappropriate antidiuretic hormone secretion (SIADH) preceding skin manifestations of disseminated varicella zoster virus infection post-BMT. (1993) (15)
- Salivary Antioxidant Capacity in Graft versus Host Disease (2006) (15)
- Nedocromil sodium ameliorates skin manifestations in a murine model of chronic graft-versus-host disease (1997) (15)
- Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma. (2021) (15)
- The expanding horizon of immunotherapy in the treatment of malignant disorders: Allogeneic hematopoietic stem cell transplantation and beyond (2014) (15)
- Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease (2019) (15)
- Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation (2018) (15)
- Thiotepa‐based versus total body irradiation‐based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantati (2016) (15)
- Campath-1G impairs human natural killer (NK) cell-mediated cytotoxicity. (1996) (15)
- Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation. (2015) (14)
- Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model (2003) (14)
- Soluble interferon-γ receptor and interferon-γ in patients undergoing allogeneic bone marrow transplantation for hematological malignancies (1997) (14)
- Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year‐old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT) (2015) (14)
- Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC (2018) (14)
- A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation* (2019) (14)
- Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians (2017) (14)
- Successful human umbilical cord blood stem cell transplantation without conditioning in severe combined immune deficiency (1999) (14)
- Radioimmunotherapy and stem-cell transplantation in the treatment of aggressive B-cell lymphoma (2007) (14)
- Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells. (1998) (14)
- BKT140 Is a Novel CXCR4 Antagonist with Stem Cell Mobilization and Antimyeloma Effects: An Open-Label First Human Trial In Patients with Multiple Myeloma Undergoing Stem Cell Mobilization for Autologous Transplantation (2010) (14)
- Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry. (2021) (14)
- Generalized granuloma annulare post autologous bone marrow transplantation in a Hodgkin's disease patient. (1994) (14)
- Chromosome 13q deletion and IgH abnormalities may be both masked by near-tetraploidy in a high proportion of multiple myeloma patients: a combined morphology and I-FISH analysis. (2007) (14)
- Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes. (2016) (14)
- ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT (2017) (14)
- Randomized Placebo-Controlled Phase III Study Of Perifosine Combined With Bortezomib and Dexamethasone In Relapsed, Refractory Multiple Myeloma Patients Previously Treated With Bortezomib (2013) (14)
- Shaping of CD56bri Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal Photopheresis (2019) (14)
- Assessment of the coagulation profile in hemato-oncological patients receiving ATG-based conditioning treatment for allogeneic stem cell transplantation (2004) (14)
- Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response (2020) (14)
- Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission (2020) (14)
- CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview (2020) (14)
- Safety, Resistance, and Efficacy Results from a Phase IIIb Study of Conventional- and Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised Patients (2019) (14)
- A novel method for detecting the cellular stemness state in normal and leukemic human hematopoietic cells can predict disease outcome and drug sensitivity (2019) (13)
- Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2017) (13)
- Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT (2017) (13)
- Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects (2018) (13)
- Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia (2018) (13)
- Activated long-term peripheral blood cultures as preparation for adoptive alloreactive cell therapy in cancer patients. (1997) (13)
- Nilotinib 300 mg BID as frontline treatment of CML: prospective analysis of the Xpert BCR-ABL monitor system and significance of 3-month molecular response. (2014) (13)
- Apaf1 in Chronic Myelogenous Leukemia (CML) Progression: Reduced Apaf1 Expression is Correlated with a H179R p53 Mutation During Clinical Blast Crisis (2007) (13)
- The use of haemopoietic growth factors in the treatment of myelodysplastic syndromes. (1990) (13)
- Current Status and Perspectives of Irradiation-Based Conditioning Regimens for Patients with Acute Leukemia Undergoing Hematopoietic Stem Cell Transplantation (2019) (13)
- Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies. (1996) (13)
- Parotid gland dysfunction in a murine model of acute graft versus host disease [aGVHD] (1998) (13)
- Isolated Extra-Medullary Relapse of Acute Leukemia after Allogeneic Stem-Cell Transplantation; Different Kinetics and Better Prognosis Than Systemic Relapse. (2008) (13)
- Sanctuary of hepatitis B virus in bone-marrow cells of patients undergoing liver transplantation. (1996) (13)
- Isradipine for the prevention of cyclosporine-induced hypertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study. (1997) (13)
- Effect of cytosine arabinoside on differentiation of normal human bone marrow cells. (1986) (13)
- Post-Transplant Cyclophosphamide after Matched Sibling, Unrelated and Haploidentical Donor Transplants in Patients with Acute Myeloid Leukemia, a Comparative Study of the ALWP EBMT (2019) (13)
- Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model (2015) (13)
- Phenotypic and gene expression diversity of malignant cells in human blast crisis chronic myeloid leukemia. (2008) (13)
- Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2019) (13)
- Relatively favorable outcome after allogeneic stem cell transplantation for BCR‐ABL1‐positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT) (2018) (13)
- Activated allogeneic cell therapy (allo-ACT) for relapsed chronic myelogenous leukemia (CML) refractory to buffy coat transfusions post-allogeneic bone marrow transplantation. (1996) (13)
- Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT (2017) (13)
- Minimal Residual Disease Post‐Bone Marrow Transplantation for Hemato‐Oncological Diseases (1996) (13)
- Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38- cells through iron chelation, induction of ROS, and inhibition of HIF1α expression. (2019) (13)
- Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT (2016) (12)
- Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. (2018) (12)
- Comparative outcomes of myeloablative and reduced‐intensity conditioning allogeneic hematopoietic cell transplantation for therapy‐related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation (2019) (12)
- Combined escBEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: An Effective Regimen and Low Positive Predictive Value of Early FDG-PET/CT Scan. (2007) (12)
- Recombinant interleukin-2 and recombinant interferon alpha immunotherapy cardiovascular toxicity. (1992) (12)
- BL-8040, a Peptidic CXCR4 Antagonist, Induces Leukemia Cell Death and Specific Leukemia Cell Mobilization in Relapsed/Refractory Acute Myeloid Leukemia Patients in an Ongoing Phase IIa Clinical Trial (2014) (12)
- Immunological studies of pancytopenia in visceral leishmaniasis. (1988) (12)
- Plerixafor (Mozobil): A Stem Cell-Mobilizing Agent for Transplantation in Lymphoma Patients Predicted to Be Poor Mobilizers - A Pilot Study (2015) (12)
- Involvement of CXCR 4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD / SCID mice (2003) (12)
- Current status and future perspectives for yttrium-90 ((90)Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphoma. (2007) (12)
- Erratum: Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium (Stem Cells (2006) 24, (772-780) DOI: 10.1634/stemcells.2005-0212) (2006) (12)
- Neutropenic enterocolitis associated with autologous bone marrow transplantation. (1992) (12)
- Potent antileukemic activity of the novel agents norsegoline and dibezine. (1995) (12)
- Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation. (2017) (12)
- Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT (2009) (12)
- Local cutaneous reaction induced by subcutaneous interleukin-2 and interferon alpha-2a immunotherapy following ABMT. (1993) (12)
- Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation. (1996) (12)
- Improvement of Oxidative Stress Parameters in MDS Patients with Iron Overload Treated with Deferasirox (2008) (12)
- Primary plasma cell leukemia in the era of novel agents for myeloma - a multicenter retrospective analysis of outcome. (2018) (12)
- Clinical Implications of Minimal Residual Disease Monitoring for Stem Cell Transplantation after Reduced Intensity and Nonmyeloablative Conditioning (2004) (12)
- The aberrant asynchronous replication — characterizing lymphocytes of cancer patients — is erased following stem cell transplantation (2010) (12)
- In vivo CAMPATH‐1 monoclonal antibodies: A novel mode of therapy for acute graft‐versus‐host disease (1996) (12)
- Characteristics and risk factors of infections following CD28-based CD19 CAR-T cells (2021) (12)
- The evolving role of allogeneic haematopoietic cell transplantation in the era of chimaeric antigen receptor T‐cell therapy (2021) (11)
- Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission (2018) (11)
- Laboratory tools for diagnosis and monitoring response in patients with chronic myeloid leukemia. (2012) (11)
- Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT (2019) (11)
- Prevention of Chronic GvHD after HLA-Identical Sibling Peripheral Hematopietic Stem Cell Transplantation with or without Anti-Lymphocyte Globulin (ATG). Results from a Prospective, Multicenter Randomized Phase III Trial (ATGfamilystudy) (2014) (11)
- Second allogeneic haematopoietic cell transplantation using HLA‐matched unrelated versus T‐cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia (2021) (11)
- The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation (2019) (11)
- Hydronephrosis in children after bone marrow transplantation: case reports. (1996) (11)
- CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34 stem/progenitor cells to the bone marrow Short title: CD44 AND HYALURONIC ACID IN HUMAN HPC TRAFFICKING (2004) (11)
- Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT (2021) (11)
- The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft‐versus host disease after stem‐cell transplantation from unrelated donors (2017) (11)
- Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning (2014) (11)
- Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment. (2001) (11)
- Thiotepa‐based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia—A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2017) (11)
- Neutropenic enterocolitis and intestinal perforation associated with carboplatin-containing conditioning regimen for autologous bone marrow transplantation. (1992) (11)
- Fludarabine-based protocol for haploidentical peripheral blood stem cell transplantation in Hurler syndrome. (2000) (11)
- Hydatid cyst of the liver rupturing into the biliary tract--mimicking acute cholecystitis on hepatobiliary scanning. (1985) (11)
- Role of NK1.1+ and AsGm-1+ Cells in Oral Immunoregulation of Experimental Colitis (2003) (11)
- Interferon-γ-induced neuronal differentiation of human umbilical cord blood-derived progenitors (2009) (11)
- Remission of acute myeloid leukemia with t(8;21) following CD19 CAR T-cells (2020) (11)
- Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK‐NUP214 shows a favourable outcome when performed in first complete remission (2020) (11)
- Long-Term Efficacy and Safety from the Copanlisib CHRONOS-1 Study in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma (2018) (11)
- Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients. (1995) (11)
- AlloHSCT for inv(3)(q21;q26)/t(3;3)(q21;q26) AML: a report from the acute leukemia working party of the European society for blood and marrow transplantation (2018) (11)
- What is the outcome in patients with acute leukaemia who survive severe acute graft‐versus‐host disease? (2018) (11)
- The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (2008) (11)
- Donor Lymphocyte Infusions and Second Transplantation as Salvage Treatment for Relapsed Myelofibrosis After Reduced-Intensity allografting. (2010) (11)
- Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT. (2016) (11)
- Indolent aspergillus arthritis complicating fludarabine-based non-myeloablative stem cell transplantation (2001) (11)
- Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMT. (2019) (10)
- Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. (2018) (10)
- The plant lectin FRIL supports prolonged in vitro maintenance of quiescent human cord blood CD34(+)CD38(-/low)/SCID repopulating stem cells. (2000) (10)
- Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status (2016) (10)
- Collection of Large-scale Expanded Lymphocyte Cultures for Adoptive Immunotherapy Using a COBE Spectra Apheresis Machine (2008) (10)
- Functional CXCR 4-Expressing Microparticles and SDF-1 Correlate with Circulating Acute Myelogenous Leukemia Cells (2006) (10)
- Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium (2008) (10)
- Solitary pulmonary cholesteroloma, multiple xanthelasmas and lipemia retinalis complicating hypercholesterolemia after bone marrow transplantation. (1996) (10)
- Safety and Efficacy of the Combination of Ibrutinib and Nivolumab in Patients with Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia (2017) (10)
- FLAMSA-based reduced intensity conditioning versus myeloablative conditioning in younger patients with relapsed/refractory acute myeloid leukemia with active disease at the time of allogeneic stem cell transplantation: an ALWP/EBMT analysis. (2020) (10)
- Efficacy, safety and long term results of prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia: a registry-based evaluation on 343 patients by the acute leukemia working party of EBMT. (2015) (10)
- Human umbilical cord blood–derived CD133+ cells enhance function and repair of the infarcted myocardium (2006) (10)
- Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphoma (2020) (10)
- Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT (2018) (10)
- Haploidentical stem cell transplantation (HaploSCT) for patients with acute leukemia—an update on behalf of the ALWP of the EBMT (2019) (10)
- Effect of Halofuginone, a Collagen α1(I) Inhibitor, on Wound Healing in Normal and Irradiated Skin: Implication for Hematopoietic Stem Cell Transplantation (2007) (10)
- Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection (2020) (10)
- Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI. (2019) (10)
- Impact of detectable measurable residual disease on umbilical cord blood transplantation (2020) (10)
- Effect of various cytokine combinations on induction of non-MHC-restricted cytotoxicity. (1993) (10)
- Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B cell lymphoma. (2022) (10)
- Night blindness and liver cirrhosis as late complications of jejunoileal bypass surgery for morbid obesity. (1984) (10)
- Combination of Rituximab with Initial Chemotherapy Improves Outcome of Primary Mediastinal B-Cell Lymphoma: A Retrospective Analysis of a Single Institution Cohort (2007) (10)
- Use of busulfan in conditioning for allogeneic hematopoietic stem cell transplantation in adults: a survey by the Transplant Complications Working Party of the EBMT (2019) (10)
- Successful allogeneic bone marrow transplantation in a patient with ATRA‐induced pseudotumor cerebri (1995) (10)
- Marrow transplantation in multiple myeloma. (1992) (10)
- Effect of bone marrow T lymphocytes treated with CAMPATH 1G on megakaryocyte colony formation. (1993) (10)
- In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available? (2015) (10)
- Cytomegalovirus pneumonia prior to engraftment following T-cell depleted bone marrow transplantation (1994) (10)
- Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party (2020) (10)
- Human pleuropulmonary gnathostomiasis: a case report from Israel. (1983) (10)
- Stable Changes in Mesenchymal Stromal Cells from Multiple Myeloma Patients Revealed through Their Responses to Toll-Like Receptor Ligands and Epidermal Growth Factor (2012) (9)
- Older patients with normal karyotype acute myeloid leukemia have a higher rate of genomic changes compared to young patients as determined by SNP array analysis. (2012) (9)
- Comparable Long-Term Outcome after Allogeneic Stem-Cell Transplantation from Sibling and Matched Unrelated Donors in AML Patients Older than 50 years. A Report on Behalf of the ALWP of EBMT. (2019) (9)
- Erratum: Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells (British Journal of Haematology 116:3 (655-661)) (2002) (9)
- Identification of miRSNPs associated with the risk of multiple myeloma (2017) (9)
- Effects of ionizing irradiation and beta-adrenergic stimulation on gene expression pattern in rat submandibular glands. (1996) (9)
- Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study (2021) (9)
- Use of Bone Marrow or Peripheral Blood Stem Cell Grafts in Non T Cell Depleted Haploidentical Transplants Using Post-Transplant Cyclophosphamide, an ALWP-EBMT Analysis (2016) (9)
- Graft‐versus‐host disease and graft‐versus‐leukaemia effects in secondary acute myeloid leukaemia: a retrospective, multicentre registry analysis from the Acute Leukaemia Working Party of the EBMT (2019) (9)
- In-vitro growth and differentiation of marrow cells from myelodysplastic patients in the presence of a retinoidal benzoic acid derivative. (1987) (9)
- Sequential administration of the high affinity CXCR4 antagonist BKT140 promotes megakaryopoiesis and platelet production (2013) (9)
- Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation—a retrospective study by the Acute Leukemia Working Party of EBMT (2020) (9)
- Efficacy and safety of ixazomib plus lenalidomide-dexamethasone (IRd) vs placebo-rd in patients (pts) with relapsed/refractory multiple myeloma (RRMM) by cytogenetic risk status in the global phase III Tourmaline-MM1 study. (2016) (9)
- Adults requiring cord blood transplants but have insufficient cell doses from a single cord blood unit can receive two units with successful engraftment kinetics similar to those of children receiving a single unit (2011) (9)
- Repeated Courses of Orally Administered Fecal Microbiota Transplantation for the Treatment of Steroid Resistant and Steroid Dependent Intestinal Acute Graft Vs. Host Disease: A Pilot Study (NCT 03214289) (2018) (9)
- Prevention and treatment of relapse by bone marrow transplantation. (1993) (9)
- Associations between B-cell non-Hodgkin lymphoma and exposure, persistence and immune response to hepatitis B (2016) (9)
- Total lymphoid irradiation, anti-lymphocyte globulin and Campath 1-G for immunosuppression prior to bone marrow transplantation for aplastic anemia after repeated graft rejection. (1994) (9)
- Non-myeloablative allogeneic stem cell transplantation for the treatment of patients with chronic myeloid leukemia (2000) (9)
- Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT (2021) (9)
- Establishment and characterization of new cellular lymphoma model expressing transgenic human MDR1. (2005) (9)
- Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party (2020) (9)
- The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors. (1996) (9)
- Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (2019) (9)
- Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation (2014) (9)
- PPARG is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target (2017) (9)
- Bone marrow cell modulation and inhibition of myelopoiesis by large granular lymphocytes and natural killer cells. (1990) (9)
- The mTOR Inhibitor Everolimus Overcomes CXCR4-Mediated Resistance to Histone Deacetylase Inhibitor Panobinostat through Inhibition of p21 and Mitotic Regulators. (2019) (9)
- Partial response of meningeal myeloma to craniospinal radiotherapy (1986) (9)
- Recombinant lnterleukin-2 and Interf eron Alpha Immunotherapγ following Autologous Bone Marrow Transplantation (1992) (9)
- Erratum: Activity and Tolerability of Nilotinib: A Retrospective Multicenter Analysis of Chronic Myeloid Leukemia Patients Who Are Imatinib Resistant or Intolerant (2011) (9)
- G-CSF-primed BM for allogeneic SCT: revisited (2015) (9)
- In vivo CAMPATH-1 followed by T cell-depleted bone marrow transplantation: a potential new mode of therapy for hepatitis-associated severe aplastic anemia (SAA). (1996) (8)
- Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study. (2018) (8)
- Soluble interleukin-2 receptor levels in cytomegalovirus disease and graft versus host disease after T-lymphocyte depleted bone marrow transplantation for hematological neoplasias. (1994) (8)
- Efficacy of Gemcitabine as Salvage Therapy for Relapsed and Refractory Aggressive Non-Hodgkin Lymphoma (2019) (8)
- Copanlisib, a PI3K Inhibitor, Demonstrates a Favorable Long-Term Safety Profile in a Pooled Analysis of Patients with Hematologic Malignancies (2019) (8)
- Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT (2022) (8)
- Prevention and treatment of relapse after stem cell transplantation with immunotherapy (2018) (8)
- Graft-Versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation (2021) (8)
- CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma: a Safety and Efficacy Study (2020) (8)
- Control of relapse due to minimal residual disease (MRD) by cell-mediated cytokine-activated immunotherapy in conjunction with bone marrow transplantation. (1991) (8)
- Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study (2019) (8)
- Recent compounds for immunosuppression and experimental therapies for acute graft-versus-host disease. (2013) (8)
- The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT (2021) (8)
- Membrane Type 1-Matrix Metalloproteinase Is Directly Involved in G-CSF Induced Human Hematopoietic Stem and Progenitor Cell Mobilization. (2004) (8)
- Bronchiolitis obliterans presenting as subcutaneous emphysema and pneumomediastinum: A case report (1996) (8)
- A Multi-Center Prospective Randomized Study Comparing Ibritumomab Tiuxetan (Zevalin) and High-Dose BEAM Chemotherapy (Z-BEAM) Vs. BEAM Alone as the Conditioning Regimen Prior to Autologous Stem-Cell Transplantation In Patients with Aggressive Lymphoma; Possible Advantage for Z-BEAM In Low-Risk Patie (2010) (8)
- Continuous treatment (CT) versus fixed duration of therapy (FDT) in newly diagnosed myeloma patients: PFS1, PFS2, OS endpoints. (2014) (8)
- Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia. (2021) (8)
- LDH and renal function are prognostic factors for long-term outcomes of multiple myeloma patients undergoing allogeneic hematopoietic stem cell transplantation (2020) (8)
- Abstract CT149: Copanlisib in patients with relapsed or refractory indolent B-cell lymphoma: Primary results of the pivotal Chronos-1 study (2017) (8)
- Anti-PD-1-Targeted Therapies Focusing on Lymphatic Malignancies: Biological Rationale, Clinical Challenges and Opportunities (2014) (8)
- Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice. (2002) (8)
- Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response (2018) (8)
- Sweet's syndrome: a presenting sign of acute myelogenous leukemia. (1985) (8)
- Association Between the Hematopoietic Cell Transplantation-Specific Comorbidity Index (CI) and Non-Relapse Mortality (NRM) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1). (2009) (8)
- Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. (2020) (8)
- Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease. (1997) (8)
- T‐cell–depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT) (2018) (8)
- The Prolonged Time to Progression with Pegylated Liposomal Doxorubicin + Bortezomib Versus Bortezomib Alone in Relapsed or Refractory Multiple Myeloma Is Unaffected by Extent of Prior Therapy or Previous Anthracycline Exposure. (2007) (8)
- Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-α2a and interleukin-2 (1992) (8)
- A simplified method for detection of N-terminal valine adducts in patients receiving treosulfan. (2019) (8)
- Upregulation of Senescent/Exhausted Phenotype of CAR T Cells and Induction of Both Treg and Myeloid Suppressive Cells Correlate with Reduced Response to CAR T Cell Therapy in Relapsed/Refractory B Cell Malignancies (2019) (8)
- Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect. (2005) (8)
- Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion. (2017) (8)
- Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia (2016) (8)
- Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. (2015) (8)
- Impact of total body irradiation‐ vs chemotherapy‐based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia (2020) (8)
- High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood (2001) (7)
- The presence of a single PML-RARA isoform lacking exon 5 in FISH-negative APL samples (2008) (7)
- Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia (2021) (7)
- Novel Agents May be Preferable to Chemotherapy for Large B-Cell Lymphoma Progressing after CD19-CAR-T: A Multicenter Observational Study (2021) (7)
- Cytokine-mediated immunotherapy following autologous bone marrow transplantation in lymphoma and evidence of interleukin-2-induced immunomodulation in allogeneic transplants. (1997) (7)
- Effects of granulocyte colony-stimulating factor therapy on in vitro hemopoiesis in myelodysplastic syndromes. (1995) (7)
- Sialochemical profile of X-irradiated major salivary glands in the rat. (1997) (7)
- Redox Metal Chelation Ameliorates Radiation-Induced Bone Marrow Toxicity in a Mouse Model (2001) (7)
- Stem cell factor (SCF) synergizes with megakaryocyte colony stimulating activity in post-irradiated aplastic plasma in stimulating human megakaryocytopoiesis (1996) (7)
- Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation (2018) (7)
- COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT B‐CELL LYMPHOMA (CHRONOS‐1) (2017) (7)
- Interleukin-3 in combination with granulocyte-macrophage-colony-stimulating factor following bone marrow transplantation in a radiation accident victim (1994) (7)
- Monoclonal antibody-based immunotherapy for multiple myeloma. (2012) (7)
- Allogeneic Transplantation in Patients with HIV-Infection:A Pair Matched Cohort Study by the European Society forBlood and Marrow Transplantation (2015) (7)
- A comparison of the safety and efficacy of ondansetron versus granisetron as prophylaxis against chemo/ radiotherapy-induced nausea and vomiting in bone marrow transplantation patients. A double-blinded, randomized, prospective, pilot study (1997) (7)
- The timing of post-transplant cyclophosphamide administration in haploidentical transplantation: a comparative study on behalf of the ALWP of the EBMT. (2020) (7)
- Acute respiratory failure in hyperleukocytotic acute myeloid leukemia: The role of perfusion lung scintigraphy (1988) (7)
- Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute Leukemia (2021) (7)
- Transient elevation of serum lactic dehydrogenase following autologous bone marrow transplantation. (1991) (7)
- STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in vivo multiple myeloma models (2018) (7)
- Short-term systemic effects of head and neck irradiation. (2000) (7)
- EFFICACY AND SAFETY IN HIGH‐RISK RELAPSED OR REFRACTORY INDOLENT FOLLICULAR LYMPHOMA PATIENTS TREATED WITH COPANLISIB (2019) (7)
- Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis (2018) (7)
- Natural killer (NK) and T cell-associated surface marker expression following allogeneic and autologous bone marrow transplantation (BMT). (2000) (7)
- Unrelated and related cord blood banking and hematopoietic graft engineering (2004) (7)
- Minitransplants and cell-based therapies for malignant and nonmalignant disorders (1999) (7)
- Eosinophils activation in post-autologous bone marrow transplanted patients treated with subcutaneous interleukin-2 and interferon-alpha 2A immunotherapy. (1994) (7)
- Autologous Hematopoietic Cell Transplantation in Elderly Patients Aged 65 and Older: A Retrospective Analysis By the Complications and Quality of Life Working Party of the EBMT (2016) (7)
- CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies (2022) (7)
- High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan (2015) (7)
- Enhancement of megakaryocytopoiesis by Campath-1G-treated natural killer cells (1997) (7)
- Plasmapheresis for Thrombotic Thrombocytopenic Purpura following Bone Marrow Transplantation (2001) (7)
- Noncardiogenic pulmonary congestion following bone marrow transplantation. (1997) (7)
- Recombinant Human Interleukin-6 Accelerates In-Virto Megakaryocytopoiesis and Platelet Recovery Post Autologous Peripheral Blood Stem Cell Transplantion (1995) (7)
- Israeli-born offspring of Jewish immigrants of Middle Eastern origin have a lower incidence of multiple myeloma than those of European origin: a cohort study of 746 200 Israeli men followed from late adolescence (2014) (7)
- Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (2018) (7)
- Epstein-Barr virus-associated post-transplant lymphoproliferative disorder. (2006) (7)
- Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT (2019) (7)
- Immune basis for cimetidine-induced pancytopenia. (1987) (7)
- Influence of preparative regimen and methotrexate for GVHD prophylaxis on engraftment after related cord blood transplant for patients with hemoglobinopathies. An eurocord group analysis (2000) (7)
- Rare complications after transabdominal fine needle aspiration. (1984) (7)
- Chemiluminescence response of polymorphonuclear leucocytes to serum-opsonized zymosan--a predictive parameter for infections and prognosis in multiple myeloma patients. (1988) (7)
- High-Throughput Imaging of CRISPR- and Recombinant Adeno-Associated Virus–Induced DNA Damage Response in Human Hematopoietic Stem and Progenitor Cells (2022) (7)
- The Hierarchy of Alternative Donors for Allogeneic Hematopoietic Stem Cell Transplantation in Poor Risk AML in CR1: 10/10 Matched Unrelated Donors Still to be Preferred over Haplo-Identical Donors or Umbilical Cord Blood (2014) (6)
- Reduced-intensity conditioning allogeneic stem cell transplantation: hype, reality or time for a rethink? (2006) (6)
- Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the (2021) (6)
- A Prospective Study of Imatinib 400 mg vs 800 mg Frontline in High Risk Ph+ Chronic Myeloid Leukemia (CML) Patients. (2007) (6)
- An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia (2022) (6)
- Nicotinamide Modulates Ex-Vivo Expansion of Cord Blood Derived CD34+ Cells Cultured with Cytokines and Promotes Their Homing and Engraftment in SCID Mice. (2006) (6)
- Ibritumomab Tiuxetan (Zevalin) in the Conditioning Regimen for Autologous and Reduced-Intensity Allogeneic Stem-Cell Transplantation in Patients with Chemo-Refractory Non-Hodgkin’s Lymphoma. (2005) (6)
- Human umbilical cord blood myeloid progenitor cells are relatively chemoresistant: A potential model for autologous transplantations in HIV‐infected newborns (1997) (6)
- Immunoglobulin synthesis in myelodysplastic syndromes: normal B-cell and immunoregulatory T-cell functions. (1987) (6)
- The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT) (2020) (6)
- Erratum: Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice (Bone Marrow Transplantatio (2014) 49 (319) DOI:10.1038/bmt.2013.210) (2014) (6)
- The implications of granulocyte-monocyte colony-stimulating factor (GM-CSF) in cytotoxicity of bone marrow transplantation. (1998) (6)
- atreatment of high-risk , Philadelphia-positive chronic myeloid leukemia : Comparison of imatinib 400 mg and 800 mg daily in (2009) (6)
- Novel Immunosuppression Compounds and Experimental Therapies for Chronic Graft-Versus-Host Disease (2013) (6)
- Toward resolving the unsettled role of iron chelation therapy in myelodysplastic syndromes (2014) (6)
- Randomized, placebo‐controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomib (2020) (6)
- The 45th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians – Poster Session (2019) (6)
- Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation. (1996) (6)
- TCR-Independent Killing of B Cell Malignancies by Anti–Third-Party CTLs: The Critical Role of MHC–CD8 Engagement (2011) (6)
- Ex Vivo Generated Donor Central Memory CD8 T Cells, Previously Shown to Enhance Engraftment of Allogeneic Bone Marrow, Also Exhibit Significant GVL Activity without Causing Gvhd In An In Vivo b Cell Lymphoma Model (2010) (6)
- Apoptotic cells in allogeneic hematopoietic stem cell transplantations: “turning trash into gold” (2012) (6)
- Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation (2020) (6)
- The gastrointestinal tract: properties and role in allogeneic hematopoietic stem cell transplantation (2017) (6)
- P105 Decrease in intra- and extra-cellular free iron species and oxidative stress parameters and increase in serum and urinary hepcidin during treatment with deferasirox in iron-loaded patients with MDS (2009) (6)
- Conditioning Regimens Prior to Allogeneic Stem-Cell Transplantation (SCT) In Acute Leukemia: The Role Of Dose Intensity (2009) (6)
- Allogeneic Genetically Modified T Cells (HSV-TK) As Adjunctive Treatment in Haploidentical Hematopoietic Stem-Cell Transplantation (haplo-HSCT) of Adult Patients with High-Risk Hematological Malignancies: A Pair-Matched Analysis from the Acute Leukemia Working Party of EBMT (2016) (6)
- Synergistic effects of interleukin-11 with other growth factors on the expansion of hematopoietic progenitors from normal individuals and chronic myeloid leukemia patients resistant to treatment with cytosine arabinoside or eilatin. (1996) (6)
- Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment (2021) (6)
- Normal hematopoietic reconstitution following ASTA-Z 7557-purged grafts in the absence of in vitro CFU-GM colony growth. (1993) (6)
- Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT) (2020) (6)
- Higher Doses of Antithymocyte Globulin (ATG) Increase the Risk of Relapse in Acute Myeloid Leukemia (AML) Patients Undergoing Matched Related Donor Allogeneic Transplantation in First Complete Remission (CR1): An Analysis from the Acute Leukemia Working Party of EBMT (2014) (6)
- Differential effects of CD4+ and CD8+ cells on lymphocyte development from human cord blood cells in murine fetal thymus explants. (1999) (6)
- Role of oral examination in newly diagnosed multiple myeloma patients: A safe and simple way to detect light chain amyloidosis. (2018) (6)
- Allogeneic hematopoietic stem cell transplantation with fludarabine, busulfan, and thiotepa conditioning is associated with favorable outcomes in myelofibrosis (2019) (6)
- How we can mitigate the side effects associated with systemic glucocorticoid after allogeneic hematopoietic cell transplantation (2021) (6)
- The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation (1994) (6)
- Incidence of Acute Graft-Versus-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation over Time: A Study from the Transplant Complications and Chronic Malignancies Working Party of the EBMT (2018) (6)
- Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission (2020) (5)
- Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria) (2020) (5)
- BCR-ABL transcripts are not detected in cord blood or the peripheral blood of the newborn child whose mother developed chronic myeloid leukemia while pregnant. (2010) (5)
- Outcome of T‐cell–replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2021) (5)
- The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA‐matched allogeneic stem cell transplantation (2019) (5)
- Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies. (1997) (5)
- Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT (2020) (5)
- Post-Transplant Cyclophosphamide (PT-Cy) for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Transplantation from HLA Identical Sibling and Matched Unrelated Donor for Patients with Acute Leukemia, on Behalf of ALWP-EBMT (2017) (5)
- Allogeneic stem cell transplantation and targeted immunotherapy for multiple myeloma. (2013) (5)
- Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia (2022) (5)
- Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia (2020) (5)
- Second line azacitidine for elderly or infirmed patients with acute myeloid leukemia (AML) not eligible for allogeneic hematopoietic cell transplantation—a retrospective national multicenter study (2017) (5)
- Cytomegalovirus retinitis in children following bone marrow transplantation. (1993) (5)
- Reduction in basic fibroblast growth factor mediated angiogenesis in vivo by linomide. (1998) (5)
- The modulation of plasma lipids and lipoproteins during bone marrow transplantation is unrelated to exogenously administered recombinant human granulocyte-mnonocyte colony-stimulating factor (rHu GM-CSF) (1996) (5)
- Long Term Follow-up of the Prospective Multicenter Study of reduced-Intensity Allogeneic Stem Cell Transplantation for Primary or Post ET/PV Myelofibrosis (2011) (5)
- Evaluation of the Risk of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors (2016) (5)
- The Use of Soybean Agglutinin (SBA) for Bone Marrow (BM) Purging and Hematopoietic Progenitor Cell Enrichment in Clinical Bone Marrow Transplantation. (1999) (5)
- Interpretable Boosted Decision Trees for Prediction of Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation (2016) (5)
- Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: a report from the EBMT acute leukemia working party. (2020) (5)
- Reduced-intensity conditioning for allogeneic stem cell transplantation: 10 years later (2009) (5)
- Fertility preservation from the point of view of hematopoietic cell transplant specialists—a worldwide-web-based survey analysis (2019) (5)
- Detection of BCR‐ABL1 mutations in chronic myeloid leukaemia by massive parallel sequencing (2013) (5)
- Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia (2019) (5)
- The CXCR4 Antagonist BL-8040 Efficiently Induces Apoptosis and Inhibits The Survival Of AML Cells (2013) (5)
- Sequential respiratory syncytial virus cytomegalovirus pneumonia following bone marrow transplantation (1995) (5)
- Long-Term Safety of Transplanting Human Bone Marrow Stromal Cells into the Extravascular Spaces of the Choroid of Rabbits (2017) (5)
- Comparison of Outcomes After Unrelated Cord Blood Transplantation and Matched Unrelated Donor RIC Transplantation for Lymphoid Malignancies - A Eurocord-Netcord Group/ Lymphoma Working Party and Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Study. (2009) (5)
- Early Normalization of Serum Free Light Chain Is Associated with Prolonged Time to Progression Following Bortezomib ± Pegylated Liposomal Doxorubicin Treatment of Relapsed/Refractory Multiple Myeloma. (2007) (5)
- Ibritumomab Tiuxetan (Zevalin) Followed by High-Dose Chemotherapy and Autologous Stem-Cell Transplantation Results in Improved Survival of Patients with Chemo-Refractory Non-Hodgkin’s Lymphoma Expected To Have Poor Outcome with Standard Pre-Transplant Conditioning. (2006) (5)
- Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT) (2022) (5)
- Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced‐intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT (2021) (5)
- Effect of 1,25-dihydroxyvitamin D3 and 13-cis-retinoic acid on in vitro hematopoiesis in the myelodysplastic syndromes. (1987) (5)
- Transplantation of Cord Blood Expanded Ex Vivo with Copper Chelator. (2004) (5)
- Production of human pluripotent progenitor cell colony stimulating activity (CFU-GEMMCSA) in patients with myelodysplastic syndromes. (1987) (5)
- Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients. (2015) (5)
- The high-affinity CXCR 4 antagonist BKT 140 is safe and induces a robust mobilization of human CD 34 + cells in patients with multiple myeloma (2013) (5)
- In vitro hemopoiesis of marrow cells from myelodysplastic patients: effects of mitogen-stimulated spleen cell-conditioned medium and vitamin A and D derivatives. (1986) (5)
- Successful Major Surgical Recovery of a Patient following Haploidentical Stem Cell Transplantation for Chronic Myeloid Leukemia in Blast Crisis and Aspergillosis (2002) (5)
- The Selective Anti Leukemic Effect of BL-8040, a Peptidic CXCR4 Antagonist, Is Mediated By Induction of Leukemic Blast Mobilization, Differentiation and Apoptosis: Results of Correlative Studies from a Ph2a Trial in Acute Myeloid Leukemia (2016) (5)
- Human Placental Derived Mesenchymal Stromal Cells (MSC) Grown in 3D-Culture (PLX-I), Promotes Engraftment of Human Umbilical Cord Blood (hUCB) Derived CD34+ Cells in NOD/SCID Mice. (2007) (5)
- How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic? (2021) (5)
- Combination of Imatinib with CXCR 4 antagonist BKT 140 overcomes the protective effect of stroma and targets CML in vitro and in vivo (2013) (5)
- Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party. (2020) (5)
- Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy. (1985) (5)
- Multiple Myeloma Presenting in Patients Younger than 50 Years of Age: A Single Institution Experience (2020) (5)
- Subdural hemorrhage in a 32-year-old man with chronic idiopathic thrombocytopenic purpura. (1986) (5)
- The role of thiotepa in autologous bone marrow transplantation for acute leukemia. (1998) (4)
- Human colon adenocarcinoma in the SCID/CB6 radiation chimera is susceptible to adoptive transfer of allogeneic human peripheral blood mononuclear cells. (2002) (4)
- Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia (2020) (4)
- Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk disease (2022) (4)
- Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell Malignancies (2022) (4)
- Progression of Follicular Lymphoma within 24 Months of First Treatment (POD -24) As a Predictor of Overall Survival - a Single Center Retrospective Analysis (2019) (4)
- Disturbances of T lymphocyte subsets preceding refractory anemia with excess blasts in transformation in a child. (1988) (4)
- Nilotinib Treatment Post - Allogeneic Stem Cell Transplantation (alloSCT) in Advanced (>CP1) Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL). (2009) (4)
- Gender disparities in the functional significance of anemia among apparently healthy adults (2017) (4)
- Copanlisib in patients with relapsed or refractory follicular lymphoma. (2017) (4)
- Recurrent spontaneous bacterial peritonitis in a patient with polycythemia vera (1988) (4)
- Allogeneic stem cell transplantation as salvage therapy in patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem cell transplantation. An analysis of the EBMT Registry (2009) (4)
- Treatment of Severe Acute Graft-Versus-Host Disease with Mesenchymal Stromal Cells. (2009) (4)
- Prediction of allogeneic hematopoietic stem cell transplantation (allo-HSCT) related mortality in acute leukemia: generation of a machine learning-based model using the data set of the acute leukemia working party (ALWP) of the EBMT (2013) (4)
- Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT (2021) (4)
- Metabolic syndrome is common following haematopoietic cell transplantation (HCT) and is associated with increased cardiovascular disease: an EBMT cross-sectional non-interventional study (2015) (4)
- Teething and acute graft vs. host disease: a clinical observation. (1996) (4)
- Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning (4)
- Longitudinal outcome over two decades of unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: an ALWP/EBMT analysis. (2022) (4)
- ELN 2017 classification significantly impacts the risk of early death in acute myeloid leukemia patients receiving intensive induction chemotherapy (2022) (4)
- Peroxisome proliferator‐activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target (2017) (4)
- Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. (2021) (4)
- Nicotinamide, a Recognized Inhibitor of SIRT1, Promotes Expansion in Ex Vivo Cultures of Short and Long-Term Repopulating Cells. (2009) (4)
- Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT (2022) (4)
- Cytokine gene transduction into non-immunogeneic murine tumor cells. (1998) (4)
- LMO2 Protein Expression Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma in the Pre- and Post-Rituximab Treatment Eras. (2007) (4)
- Dissecting the mechanisms involved in anti-human T-lymphocyte immunoglobulin (ATG)-induced tolerance in the setting of allogeneic stem cell transplantation - potential implications for graft versus host disease (2017) (4)
- Total leucoderma: a rare manifestation of cutaneous chronic graft‐versus‐host disease (1996) (4)
- Adoptive cell-mediated immunotherapy with interleukin-2 (IL-2) for relapsing lymphoblastic crisis following mismatched unrelated bone marrow transplantation in a chronic myelogenous leukemia patient (1998) (4)
- ASBMT Statement on Routine Prophylaxis for Central Nervous System Recurrence of Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation. (2019) (4)
- Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission: Better Outcome Following Busulfan and Melphalan Compared to Busulfan and Cyclophosphamide : A Retrospective Study from the Acute Leukemia Working Party of the EBMT (2015) (4)
- Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party (2020) (4)
- Pathogenesis of Ponatinib Associated Vascular Disease in Chronic Myeloid Leukemia: An in Vitro Study (2015) (4)
- Selinexor, Bortezomib, and Dexamethasone for Heavily Pretreated Multiple Myeloma: A Case Series. (2020) (4)
- The putative role of arylsulfatase in interleukin-2- mediated cytotoxicity and interleukin-7-mediated bactericidal activity of natural killer cells (1997) (4)
- Development of Secondary Anaplastic Oligoastrocytoma after Matched Unrelated Bone Marrow Transplantation in a Child with Acute Myeloid Leukemia (2003) (4)
- Compatibility of HLA-C KIR ligands & donor recipient KIR genotypes influence outcome following single haplotype matched stem cell transplantation (2002) (4)
- Infusion of Donor Lymphocytes Genetically Engineered to Express the Herpes Simplex Virus Thymidine Kinase (HSV-TK) Suicide Gene after Haploidentical Hematopoietic Stem Cell Transplantation (HSCT): Preliminary Efficacy Data from the Randomized TK008 Study (2014) (4)
- Ibritumomab tiuxetan (Zevalin) in the conditioning regimen for autologous and reduced-intensity allogeneic stem-cell transplantation (SCT) in patients with chemo-refractory non-hodgkin’s lymphoma (2006) (4)
- The novel compound STK405759 is a microtubule-targeting agent with potent and selective cytotoxicity against multiple myeloma in vitro and in vivo (2016) (4)
- Fludarabine and Treosulfan Conditioning for Allogeneic Stem-Cell Transplantation; a Dose- Intense Regimen with Limited Toxicity. (2010) (4)
- From patient centered risk factors to comprehensive prognostic models: a suggested framework for outcome prediction in umbilical cord blood transplantation. (2017) (4)
- The effect of low dose ARA-C on in-vitro haemopoiesis of marrow cells from myelodysplastic patients. (1987) (4)
- Post-Transplant Sorafenib Improves Overall Survival in FLT3 Mutated AML: A Report from the EBMT Acute Leukemia Working Party (2018) (4)
- Combining the ras inhibitor salirasib and proteasome inhibitors: A potential treatment for multiple Myeloma (2010) (4)
- Function of peripheral blood and bone-marrow monocytes in preleukemic patients: normal phagocytosis and intracellular killing of Candida albicans. (1984) (4)
- Newly diagnosed multiple myeloma patients carrying monoallelic deletion of the whole locus of immunoglobulin heavy chain gene have a better prognosis compared to those with t(4;14) and t(14;16) (2019) (4)
- Post remission consolidation by autologous HCT for AML in CR1, negative implications for subsequent allogeneic HCT in CR2. A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). (2019) (4)
- Nilotinib Exhibits an in Vitro Antiviral Activity Against Human Cytomegalovirus (HCMV): Potential Clinical Applications (2012) (4)
- Should soybean agglutinin purging be performed in breast cancer patients undergoing autologous stem cell transplantation? A retrospective analysis of 48 patients. (1997) (4)
- Pegylated Liposomal Doxorubicin (PLD) in Combination with Bortezomib (B) May Provide Therapeutic Advantage for High-Risk Multiple Myeloma Patients Relapsing within 12 Months of Stem Cell Transplant. (2007) (4)
- Mast Cell and Fibroblast Functional Activity Are Affected by Immunocompetent Cells in Chronic Grafts-vs.-Host Disease. (1992) (4)
- Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen (2012) (4)
- Outcomes for Patients with High-Risk Relapsed or Refractory Indolent B-Cell Lymphoma Treated with Copanlisib in the CHRONOS-1 Study (2018) (4)
- Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging. (1993) (4)
- Comparison of outcomes after unrelated double-unit cord blood and haploidentical peripheral blood stem cell transplantation in adults with acute myeloid leukemia, a study on behalf of Eurocord and ALWP-EBMT. (2022) (4)
- 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation. (2022) (4)
- Induction of cell-mediated IL-2-activated antitumor responses in conjunction with autologous and allogeneic bone marrow transplantation. (1991) (4)
- Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT (2022) (4)
- An instructive role for IL7RA in the development of human B-cell precursor leukemia (2020) (4)
- Impaired liver function tests in patients treated with antithymocyte globulin: Implication for liver transplantation (1997) (4)
- Adoptive transfer of short-term cultured tumor-infiltrating lymphocytes (young TIL) in metastatic melanoma patients. (2011) (4)
- Imatinib Long Term Effects (ILTE) Study: An Independent, International Study in CML Patients. (2008) (3)
- Allogeneic HCT with Reduced Intensity Conditioning Versus Autologous HCT for > 55 Years Old Patients with Acute Lymphoblastic Leukemia in First Complete Remission: An Analysis from Acute Leukemia Working Party of the EBMT (2014) (3)
- Autologous Stem Cell Transplantation for Primary Mediastinal B Cell Lymphoma in the Rituximab Era: A Retrospective Study By the EBMT Lymphoma Working Party (2014) (3)
- Matched Unrelated Donor Stem Cell Transplantation for Patients with Diffuse Large Cell B Cell Lymphoma: A Retrospective Analysis of 118 Patients Registered through the European Group for Blood and Marrow Transplantation (EBMT). (2006) (3)
- Maintenance Therapy with Nilotinib (Tasigna) Post Allogeneic Stem Cell Transplantation (AlloSCT) for Advanced (>CP1) Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL) (2011) (3)
- Ibrutinib, Bendamustine, Rituximab Combination for Relapsed and Refractory Aggressive B Cell Lymphoma — Interim Analysis of Phase II Clinical Trial (2018) (3)
- Impact of FAB classification on predicting outcome in acute myeloid leukemia , not otherwise specified , patients undergoing allogeneic stem cell transplantation in CR 1 (3)
- Skin calcinosis following allogenic bone marrow transplantation in an acute lymphoblastic leukaemia patient. (1999) (3)
- HLA-DP1 matching: are we there yet? (2014) (3)
- Impact of prior thalidomide (T) therapy on the efficacy of pegylated liposomal doxorubicin (PLD) and bortezomib (B) in relapsed/refractory multiple myeloma (RRMM) (2007) (3)
- Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia – a study of the Acute Leukemia Working Party of the EBMT (2020) (3)
- Granulocyte-monocyte and Granulocyte-Colony Stimulating Factors in Myelodysplastic Syndromes. (1991) (3)
- Reduced Intensity Versus Conventional Myeloablative Conditioning (RIC vs. MAC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Lymphoblastic Leukemia (ALL): A Survey from the Acute Leukemia Working Party of EBMT (2008) (3)
- Allogeneic haematopoietic cell transplantation for myelofibrosis: a real‐life perspective (2021) (3)
- A Randomized Phase II Study Comparing Imatinib and the Combination of Imatinib and Pegylated Interferon Alpha-2b in Newly Diagnosed Non-High Risk Chronic Myeloid Leukemia (CML) Patients in Complete Hematological Remission After Imatinib Induction Therapy. (2009) (3)
- CD45 Phosphatase Is Involved in Motility and Development of Hematopoietic Stem and Maturing Cells by the Regulation of Cell Adhesion and Cytokine Signaling. (2004) (3)
- Retrospective Comparison between 12-Gray and 8-Gray Total Body Irradiation (TBI) before Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia in First Complete Remission (2021) (3)
- Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients (2021) (3)
- Established and emerging targeted therapies in the myelodysplastic syndromes (2016) (3)
- The Disease Risk Index Is a Robust Tool for Allogeneic Hematopoietic Stem Cell Transplantation Risk Stratification: An Independent Validation Study on a Large Cohort of the European Society for Blood and Marrow Transplantation (EBMT) (2016) (3)
- Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study (2021) (3)
- Mucosal melanoma following autologous stem cell transplantation for non-Hodgkin's lymphoma (NHL). (1996) (3)
- Immunobiology and Pharmacologic Manipulation of Dendritic and Regulatory Cells (2013) (3)
- Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation (2021) (3)
- Acquisition of a Ph chromosome with minor BCR/ABL fusion in treatment-related myelodysplastic syndrome with chromosome 7 abnormalities in a patient treated for Hodgkin disease. (2005) (3)
- Combined therapy of granulocyte transfusions, intravenous opsonins and antibiotics for gram-negative pneumonia in neutropenic cancer patients. (1994) (3)
- Effect of Disease Stage and Time Since Diagnosis on Time to Progression for Pegylated Liposomal Doxorubicin + Bortezomib vs Bortezomib Alone in Relapsed or Refractory Multiple Myeloma. (2007) (3)
- Allogeneic Hematopoietic Cell Transplantation After CAR T-cell Therapy in Large B-cell Lymphoma: Allogeneic-HCT after CAR T-cell therapy. (2022) (3)
- Ganciclovir for the treatment of disseminated CMV disease without pneumonia in allogeneic T-lymphocyte depleted bone marrow transplantation. (1993) (3)
- Continuous Interleukin-2 Infusion Combined with Cyclophosphamide- Based Combination Chemotherapy in the Treatment of Hemato-Oncological Malignancies (1998) (3)
- regulates their interaction with endothelial cells (2004) (3)
- Impact of the addition of antithymocyte globulin to post-transplant cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplant cyclophosphamide alone in acute myeloid leukemia: a retrospective study on behalf of the Acute Leukemia Working Party of the EBMT. (2022) (3)
- Recombinant interleukin-2 and interferon alpha immunotherapy following autologous bone marrow transplantation. A case report of cardiovascular toxicity with serial echocardiographic evaluation. (1992) (3)
- Updated Safety and Efficacy from the Copanlisib CHRONOS-1 Trial in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma: Low Incidence of Late-Onset Severe Toxicities (2017) (3)
- Effects of interleukin 2 on engraftment following autologous bone marrow transplantation (ABMT) in dogs. (1992) (3)
- Bone Marrow Transplantation for Cancer and Autoimmunity (2000) (3)
- CXCR4 Antagonist BKT140 Synergizes with Rituximab, Targeting Non Hodgkin Lymphoma (NHL) In Vitro and In Vivo in a Xenograft Model with Bone Marrow Involvement (2011) (3)
- Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT (2020) (3)
- Common gene variants within 3′‐untranslated regions as modulators of multiple myeloma risk and survival (2020) (3)
- The EBMT Score Predicts Transplant Related Mortality and Overall Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes (2015) (3)
- Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1 Trial (2017) (3)
- Analysis of & Globin Mutations Shows Stable Mixed Chimerism in Patients With Thalassemia After Bone Marrow Transplantation (2002) (3)
- Successful matched unrelated transplantation from a donor with idiopathic thrombocytopenic purpura (ITP) (1995) (3)
- Burkitt leukaemia following chemoradiotherapy in a patient with Hodgkin's disease. (1986) (3)
- Detection of systemic chimerism in sex-mismatched liver transplant recipients by fluorescent in situ hybridization (FISH) (1993) (3)
- Measurable residual disease, FLT3‐ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1‐mutated acute myeloid leukemia (2022) (3)
- Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMT (2020) (3)
- Human stem cell colony-stimulating activity (CFU-GEMMCSA) in medium conditioned by leukemic B-lymphocytes. (1987) (3)
- Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remission (2019) (3)
- Progression of disease within 24 months of initial therapy (POD24) detected incidentally in imaging does not necessarily indicate worse outcome (2020) (3)
- The HPSE Gene Insulator—A Novel Regulatory Element That Affects Heparanase Expression, Stem Cell Mobilization, and the Risk of Acute Graft versus Host Disease (2021) (3)
- 685 Adoptive transfer of NKT cells alleviates graft versus host disease and improves survival in a murine model of semi-allogeneic bone marrow transplantation: The role of the liver in tolerance induction (2003) (3)
- ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES (1993) (3)
- PAR1 Expression Predicts Clinical G-CSF CD34+ HSPC Mobilization and Repopulation Potential in Transplanted Patients (2019) (3)
- Mechanism of HPSE Gene SNPs Function: From Normal Processes to Inflammation, Cancerogenesis and Tumor Progression. (2020) (3)
- Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs (2022) (3)
- Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT (2019) (3)
- Comparison of Allogeneic Stem Cell Transplantation for Transformed Acute Myeloid Leukemia Derived from MDS, CMML or MPN. a Report of the Chronic Malignancies Working Party of EBMT (2016) (3)
- Autologous stem cell transplantation (ASCT) in first remission improves outcome in adult patients (PTS) with lymphoblastic lymphoma (LBL): Results from a randomized trial of the European group for blood and marrow transplantation (EBMT) and the UK lymphoma group (UKLG). (1998) (3)
- Is fluorescence in-situ hybridization sufficient in patients with myelodysplastic syndromes and insufficient cytogenetic testing? (2018) (3)
- Eosinophilic fibrohistiocytic lesion of bone marrow associated with monoclonal gammopathy and osteolytic lesions (1986) (3)
- The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML (2022) (3)
- A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia (2020) (3)
- Analysis of the GeneXpert System on the International Multicentre ICORG 08-02 Phase II Study of Nilotinib 300mg BID as Frontline Treatment in Patients with Early Chronic Phase Chronic Myeloid Leukemia (ECPCML) (2011) (3)
- COVID-19 in Hematologic Malignancies: Big Challenges (2020) (3)
- HLA Disparities Impact on Outcomes after Unmanipulated Haploidentical Hematopoietic Stem Cells Transplantation (HaploSCT) in Acute Leukemia: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) (2015) (3)
- Real-Life Experience of Nivolumab in Heavily Pretreated Relapsed and Refractory Classical Hodgkin Lymphoma (2016) (3)
- The Use of Tevagrastim (Biosimilar Filgrastim XMO2) for Hematopoietic Stem Cell Mobilization in HLA Matched Sibling Donors for Allogeneic Stem Cell Transplantation to AML/MDS Patients (2013) (3)
- Oral Mucositis Is Associated with Distinctive Patterns of Oral Microbiota Injury in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (2019) (2)
- 17 Application of immune-therapeutic interventions after allogeneic stem-cell transplantation based on MRD detection with combined morphological and cytogenetic analysis (2003) (2)
- Comparison of Outcomes After Allogeneic HSCT for Adult Patients with AML in Remission Using in the Conditioning Regimen Either I.V. Busulfex (BU) Plus Cyclophosphamide (Cy) or TBI Plus Cy: An- ALWP-EBMT Survey. (2009) (2)
- Stem Cell Transplantation (2005) (2)
- [Idiopathic transient osteoporosis of the hip]. (1985) (2)
- Effects of treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor. (1990) (2)
- Early Organ Toxicity Following Allogeneic Hematopoietic Stem Cell Transplantation Differs By Conditioning Regimen (2019) (2)
- Acute Myeloid Leukemia Patients Requiring Two Cycles of Intensive Induction for Attainment of Remission Experience Inferior Survival Compared with Patients Requiring a Single Course of Induction Chemotherapy. (2021) (2)
- Second Allogeneic Hematopoietic Stem-Cell Transplantation Using Fludarabine Treosulfan Conditioning Regimen in Patients Previously Treated with Busulfan-Based Regimens; Myeloablation with Acceptable Toxicity. (2009) (2)
- Irradiation induced injury to the HSG human cell line: In vitro model for reproductive cell death in major salivary glands (1995) (2)
- Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT (2022) (2)
- Salivary Microbial and Metabolic Determinants of Oral Mucositis in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation (2020) (2)
- Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis (2021) (2)
- HLA-C KIR ligands and donor recipient KIR genotypes influence outcome of haploidentical stem cell transplantation (2002) (2)
- Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT (2021) (2)
- [Bone marrow transplantation]. (1995) (2)
- Lactate Dehydrogenase Is a Key Prognostic Factor in Acute Myeloid Leukemia and Lymphoma Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (2019) (2)
- Outcomes for Patients with Pre-Existing Diabetes or Hypertension Treated with Copanlisib from the CHRONOS-1 Study in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma (2018) (2)
- Randomized Trial of Busulfan with Cyclophosphamide Versus Busulfan with Fludarabine As Preparative Regimen to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia: A Study from the Gruppo Italiano Trapianto Midollo Osseo (GITMO) (2014) (2)
- Comparison of Matched/Mismatched Unrelated Donor Stem Cell Transplantation to Autologous Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) (2015) (2)
- Erratum: Mast cells induce activation of human lung fibroblasts in-vitro (Experimental Lung Research 30, 8 (705-721)) (2005) (2)
- Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT (2022) (2)
- The Outcome of Patients with Primary Refractory or Relapsed Peripheral T-Cell Lymphoma: Analysis of 1020 Cases Registered in the Prospective T-Cell Project (2016) (2)
- Activity and Tolerability of Azacitidine in Patients Who Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplasia (MDS): a Survey from the European Society for Blood and Marrow Transplantation (EBMT (2014) (2)
- Increasing the dose intensity of the conditioning regimen prior to allogeneic hematopoietic stem cell transplant: the role of pharmacokinetic monitoring (2010) (2)
- Maintenance 5-Azactidine May Improve Outcomes after Allogeneic Stem-Cell Transplantation in High-Risk AML and MDS Patients (2019) (2)
- ETV6-NCOA2 fusion induces T/Myeloid mixed-phenotype leukemia by transformation of non-thymic hematopoietic progenitors. (2021) (2)
- Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prophylaxis in Alternative Donor Stem Cell Transplantation: Immune Reconstitution and Infection Risk. (2021) (2)
- The Prognostic Role of Pretransplant Serum Lactate Dehydrogenase Levels in Acute Myeloid Leukemia and Lymphoma Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation (2020) (2)
- The Humanized Anti PD-1 Antibody, CT-011, Increases Specific CD4+ Effector/Memory and Memory T Lymphocytes in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Following Autologous Stem Cell Transplantation (AuSCT). (2009) (2)
- Selective Death of Leukemia Initiating Cells Induced By Deferasirox (2016) (2)
- Inferior Outcome of Allogeneic Stem Cell Transplantation in First Complete Remission for Secondary AML As Compared to De Novo Disease: Results from a Retrospective, Registry-Based Analysis on Behalf of the Acute Leukemia Working Party of the EBMT (2018) (2)
- Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMT (2021) (2)
- MAJOR MOLECULAR RESPONSE RATE AT ONE YEAR IS HIGHER IF PEGYLATED INTERFERON ALPHA-2B IS ADDED TO IMATINIB IN NON-HR CHRONIC MYELOID LEUKEMIA PATIENTS IN IMATINIB INDUCED COMPLETE HEMATOLOGICAL REMISSION in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol 95, issue , pp 457-457 (2010) (2)
- Prediction of Non-Relapse Mortality in Recipients of Reduced Intensity Conditioning Allo-HSCT with Acute Myeloid Leukemia in First Complete Remission: Integrating the Seattle Comorbidity Index (HCT-CI) and EBMT Scoring Systems (2012) (2)
- Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support. (2002) (2)
- Validation of Digital-PCR Analysis through Programmed imatinib Interruption in Q-RT-PCR Negative Chronic Myeloid Leukemia Patients (2013) (2)
- Faculty of 1000 evaluation for Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant. (2012) (2)
- Interest of Non-Myeloablative Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma: A Multicenter Retrospective Study. (2008) (2)
- HLA-haploidentical transplantation for relapsed/refractory AML: better LFS with BM than with PBSC in patients ≥ 55 years of age. (2022) (2)
- Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocol (2022) (2)
- The role of activated T lymphocytes in megakaryocytopoiesis (1992) (2)
- Stem-cell dose for allogeneic hematopoietic stem cell transplantation in hematological malignancies: is more better? (2009) (2)
- Cutaneous hypersensitivity to co-trimoxazole after autologus bone marrow transplantation and immunotherapy with interferon alpha-2A and interleukin-2. (1993) (2)
- Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM): introduction by the co-chairpersons of the COSTEM Congress (2012) (2)
- The effect of pegylated liposomal doxorubicin plus bortezomib in multiple myeloma patients with renal insufficiency (2008) (2)
- Underdiagnosed Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome(VOD/SOS) As a Major Cause of Multi-Organ Failure in Acute Leukemia Transplant Patients: An Analysis from the EBMT Acute Leukemia Working Party (2019) (2)
- CT assessment of bone marrow transplant patients with rhinocerebral aspergillosis. (2002) (2)
- Cancer Therapy : Preclinical Targeting the CD 20 and CXCR 4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Af fi nity CXCR 4 Antagonist BKT 140 (2013) (2)
- Severe migratory polyarthritis following in vivo CAMPATH-1G. (1995) (2)
- Isochromosome X in Myelodysplastic Syndrome (2015) (2)
- RIC Allo-SCT with Flu/Bu in Comparison to Flu/Mel for AML Results in Similar Overall Survival: A Report from the ALWP of the EBMT (2014) (2)
- INTERLEUKIN-18 (IL-18) And IL-18 binding protein (IL-18bp) And acute graft versus host disease (Gvhd) (2000) (2)
- A novel platform for minimally invasive delivery of cellular therapy as a thin layer across the subretina for treatment of retinal degeneration (2015) (2)
- Final Overall Survival Results of a Randomized Trial Comparing Bortezomib Plus Pegylated Liposomal Doxorubicin with Bortezomib Alone in Subjects with Relapsed or Refractory Multiple Myeloma (2014) (2)
- Anti-Thymocyte Globulin for Graft-Versus-Host Disease Prophylaxis in Patients with Acute Myeloid Leukemia Undergoing Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation in First Complete Remission: A Survey on Behalf of the EBMT Acute Leukemia Working Party (2016) (2)
- CMV Seropositive Status Increases Heparanase SNPs Regulatory Activity, Risk of Acute GVHD and Yield of CD34+ Cell Mobilization (2021) (2)
- Normalization of serum lactic dehydrogenase in β‐thalassemia patients following bone marrow transplantation (1996) (2)
- Allogeneic Hematopoietic Stem-Cell Transplantation in Adult Acute Lymphoblastic Leukemia: Better Outcome in Transplantation during First Complete Remission and with Myeloablative Conditioning (2008) (2)
- Comparison between Anti-Thymocyte Globulin and Alemtuzumab and the Possible Impact of KIR-Ligand Mismatch in Melphalan/Fludarabine Dose-Reduced Conditioning Followed by HLA-Matched and Mismatched Unrelated Stem Cell Transplantation in Patients with Multiple Myeloma. (2004) (2)
- High lactate dehydrogenase at time of admission for allogeneic hematopoietic transplantation associates to poor survival in acute myeloid leukemia and non-Hodgkin lymphoma (2021) (2)
- Long-Term Efficacy and Safety of Copanlisib in Multiply Relapsed or Refractory Patients with Marginal Zone Lymphoma (2019) (2)
- Influence of Preexisting Invasive Aspergillosis on Allo-HSCT Outcome: A Retrospective EBMT Analysis from the Infectious Diseases and Acute Leukemia Working Parties (2014) (2)
- Prediction of allogeneic HSCT related mortality in acute leukemia: exploring boundaries of prediction through machine learning based modeling. A data mining study from the acute leukemia working party (ALWP) of the EBMT (2014) (2)
- Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients (2020) (2)
- Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation (2021) (2)
- Graft-Versus-Leukemia Effect after Haplo-Identical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Patients with AML- No Association with Graft-Versus-Host Disease (GVHD): A Study on Behalf of the Acute Leukemia Working Party of EBMT. (2019) (2)
- A polygenic risk score for multiple myeloma risk prediction (2021) (2)
- Faculty Opinions recommendation of Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report. (2015) (2)
- Graft-Versus-Leukemia Effect after Haplo-Identical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Patients with AML- No Association with Graft-Versus-Host Disease: A Study on Behalf of the Acute Leukemia Working Party of EBMT (2018) (2)
- Weathering the storm: COVID-19 infection in patients with hematological malignancies* (2020) (2)
- Comparison of RIC-alloHCT and autoHCT for > 55 years old patients with acute lymphoblastic leukemia: an analysis from Acute Leukemia Working Party of the EBMT (2015) (2)
- transplanted NOD/SCID mice are elastase dependent. (2005) (2)
- Acute Myeloid Leukemia in Adults (2018) (2)
- Enriching hematopoietic, endothelial and mesenchymal functional progenitors by short-term culture of steady-state peripheral blood mononuclear cells obtained from healthy donors and ischemic patients. (2014) (2)
- Adaptor Protein LNK Binds to and Is Phosphorylated by JAK3 and May Serve as a Scaffold for JAK3 Autophosphorylation In the Absence of An Appropriate Cytokine Receptor (2010) (2)
- Analysis of risk factors of cord blood transplantation for children (2013) (2)
- Allogeneic Stem Cell Transplantation from Unmanipulated Haploidentical Donors Versus Matched or Mismatched 9/10 Unrelated Donors in Acute Lymphoblastic Leukemia in First Complete Remission: On Behalf of the ALWP of the EBMT (2018) (2)
- Decision-analytic modeling as a tool for selecting optimal therapy incorporating hematopoietic stem cell transplantation in patients with hematological malignancy (2020) (2)
- Better leukemia-free survival with allogeneic than with autologous HCT in AML patients with isolated trisomy 8: a study from the ALWP of the EBMT (2020) (2)
- Double Cord Blood Transplantation: Incidence, Organ Involvement and Risk Factors of Acute Graft Versus Host Disease. a Retrospective Analysis on Behalf of Eurocord, ALWP and Cqwp-EBMT (2014) (2)
- Cyclosporine safety and bioavailability with two second-generation softgel capsules using serum concentrations/TDM and modeling in transplant patients--a retrospective, parallel, comparative evaluation study. (2008) (2)
- Maintenance 5-Azactidine May Improve Outcomes after Allogeneic Stem-Cell Transplantation in High-Risk AML and MDS Patients (2019) (2)
- Recombinant human interleukin-6 accelerates in-vitro megakaryocytopoiesis and platelet recovery post autologous peripheral blood stem cell transplantation. (1995) (2)
- In 2022, which is preferred: haploidentical or cord transplant? (2022) (2)
- Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide for Acute Lymphoblastic Leukemia: ALWP of the EBMT Study (2019) (2)
- Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year‐old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT) (2016) (2)
- Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2019) (1)
- Looking Ahead: Clinical Hematology International Turns One (2020) (1)
- [Agranulocytosis associated with mebhydrolin napadisylate (Incidal)]. (1984) (1)
- Matching of MHC Class I Chain-Related Genes a and B Is Associated with Reduced Incidence of Severe Acute Graft-Versus-Host Disease after Unrelated Hematopoietic Stem Cell Transplantation (2014) (1)
- Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT (2020) (1)
- Salvage High‐Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002‐2012 (2017) (1)
- No Evidence for Increased Transplant Related Complications in Ph+ Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia with Prior Treatment with Dasatinib. (2006) (1)
- Cancer Therapy : Clinical The High-Af fi nity CXCR 4 Antagonist BKT 140 Is Safe and Induces a Robust Mobilization of Human CD 34 þ Cells in Patients with Multiple Myeloma (2014) (1)
- Outcome differences in patients with precursor B cell acute lymphocytic leukemia over time: a retrospective analysis. (2014) (1)
- Efficacy of HSV-TK+ suicide gene donor lymphocytes after haploidentical transplantation (haplo-HSCT): Preliminary results of randomized TK008 study. (2014) (1)
- Allogeneic Stem-Cell Transplantation for AML and MDS with Tresosulfan Compared with Busulfan-Based Regimens; Reduced Toxicity Vs. Reduced Intensity (2011) (1)
- Encouraging Survival and High Rates of Toxicity: Allogeneic Hematopoietic Cell Transplantation after Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Aggressive Lymphoma Patients (2021) (1)
- GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT (2023) (1)
- Fludarabine based low intensity conditioning protocol for unrelated matched stem cell transplantation (NST/MUD) in chronic myelogenous leukemia(CML) (2000) (1)
- Imatinib Long Term Effects (ILTE) Study: An International Study to Evaluate Long-Term Effects in CML Patients. (2009) (1)
- Impact of Cytogenetic Risk on Outcomes of Non-T Cell Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia. (2022) (1)
- Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucel (2022) (1)
- Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- a Report from the Acute Leukemia Working Party of the EBMT (2015) (1)
- Myeloablative Versus Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in Patients with Prior Myelodysplastic Syndrome/ Myeloproliferative Disorders: An ALWP of EBMT Study (2017) (1)
- Mobilized peripheral blood stem cells compared with bone marrow for related reduced-intensity transplantation in acute myeloid leukaemia in complete remission: a retrospective analysis from the ALWP of EBMT in BONE MARROW TRANSPLANTATION, vol 45, issue , pp S21-S22 (2010) (1)
- Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis (2021) (1)
- 123: Increased Expansion, Homing and Engraftment of Cytokine-Cultured Cord Blood-Derived CD34+ Cells by Treatment with Nicotinamide, a form of Vitamin B3 (2008) (1)
- Allogeneic Stem Cell Transplantation for MDS Patients More Than 70 Years of Age: a Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT (2015) (1)
- Erratum: Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma (Leukemia (2008) vol. 22 (1250-1255) 10.1038/leu.2008.88) (2008) (1)
- Shifting Towards Better Immunotherapy Rather Than More Intensive Chemoradiotherapy Using a Non-Myeloablative Approach in Patients with Leukemia (2001) (1)
- Senescent/Exhausted Phenotype of CAR T Cells and Induction of Immunoregulatory Environment Correlate with Reduced Response to CAR T Cell Therapy in Relapsed/Refractory B Cell Malignancies (2020) (1)
- Prognostic Pre-Transplant Factors in Myelodysplastic Syndromes Primarily Treated by Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective Study on Behalf of the MDS Subcommittee of the Chronic Leukaemia Working Party of the EBMT (2011) (1)
- Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen—A Report from the Acute Leukemia Working Party of the EBMT (2015) (1)
- Higher Efficacy of TBI + Cyclophosphamide Than TBI + Fludarabine As Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia: An Analysis By the Acute Leukemia Working Party of the EBMT (2021) (1)
- The Role Of High Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT) In Patients With POEMS Syndrome: A Retrospective study Of The Plasma Cell Disorders Subcommittee Of The Chronic Malignancy Working Party Of The EBMT (2013) (1)
- Donor Age Determines Outcome in Acute Leukemia Patients Undergoing Haploidentical Hematopoietic Cell Transplantation (2017) (1)
- Non-myeloablative stem-cell transplantation in the treatment of malignant and non-malignant disorders. (2002) (1)
- Impact of dose intensity on unrelated cord blood transplantation outcomes in adults patients with acute leukemia: A Report from Eurocord, the ALWP and the Cord Blood Committee of the CTIWP of the EBMT (2016) (1)
- Ibritumomab tiuxetan combined with high-dose chemotherapy and autologous stem-cell transplantation (SCT) in patients with chemo-refractory aggressive non-Hodgkin's lymphoma. (2006) (1)
- P-287 Infectious events are much more prevalent following a seven compared to five days cycle of azacitidine regardless of patient's age (2013) (1)
- Allogeneic Hematopoietic Stem Cell Transplantation (SCT) Using Fludarabine/Treosulfan Conditioning Regimen Compared With Busulfan-Based Myeloablative And Reduced-Intensity Conditioning In Patients With AML And MDS; Relative Outcomes Depend On Disease Status At SCT (2010) (1)
- Use of Busulfan in Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Adults: A Survey By the Complications and Quality of Life Working Party of the EBMT (2017) (1)
- A haploidentical may be a better choice than a female genoidentical donor to transplant a patient with high risk acute myelogenous leukemia in first remission (2019) (1)
- Clinical Hematology International: Why a New Journal in Hematology? (2019) (1)
- Donor lymphocyte infusion (DLI) post haploidentical stem cell transplantation (Haplo) with post-transplant cyclophosphamide (PTCy): crossing the human leukocyte antigen (HLA) barrier (2022) (1)
- Towards Stopping Imatinib Therapy under the Umbrella of Interferone: Alpha-Interferone Improves Molecular Response in CML Patients with Imatinib Induced Complete Cytogenetic Remission: An Early Observation from a Study of Pegylated Interferone in the Set up of Minimal Residual Disease. (2006) (1)
- Allogeneic stem cell transplantation in adult patients with acute myeloid leukemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European society of Blood and Marrow Transplantation (EBMT) (2016) (1)
- Isocitrate Dehydrogenase (IDH) 1 and 2 Mutation Is an Independent Predictor of Better Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Study of the ALWP of EBMT (2021) (1)
- Halofuginone Exerts Antiproliferative and Antiangiogenic Actions on Acute Promyelocytic Leukemia Cells through Modulation of the TGFβ Pathway. (2007) (1)
- Establishment of an In Vitro Culture Method for Multiple Myeloma Cells. (2004) (1)
- Post‐transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA‐mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT (2022) (1)
- Underlying coronary artery disease and successful bone marrow transplantation: a case report. (1994) (1)
- Halofuginone Induces Post-Transcriptional Down-Regulation of Cyclin D1, Cell Cycle Arrest and Apoptosis In Mantle Cell Lymphoma Cells through Activation of Integrated Stress Response Pathways (2010) (1)
- EUROPEAN SUB-REGISTRY OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS (PTS) IN FAILURE AFTER IMATINIB THERAPY (IFP): RATIONALE, STUDY DESIGN AND CURRENT STATUS. A STUDY FROM THE EUROPEAN LEUKEMIANET (ELN) (2010) (1)
- Human leukocyte antigen‐haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia‐free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age (2022) (1)
- Correlation Between Chronic Graft-vs-HOST Disease, Mast Cell Degranulation and Fibrosis (1997) (1)
- The impact of GVHD on outcomes after adult single cord blood transplantation in European and Japanese populations (2021) (1)
- Predictive Limitations of Hematopoietic Stem Cell Transplantation Associated Mortality: A Machine Learning in-Silico Analysis of the EBMT - Acute Leukemia Working Party Registry (2015) (1)
- Allogeneic stem-cell transplantation in patients with AML and MDS using myeloablative versus reduced-intensity doses of intravenous busulfan (Busulfex): The role of dose intensity (2005) (1)
- Characterization of Factors Determining the Kinetics of Disease Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) or Chemotherapeutic Consolidation for Acute Myeloid Leukaemia (AML) in First CR: A Survey from HOVON-SAKK and the Acute Leukaemia Working Party of the EBMT (2016) (1)
- Comparison of Matched-Sibling Donors Versus Unrelated Donors in Allogeneic Stem Cell Transplantation (allo-SCT) for Primary Refractory Acute Myeloid Leukemia (PRF AML): A Report of 1041 Patients from the Acute Leukemia Working Party of the EBMT (2015) (1)
- The role of hypomethylating agents in myelodysplastic syndrome: changing the management paradigm (2013) (1)
- Reduced Toxicity Myeloablative Conditioning Regimens (RTC) Compared With Standard Myeloablative Conditioning Prior to Allogeneic Stem Cell Transplantation in AML and MDS; RTC Has More Favorable Toxicity Profile But More Limited Leukemia Control in Advanced Disease (2011) (1)
- Safety and Efficacy of Thiotepa-Based Conditioning Therapy for Allogeneic Transplantation in Acute Myeloid Leukemia - a Survey from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (2014) (1)
- Cyclosporine and Methotrexate Compared with Cyclosporine and Mycophenolate Mofetil as GVHD Prevention Regimens In Allogeneic Stem-Cell Transplantation From Unrelated Donors; Relative Outcomes Are Dependant on Disease Status at Transplantation (2010) (1)
- Outcomes after HLA-Identical Sibling Allogeneic Peripheral Blood Stem Cell Transplantation Using Reduced Intensity Conditioning Compared to Autologous Peripheral Blood Stem Cell Transplantation for Elderly Patients with De Novo Acute Myeloid Leukemia. (2005) (1)
- Blocking of Transient Receptor Potential Vanilloid1 (TRPV1) Promotes Lysosomal Destabilization and Enhances Bortezomib-induced ER Stress and Cell Death via HSP70 and LAMP3 Down-regulation: Novel Therapeutic Target for Multiple Myeloma (2017) (1)
- Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3‐ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation (2022) (1)
- Final Phase IIa Study Results Evaluating the CXCR4 Antagonist BL-8040 in Combination with Cytarabine (Ara-C) for the Treatment of Relapsed/Refractory AML Patients (2016) (1)
- Assessment of the Effect of Nilotinib (Tasigna) Maintenance Therapy After Allogeneic Stem Cell Transplantation in Patients with Advanced CML and Ph+ ALL On Immune Reconstitution and Lymphocyte Function (2012) (1)
- Immunotherapy for B-cell lymphoma (2010) (1)
- No Inhibition of Anti-Viral and Anti-Leukemia Effects By Extracorporeal Photopheresis Therapy (2018) (1)
- Low Protein Z levels in patients with plasma cell neoplasms are inversely correlated with IL-6 levels. (2017) (1)
- Impact of ABO-Mismatching Following HLA- Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for AML—a Report From the ALWP of the EBMT (2017) (1)
- PV-0042: Fractionated-TBI schedules prior to allograft: Study from the Acute Leukemia Working Party (EBMT) (2017) (1)
- Comparison of Reduced Intensity Conditioning - Allogeneic HCT and Autologous HCT for Elderly Patients with Acute Lymphoblastic Leukemia. an Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2020) (1)
- A Machine Learning Based Model to Predict Two-Year Leukemia Free Survival in Cord Blood Transplantation for Acute Leukemia - a Data Mining Study, on Behalf of Eurocord, Cord Blood Committee and the Acute Leukemia Working Party of the EBMT (2015) (1)
- Anti-Leukemia and Multiple Myeloma Selective Activity of CXCR4 Antagonist 4F-Benzoyl-TN14003 Involves Apoptotic Death Pathway. (2009) (1)
- HSC-specific roles of CHEK2 and cell death in suppressing oncogenic potential of non homologous end joining DNA repair in human hematopoietic stem cells (2016) (1)
- An EBMT Prospective Non-Interventional Study of Outcomes and Toxicity of Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Patients Previously Treated with Second Generation Tyrosine Kinase Inhibitors (2016) (1)
- Metabolic Syndrome Is Common Following Haematopoietic Cell Transplantation (HCT) and Is Associated with Increased Cardiovascular Disease and Second Cancers: An EBMT Cross-Sectional Non-Interventional Study (2018) (1)
- Comparison between anti-thymocyte globulin and alemtuzumab as part of the melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated stem cell transplantation in patients with lymphoid malignancies (2004) (1)
- Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic Leukemia. (2021) (1)
- Allogeneic Hematopoietic Cell Transplantation in AML with Normal Karyotype and NPM1 Mutated FLT3-ITD Negative: A Retrospective Analysis from the Acute Leukemia Working Party of EBMT (2014) (1)
- Busulfan (Bu) Plus Cyclophosphamide (Cy) Versus TBI Plus Cy Conditioning for Allogeneic Stem Cell Transplantation (alloSCT) From Matched Unrelated Donors (MUD) In Adult Patients with AML in First Relapse: A Survey From the Acute Leukemia Working Party of EBMT (2011) (1)
- Functional CXCR4 Expressing Microparticles and SDF-1 Correlate with Circulating AML Cell Counts. (2006) (1)
- 226Preferential expansion of cord blood early progenitors enabled by linear polyamine copper chelators (2003) (1)
- Low Levels of Circulating CS1, a Newly Identified Multiple Myeloma (MM) Antigen for a Novel Humanized HuLuc63 Monoclonal Antibody, Is Detected in MM Patient Sera and Correlates with Active Disease. (2007) (1)
- Secondary AML Is an Independent Risk Factor for Outcome after SCT in First Complete Remission - a Registry-Based Comparison to De Novo AML on Behalf of the EBMT Acute Leukemia Working Party (2019) (1)
- Intravenous Busulfan-Based Conditioning Prior to Allogeneic Stem Cell Transplantation in Adults Patients with AML - An ALWP-EBMT Survey. (2007) (1)
- ELN 2017 Classification Significantly Impacts on the Risk of Early Death in Acute Myeloid Leukemia Patients Receiving Intensive Induction Chemotherapy (2021) (1)
- Predictive Parameters for Infections During Azacitidine Therapy in High Risk MDS Patients (2011) (1)
- Allogeneic Hematopoietic Stem-Cell Transplantation Using Fludarabine/Treosulfan Conditioning Regimen Compared with Busulfan-Based Myeloablative and Reduced-Intensity Conditioning in Patients with AML and Mds; Relative Outcomes Depend On Disease Status at Transplantation. (2009) (1)
- Halofuginone— A new therapy for liver fibrosis: Mechanism of action and phase I study (2003) (1)
- Manufacturing mesenchymal stromal cells for the treatment of graft-versus-host disease: a survey amongst centers affiliated to the European Group of Blood and Marrow Transplantation (2018) (1)
- Association Between The Hematopoietic Cell Transplantation-Specific Comorbidity Index (CIn) And Non-Relapse Mortality (NRM) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (Allo-SCT) For Acute Myeloid Leukemia (AML) In First Complete Remission (CR1) (2010) (1)
- The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation – a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR (2018) (1)
- NK cell destiny after haploSCT with PT-Cy. (2018) (1)
- Matched Unrelated Donor Transplantation Is Curative In Selected Patients with Diffuse Large B Cell Lymphoma: A Report of the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT) (2010) (1)
- Copanlisib treatment in patients with relapsed or refractory indolent B-cell lymphoma: Subgroup analyses of diabetic patients from the phase II CHRONOS-1 study. (2018) (1)
- The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study (2020) (1)
- P1208: CHARACTERISTICS AND CLINICAL OUTCOMES OF PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: REPORT FROM THE PROSPECTIVE INTERNATIONAL T-CELL LYMPHOMA PROJECT (2022) (1)
- The Oral Iron Chelator Deferiprone Decreases Iron Overload and Oxidative Stress in Transfusion Dependent Patients with Myelodysplastic Syndromes (MDS) (2017) (1)
- Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (2022) (1)
- Frequency and Impact of Pre-Transplant Somatic Co-Occurring Mutations on Clinical Outcomes of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: On Behalf of the EBMT Acute Leukemia Working Party (2022) (1)
- 9200 ORAL A Phase 3 Study Comparing Melphalan-Prednisone-Lenalidomide (MPR) With High-dose Melphalan and Autologous Transplantation (MEL200) in Newly Diagnosed Patients With Multiple Myeloma (MM) (2011) (1)
- 980-90 Superior Vena Cava Versus Right Atrium Central Venous Catheter Placement Avoids Thrombosis: The Role of Transesophageal Echocardiography in Diagnosis and Evaluation — A Prospective Study (1995) (1)
- Phase 3, Placebo-Controlled, ASPIRE Study (TRC114968) of Eltrombopag (EPAG) Treatment of Thrombocytopenia (TCP) in Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Assessment of Clinical Benefit, Safety, and Tolerability (2015) (1)
- Allogeneic Hematopoietic Cell Transplantation for Adult Patients with ALL: Current Results and Prognostic Factors. an Analysis from Acute Leukemia Working Party of the EBMT (2015) (1)
- Bloodstream infections' origins following fecal microbiota transplantation: a strain-level analysis (2021) (1)
- remission at transplantation in adults with high-risk acute leukemia : a risk factor analysis of A survey of fully haploidentical hematopoietic stem cell transplantation (2008) (1)
- HLA and acute graft vs host disease (GVHD) following allogeneic bone marrow transplantation (BMT) (1994) (1)
- The CXCR4 Antagonist BL-8040 Induces a Robust Mobilization of CD34+CD38−CD45RA−CD90+ CD49f+ HSCs with Long-Term and Secondary Myeloid and Lymphoid Repopulating Activity (2017) (1)
- Thoracic root pain in diabetes mellitus. (1984) (1)
- Relapse of Acute Myeloid Leukemia after Allogeneic Stem-Cell Transplantation (SCT) with Myeloablative Conditioning Is Associated with Longer Survival Than Relapse after Reduced-Intensity Conditioning (RIC). (2007) (1)
- Non-T Depleted Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Secondary Versus De Novo AML: A Study from the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2023) (1)
- Use of First or Second Generation TKI for CML after Allogeneic Stem Cell Transplantation: a Study By the CMWP of the EBMT (2016) (1)
- Allogeneic stem cell transplantation (SCT) from hla matched family donors other than siblings (2000) (1)
- The Combination of Cyclosporine and Mycophenolate Mofetil Is Less Effective Than Cyclosporine and Methotrexate in the Prevention of Acute Graft-Versus Host Disease after Allogeneic Stem Cell Transplantation from Unrelated Donors (2015) (1)
- Prognostic Value of Interim and End of Treatment FDG-PET/CT Scan Results in Adult Patients with Burkitt Lymphoma - a Retrospective Analysis of a Single Center Cohort (2015) (1)
- Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT (2021) (1)
- 8: Factors Affecting 100-Day and 1-Year Mortality Following Myeloablative Single-Unit Cord Blood Transplantation in Adults and Adolescents: A Comprehensive Meta-Analysis of CIBMTR, NCBP and Eurocord (2008) (1)
- Late Development of Cytogenetic Abnormalities in Ph Negative Cells of Chronic Myeloid Leukemia Patients Treated with Imatinib. (2009) (1)
- The Impact of Center Experience on Results of Reduced Intensity – Allogeneic Hematopoietic Stem Cell Transplantation. A Survey From the Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow Transplantation (EBMT) (2010) (1)
- Comparable Results of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia in First Complete Molecular Remission: An Analysis By the Acute Leukemia Working Party of the EBMT (2016) (1)
- Comparison between Two Reduced-Intensity Conditioning Regimens Prior to Allogeneic Stem Cell Transplantation: Fludarabine and Melphalan Is Associated with Higher Incidence of Acute Graft-Versus-Host Disease and Non-Relapse Mortality and Lower Incidence of Relapse Than Fludarabine and Busulfan. (2006) (1)
- Long-Term Survival and Late Events After Allogeneic Stem-Cell Transplantation with Reduced-Intensity Conditioning (RIC) for AML and Mds; Comparable Results with Myeloablative Conditioning. (2009) (1)
- Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT (2022) (1)
- Outcome Of Patients With HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma (ATL) Who Have Undergone Stem Cell Transplantation: A Retrospective Study Of The EBMT Lymphoma Working Party (2013) (1)
- Expansion of human umbilical cord blood-derived CD34+stem/progenitor cells to treat myocardial infarction (2004) (1)
- A novel index using inflammatory markers improves the diagnosis of hemophagocytic lymphohistiocytosis in patients with hematologic malignancies. (2021) (1)
- Non-myeloablative stem cell transplantation (Nst) For the treatment of malignant and non-malignant diseases (2000) (1)
- CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression (2022) (1)
- Treatment of Relapsed AML and MDS After Allogeneic Stem Cell Transplantation: A Second Transplant From a Different Donor May Be the Most Effective Option (2012) (1)
- Thiotepa-Based Vs TBI-Based Myeloablative Conditioning Prior To Allogeneic Stem Cell Transplantation (HSCT) For Acute Myeloid Leukemia (AML) In First Complete Remission (CR1): A Retrospective Analysis From The ALWP Of The EBMT (2013) (1)
- Early fulminant leukaemia post autologous bone marrow transplantation in non-hodgkin’s lymphoma patients (1998) (1)
- PATIENTS WITH OUT OF SPECIFICATION TISAGENLECLEUCEL CAN BE SALVAGED WITH A POINT‐OF‐CARE CAR T‐CELLS: AN OBSERVATIONAL INTENTION‐TO‐TREAT SINGLE‐CENTER ANALYSIS (2021) (1)
- Anti-emetic efficacy & tolerability of tropisetron in patients (PTS) conditioned with high dose chemoradiotherapy (HDC) pre-bone marrow transplantation (BMT) (1993) (1)
- Immunotherapy for Multiple Myeloma (2012) (1)
- Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia (2022) (1)
- Recent developments in human umbilical cord blood transplantation in Israel. (2009) (1)
- Manufacturing of Mesenchymal Stromal Cells for the Treatment of Graft-Versus-Host Disease: A Survey within the European Society of Blood and Marrow Transplantation (2016) (1)
- IRp60 modulates an array of human mast cell functions (2005) (1)
- The Role of Donor Selection for a Second Allogeneic Stem Cell Transplantation in Patients with AML Relapsing after a First Transplant; A Study on Behalf of the Acute Leukemia Working Party of EBMT (2018) (1)
- Primary Plasma Cell Leukemia Has a Poor Prognosis Even in the Era of Novel Agents - a Multicenter Case Series (2016) (1)
- [Fever as the sole symptom of Crohn's disease in an old man]. (1988) (1)
- Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT (2023) (1)
- Brentuximab Vedotin in Combination with Donor Lymphocyte Infusion for Patients with Hodgkin Lymphoma Relapsing after Allogeneic Stem Cell Transplantation (2015) (1)
- FLT3 and NPM1 Are Powerful Determinants of Outcome in Acute Myeloid Leukemia Patients Treated with Autologous Stem Cell Transplantation: An Analysis By the Acute Leukemia Working Party of the EBMT (2018) (1)
- Functional rs4693608 SNP is Located into Strong Hpse Gene Intron Enhancer and Thereby Influences to the Ability of Nuclear Proteins Binding and Activity of This Enhancer in Broad Number of Hematological Cell Lines and ALL/AML Primary Samples (2016) (1)
- Predictive Model of Early Relapse in Newly Diagnosed Multiple Myeloma: Analysis from a Pooled Dataset (2019) (1)
- Intravenous Busulfan (IV Bu)-Based Conditioning Regimen Before Allogeneic Stem Cell Transplantation (allo-SCT) for Adults with Acute Lymphoid Leukemia (ALL): A Aurvey From the Acute Leukemia Working Party of EBMT (2011) (1)
- 860PIMPACT OF RESPONSE TO INDUCTION CHEMOTHERAPY IN PATIENTS WITH GERM CELL TUMORS (GCT) RECEIVING SALVAGE HIGH-DOSE CHEMOTHERAPY (HDCT): A STUDY OF THE EBMT SOLID TUMORS WORKING PARTY (STWP). (2014) (1)
- Is There a Stronger Graft-Versus-Leukemia Effect Using HLA-Haplo-Identical Donors Compared to HLA-Identical Sibling Donors? (2015) (1)
- Intravenous busulfan versus melphalan-based low intensity conditioning prior to allogeneic stem-cell transplantation: lower TRM and a more favorable toxicity profile (2004) (1)
- Allogeneic stem-cell transplantation with matched unrelated donors in elderly patients (55–67 years); age by itself is no longer a contraindication (2004) (1)
- Thromboprophylaxis for Newly Diagnosed Multiplemyeloma Patients Treated With Lenalidomide-Basedregimens: A Randomized Phase Iii Study of Aspirinvs Enoxaparin (2011) (1)
- LDH and Renal Function are Prognostic factors for Long-term Outcomes of Multiple Myeloma Patients undergoing Allogeneic Hematopoietic Stem Cell: a Cohort of 100 Recipients (2019) (1)
- myeloproliferative neoplasms negative - leukemic transformation of Philadelphia chromosome Prevalence and prognostic impact of allelic imbalances associated with (2011) (1)
- Machine learning based predictive modeling for mortality 100 days post allogeneic hematopoietic stem cell transplantation (ALLO-HSCT) in acute leukemia: an EBMT-acute leukemia working party (ALWP) registry study (2014) (1)
- 55 Intravenous busulfan conditioning prior to allogeneic hematopoietic stem cell transplantation: Myeloablation with reduced toxicity (2003) (1)
- Malignant Progression of Human CML Clone Demonstrates a Unique Developmental Pathway Characterized by Altered Expression Pattern of Cancer, Adhesion and Drug Resistance Genes. (2006) (1)
- Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide for Acute Myelogenous Leukemia: ALWP of the EBMT Study (2019) (1)
- Safety and Efficacy of Donor T Cells Engineered with Herpes Simplex Virus Thymidine-Kinase Suicide Gene (TK Cells) Given after T-Cell Depleted (TCD) Haploidentical Hematopoietic Transplantation (Haplo-HSCT): Results of a 14-Year Follow-Up in 45 Patients (2017) (1)
- Allogeneic Stem Cell Transplantation for Patients with Chronic Myeloid Leukemia After Prior Treatment with Nilotinib or Dasatinib (2010) (1)
- Interaction Between Center Effect and Strategy for Graft Vs. Host Disease Prophylaxis on Outcome of T-Cell Depleted and T-Cell Replete Haploidentical Transplants, an Analysis on Behalf of ALWP-EBMT (2016) (0)
- Sensitization of resting T cells to autologous natural-killer-cell-mediated lysis by phytohemagglutinin (1999) (0)
- Working Parties (1991) (0)
- The International Multiple Myeloma Research (IMMEnSE) Consortium: Genetics of Multiple Myeloma Risk and Prognosis (2014) (0)
- Posttransplant cyclophosphamide‐based anti–graft‐vs‐host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen‐mismatched unrelated donors versus haploidentical donors: A study o (2022) (0)
- A Sensitive Replicate RQ-PCR of BCR ABL Transcripts Suggests That A Large Portion of Long Term Post Allogeneic SCT CML Patients Are in Deep MR and May Therefore Be Cured From Their Disease (2012) (0)
- Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases (2015) (0)
- [Fever and neutropenias]. (1985) (0)
- Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation (2022) (0)
- Immunologic approaches for breast cancer patients in the setting of stem cell transplantation (1999) (0)
- Allogeneic Hematopoietic Stem-Cell Transplantation with Reduced-Intensity Conditioning in Patients with Refractory and Relapsing Multiple Myeloma: Long-Term Follow-up. (2009) (0)
- Prior Response to Imatinib Predicts Response to Second Line Treatment with Nilotinib in CML Patients Resistant or Intolerant to Imatinib. (2009) (0)
- ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA WITH NORMAL CYTOGENETICS (CN-AML): OUTCOME, RISK FACTORS AND ROLE OF MOLECULAR SUBGROUPS IN 1006 PATIENTS - A REPORT FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT (2014) (0)
- Ex-Vivo Expanded Human Bone Marrow-Derived AC133+ Cells To Treat Myocardial Infarction. (2004) (0)
- Haploidentical Transplantation Outcomes for Secondary Acute Myeloid Leukemia—on Behalf of the ALWP of the EBMT (2018) (0)
- Enhanced Survival and Neurite Network Formation of Human Umbilical Cord Blood Neuronal Progenitors in Three-Dimensional Collagen Constructs (2012) (0)
- Abstract session I–Transplantation (2004) (0)
- 259: Treatment of Donor Graft Failure with Autologous or Allogeneic Stem Cell Boost or a Second Allogeneic Transplant Based on Chimerism Testing (2008) (0)
- Persistent mixed chimerism in plasma cells following allogeneic stem-cell transplantation (SCT) in patients with acute leukemia is a surrogate marker for leukemia relapse (2006) (0)
- Extracellular Vesicles Released By Anti-Human Thymocyte Globulins (ATG)-Exposed Mononuclear Cells Can Contribute to Immune Modulation in Allogeneic Stem Cell Transplantation (2023) (0)
- Halofuginone, an Old Anticoccidosis Drug, Induces Apoptosisin Multiple Myeloma Cells, Associated with Down Regulation of MCL1. (2007) (0)
- Adult Acute Lymphoblastic Leukaemia (2022) (0)
- Favorable Outcome For Patients With Lymphoid Malignancies Following Allogeneic Stem Cell Transplantation Using Fludarabine Treosulfan, Compared With Other Reduced Intensity Conditioning Regimen (2013) (0)
- Cell Cycle Progression and Self-Renewal Divisions of Cord Blood Derived CD34+ Cells Treated with the Polyamine Copper-Chelator Tetraethylenepentamine. (2004) (0)
- Translocation t(4;14) Is Not an Adverse Prognostic Factor in Patients with Multiple Myeloma Undergoing Allogeneic Stem Cell Transplantation. (2007) (0)
- Mechanisms of interactions between Natural Killer cells and fibroblasts in graft versus host disease (2001) (0)
- Winning Cord Blood Unit Characteristics Impacting on Outcomes after Double Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: a Collaborative Study of Eurocord and the Acute Leukemia Working Party of EBMT (2016) (0)
- Pgp (MDR1)-dependent resisrance of malignant cells towards natural killer (NK) cells is reversed by IL-2 and by the Pgp inhibitor KT-5720: implications on graft versus tumor (GVT) effects in adoptive immunotherapy (B144) (2007) (0)
- Haploidentical Versus Autologous Stem Cell Transplantation in Adult Acute Leukemia: A Matched Pair Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2014) (0)
- [The preleukemia syndrome--morphologic and biologic features]. (1984) (0)
- Second hematopoietic stem cell transplantation as salvage therapy for relapsed acute myeloid leukemia/ myelodysplastic syndromes after a first transplantation. (2022) (0)
- Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Poor Karnofsky Performance Status Score. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2020) (0)
- 373 Halofuginone regulates protein tyrosine phosphatase of regeneration liver -1 (PRL-1): upregualtes the gene expression and causes cellular translocation (2003) (0)
- How I treat refractory/relapsed diffuse large B‐cell lymphomas with CD19‐directed chimeric antigen receptor T cells (2023) (0)
- Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2019) (0)
- Down-Regulation of Activin A by Lymphoma: A Possible Mechanism of Bone Marrow Involvement. (2005) (0)
- Feasibility and toxicity of high-dose chemotherapy with/without BCNU for autologous bone marrow transplantation (ABMT) in breast carcinoma (1993) (0)
- Comparison of Mycophenolate Mofetil and a Calcineurin Inhibitor Versus Calcineurin Inhibitor Based Graft-Versus-Host-Disease Prophylaxis for Matched Unrelated Donor Transplant for Acute Myeloid Leukemia. a Study from the ALWP of the EBMT (2019) (0)
- Allogeneic Stem Cell Transplantation For Acute Myeloid Leukemia With Normal Cytogenetics (CN-AML): Outcome, Risk Factors and Role Of Molecular Subgroups In 752 Patients – A Report From The Acute Leukemia Working Party Of EBMT (2013) (0)
- TRANSPLANTATION Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation Group of Bone Transplantation (2015) (0)
- Comorbidity-Associated Risk of Overall Mortality Following Hematopoietic Stem-Cell Transplantation Is Regimen-Dependent: A Study from the Acute Leukemia Working Party of the EBMT (2018) (0)
- Continuously Improving Outcome over Time after Second Allogeneic Stem Cell Transplantation in Relapsed Acute Myeloid Leukemia - a Retrospective Analysis of 1540 Patients on Behalf of the Acute Leukemia Working Party of EBMT (2022) (0)
- THIOTEPA-BASED CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ACUTE MYELOID LEUKEMIA (AML) - A SURVEY FROM THE ALWP OF THE EBMT (2014) (0)
- (F2) Granulocyte colony-stimulating factor (G-CSF) in the treatment of myelodysplastic syndromes (MDS) (1991) (0)
- The mTOR Inhibitor Everolimus Overcomes CXCR4-Mediated Resistance to HDAC Inhibitor Panobinostat through Inhibition of p21 and Mitosis Regulators, Sensitizing MM Cells to DNA-Damaged Induced Apoptosis (2016) (0)
- Traitement et prevention des adherences (1998) (0)
- Acute Myeloid Leukemia Patients Requiring Two Cycles of Intensive Induction for Attainment of Remission Experience Inferior Survival Compared with Patients Requiring a Single Course of Induction Chemotherapy (2021) (0)
- Long-Term Survival and Quality of Life (QOL) Assessment After Allogeneic Stem-Cell Transplantation (SCT) for Acute Leukemia and MDS; Comparable Results With Myeloablative and Reduced-Intensity Conditioning (2011) (0)
- Induction of oral tolerance in a murine model of chronic graft versus host disease ameliorates disease manifestation (1998) (0)
- Detection of minimal residual disease (MRD) following BMT by multi-parameter flow cytometry (MPFC) (1996) (0)
- Calcineurin Inhibitor Alone or in Combination with Mycophenolate Mofetil for Graft-Versus-Host-Disease Prophylaxis in Patients with Acute Myeloid Leukemia Undergoing Transplantation from Matched Unrelated Donors: A Study from the ALWP of the EBMT (2020) (0)
- Hematopoietic Stem Cell Transplantation from Human Leukocyte Antigen Haploidentical Donor (2006) (0)
- Cutting Edge Communication Interleukin-18 Binding Protein in Acute Graft versus Host Disease and Engraftment Following Allogeneic Peripheral Blood Stem Cell Transplants (2001) (0)
- Outcome after Allogeneic Stem Cell Transplantation for Adult Acute Myeloid Leukaemia Patients Exhibiting Isolated or Associated Trisomy 8 Chromosomal Abnormality (2008) (0)
- Motility, proliferation and egress to the circulation of human AML cells in transplanted NOD/SCID mice are elastase dependent. (2005) (0)
- Haploidentical hematopoietic stem cell transplantation in severe aplastic anemia: time for long term and quality of life assessed studies. (2022) (0)
- Hematopoietic Stem-Cell Transplantation from Unrelated Donors in Elderly Patients (> 55 Years): Older Age Is No Longer a Contraindication When Using Reduced Intensity Conditioning. (2004) (0)
- Allogeneic Transplant for Mixed Phenotype Acute Leukemia (MPAL): Characteristics and Outcome in the ALWP-EBMT Database (2017) (0)
- Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission. (2023) (0)
- Inhibition of conditions associated with tissue trauma pathogenic processes (1999) (0)
- Treatment of Donor Graft Failure with Autologous or Allogenenic Stem-Cell Boost or a Second Allogeneic Transplant Based on Chimerism Testing. (2007) (0)
- A comparative multi-center study of Y-90 ibritumomab tiuxetan with high-dose BEAM chemotherapy versus BEAM alone prior to autologous stem-cell transplantation in patients with aggressive lymphoma (2013) (0)
- Comparison of Fludarabine/Melphalan (FluMel) with Fludarabine/Melphalan/BCNU or Thiotepa (FBM/FTM) in Patients with AML in First Complete Remission Undergoing Allogeneic Hematopoietic Stem Cell Transplantation - a Registry Study on Behalf of the EBMT Acute Leukemia Working Party (2022) (0)
- Cord Blood Derived CD34+ and AC133+ Progenitor Cells Ex-Vivo Expanded in the Presence of Tetraethylenepentamine: Reproducibility among Cord Blood Units. (2004) (0)
- [Culture studies of human bone-marrow hemopoietic progenitors]. (1985) (0)
- Postsplenectomy pericardial effusion in two patients with myeloid metaplasia. (1986) (0)
- 134: No evidence for increased transplant related toxicity in Ph+ chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) with prior exposure to Dasatinib (2007) (0)
- STK405759 as a novel drug for Multiple Myeloma therapy (2015) (0)
- CXCR4 Promotes the Tumorogenicity of Multiple Myeloma, Including Increased Motility, Clonogenicity, up-Regulation of VLA-4, Protection From Chemotherapy and Aggressive Tumor Development In Vivo (2011) (0)
- Abdominal CT in the Clinical Evaluation of Acute Graft-Versus-Host Disease of the Gastrointestinal Tract: Diffuse Small Intestine Involvement Is Associated with Severity and Outcome. (2004) (0)
- which can functionally be expressed and provide NOD/SCID repopulation (2016) (0)
- Allogeneic Stem Cell Transplantation from Two Loci Mismatched (≤6/8) Unrelated Donors in Acute Leukemia: On Behalf of the ALWP of the EBMT (2020) (0)
- Analysis of the Crosstalk Between TGF-β–VEGF-Angiogenesis in an In Vivo Model of Acute Promyelocytic Leukemia (2010) (0)
- CNS Involvement at Initial Diagnosis and Risk of Relapse After Allogeneic HCT for Acute Lymphoblastic Leukemia in First Complete Remission (2022) (0)
- Unrelated Cord Blood Versus Non-T Cell Depleted Haploidentical Stem Cell Transplantation: Comparable Results in Adults with Acute Leukemia, a Eurocord and ALWP-EBMT Study (2014) (0)
- Treosulfan: reduced toxicity conditioning for allogeneic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome (2013) (0)
- 4225 Hematopoeitic stem cell donation: the sibling emotional experience (2009) (0)
- Efficacy of radioimmunotherapy-based conditioning with high-dose chemotherapy and autologous stem cell transplantation for transformed lymphoma. (2013) (0)
- 952 CXCR 4 Antagonist BKT 140 Synergizes with Rituximab , Targeting Non Hodgkin Lymphoma ( NHL ) In Vitro and In Vivo in a Xenograft Model with Bone Marrow Involvement (2012) (0)
- Impact of alemtuzumab versus anti-thymocyte globulin after unrelated allogeneic stem cell transplantation with reduced-intensity conditioning as treatment for AML in CR1: a survey from the Acute Leukaemia Working Party of the EBMT (2012) (0)
- Impact of drug development on the use of stem cell transplantation. A report by the activity survey of the European Society for Blood and Marrow Transplantatio (EBMT) (2016) (0)
- Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome; A More Favorable Outcome after Fludarabine and Treosulfan Conditioning. a Survey on Behalf of the Chronic Malignancies Working Party of the EBMT (2014) (0)
- Maintaining the Cellular Anti-Viral and Anti-Leukemic Activities in GvHD Patients Undergoing Extracorporeal Photophoresis Therapy (2019) (0)
- Post-irradiated canine serum (PICS-J) stimulates megakaryocyte (MK) progenitors and thrombopoiesis in-vitro (1996) (0)
- CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): A Large Real-World Series from Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2022) (0)
- Reduced Intensity Vs. Non-Myeloablative Conditioning Regimens for Haploidentical Transplantation in Complete Remission Acute Myeloid Leukemia: A Study from the ALWP of the EBMT (2020) (0)
- 831 Effects of ionizing irradiation and adrenergic stimulation on gene expression pattern in rat submandibular glands (1995) (0)
- Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning for adults with Ph(-) all undergoing Allo-Hct. A study from the Acute Leukemia Working Party of the EBMT. (2017) (0)
- The Neglected Role of Hematologic Disorders in Pulmonary Embolism (2016) (0)
- Significance of Busulfan Dose Intensity On Outcomes of Hematopoietic Cell Allografting for AML in Second Complete Remission or Beyond: A Report From the EBMT Acute Leukemia Working Party (2012) (0)
- Extracorporeal Photopheresis (ECP) for Acute Graft-Versus Host Disease (GvHD) after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) (2015) (0)
- Standard Versus Single Dose-Daily Fractionated Total Body Irradiation Schedules Prior to Allotransplant for Acute Leukemia: The Sarasin Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2017) (0)
- PB1809: CLINICAL TRAJECTORY OF LONG-TERM SURVIVORS OF ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE INDUCTION CHEMOTHERAPY (2022) (0)
- Gut microbiome modulates cytokine release syndrome and therapeutic response to CAR-T therapy in hematologic malignancies (2021) (0)
- IRp60 is expressed and functional on human cord blood derived mast cells (2004) (0)
- Conditioning Regimen-Specific Patterns and Determinants of Acute Severe Organ Toxicity Following Allogeneic Transplantation (2020) (0)
- PF562 BLOCKING OF WIP1 PHOSPHATASE OVERCOMES BORTEZOMIB RESISTANCE AND PROMOTES CELL DEATH VIA ER STRESS-INDUCED APOPTOTIC JNK/C-JUN SIGNALING: NOVEL THERAPEUTIC TARGET IN MULTIPLE MYELOMA (2019) (0)
- Personalized Risk-Profiling for Acute Leukemia Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Acute Leukemia Working Party of the EBMT (2020) (0)
- Factors determining the Kinetics of Disease Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukaemia (AML): a survey from the Acute Leukaemia Working Party of the EBMT (2015) (0)
- Sustained high thrombopoietin (TPO) levels in severe aplastic anemia (SAA) patients may facilitate platelet engraftment following allogeneic bone marrow transplantation (BMT) (1998) (0)
- Reduced-Intensity Conditioning for Allogeneic Stem-Cell Transplantation (SCT) with Fludarabine and Intravenous Busulfan Is Associated with Improved Toxicity Profile and Longer Survival Than Conditioning with Fludarabine and Melphalan in Patients with Chemo-Sensitive Hematological Malignancies. (2007) (0)
- Monoallelic Deletion of the Whole Locus of Immunoglobulin Heavy Chain Gene [Del(IGH)] Is Associated with a Better Prognosis in Newly Diagnosed Multiple Myeloma (2017) (0)
- Update on chimeric antigen receptor – T cells (CAR-T) CD19 therapy: the Sheba experience (2020) (0)
- Clofarabine Containing Conditioning Regimen for Allo-SCT in AML/ALL Patients: A Survey From the Acute Leukemia Working Party of EBMT (2011) (0)
- Cellular Therapy by Non-Myeloablative Stem Cell Transplantation and Immunotherapy of Minimal Residual Disease (1999) (0)
- Multiple Myeloma and Microenvironment Formation: The Role of CXCR4/CXCL12 Chemokine Pathway (2010) (0)
- Contents, Vol. 99, 1992 (1992) (0)
- Impact of Donor Type in Patients with Acute Myeloid Leukemia Given Allogeneic Hematopoietic Cell Transplantation after Low-Dose TBI Based Regimen: A Study from the Acute Leukemia Working Party of the EBMT and Eurocord (2017) (0)
- A retrospective IDWP-ALWP study on Candida infections in allogeneic haematopoietic stem cell transplant patients (2015) (0)
- Nicotinamide, a Potent SIRT2 Inhibitor, Delays Differentiation of Hematopoietic Progenitor Cells. (2004) (0)
- Autologous Vs Related Vs Unrelated Hematopoietic Stem Cell Transplantation for Adults with NPM1 Mutated/FLT3-ITD Negative Acute Myeloid Leukemia in First Remission: A Study from the Acute Leukemia Working Party (ALWP) of the EBMT (2017) (0)
- Evaluation of Trends in Outcome over 2 Decades of Patients with Relapsed/Refractory Acute Myelogenous Leukemia Undergoing Allogeneic Stem Cell Transplantation from Unrelated Donors: An ALWP/EBMT Analysis (2022) (0)
- Is nonmyeloablative stem cell transplantation (Nst) Associated with increased risk of delayed hemolysis (2000) (0)
- High-Dose T herapy a nd A utologous S tem-Cell T ransplantation Versus C onventional T herapy f or P atients W ith A dvanced Hodgkin's L ymphoma R esponding t o F ront-Line T herapy (2003) (0)
- Impact of chronic graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukaemia: A report from the Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (2012) (0)
- Is locus C matching important in bone marrow transplantation (1994) (0)
- Long-Term Analysis of an Open-Label, Multicentre, Randomized Phase 3 Trial Comparing Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine As a Preparative Regimen for Allogeneic Stem-Cell Transplantation in Patients with Acute Myeloid Leukemia (2022) (0)
- Donor Immunization Vaccination and Transfer of Donor Immunity to Bone Marrow Transplant Recipients in the Course of Allogeneic Cell Therapy for Prevention and Treatment of Relapse (1998) (0)
- Autologous bone marrow transplantation (ABMT) for non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD): The role of immunotherapy (1993) (0)
- Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma (2022) (0)
- Serum cytokines in patients with chronic myelogenous leukemia treated with IL-2 and aIFN (1991) (0)
- Survival Advantage for Patients with AML and MDS Given Allogeneic Hematopoietic STEM CELL Transplantation Using Myeloablative Versus Reduced Intensity Conditioning (RIC) MAY Become Apparent 5-10 YEARS after Transplantation (2014) (0)
- Comparative Efficacy Analysis of Busulfan Dose Intensity Between Two Reduced Intensity Conditioning Regimens (FB2 vs. FB4) for Allogeneic HCT for AML in First Complete Remission: A Report From the EBMT Acute Leukemia Working Party (2012) (0)
- Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT (2022) (0)
- Title: Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia (2018) (0)
- Nilotinib (Tasigna) Therapy Post Allogeneic Stem Cell Transplantation (AlloSCT) for Advanced (>CP1) Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL) (2012) (0)
- ABO Mismatching and Haploidentical Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia—a Report from the ALWP of the EBMT (2017) (0)
- Somatic Expansion of the Frataxin Gene GAA Repeats in MDS Patients. (2008) (0)
- Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years, (2011) (0)
- The utility of the novel optimized HLH inflammatory (OHI) index for predicting the risk for mortality and causes of death in lymphoma. (2022) (0)
- Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia and Poor Karnofsky Performance Status. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2020) (0)
- Composition and method for treating or preventing musculoskeletal fibrosis (2008) (0)
- Non-T-Cell Depleted Haploidentical Stem Cell Transplantation (haploHCT) with Post Transplantation Cyclophosphamide (PTCy)- the Role of Donor Kinship: From the ALWP of the EBMT (2021) (0)
- Umbilical cord blood cells for cardiac repair (2008) (0)
- The Role of Cytogenetic Risk Stratification in FLT3 Mutated NPM1 Negative AML Patients Undergoing Allogeneic Stem Cell Transplantation (alloSCT) in Remission: A Study on Behalf of the ALWP of the EBMT (2021) (0)
- Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma (2023) (0)
- Efficacy and safety of Copanlisib in patients with relapsed/refractory follicular lymphoma: a subset analysis of the Chronos-1 study (2017) (0)
- 366: Fludarabine and treosulfan; A novel reduced-toxicity regimen with effective anti-leukemia activity in patients with AML and MDS (2007) (0)
- Anti-Thymocyte Globulin Induces Higher Response Rates and Less Graft-Versus-Host Disease in Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplantation. (2007) (0)
- Impact of chronic graft-versus-host disease (GVHD) after reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) as treatment for acute myeloid leukemia (AML) : a survey from the Acute Leukemia Working Party of the EBMT (2011) (0)
- Cig-FISH-Analysis of Extramedullary Myeloma Manifestations Shows Similar Incidence of Prognostic Genetic Aberrations Compared to Bone Manifestations or Soft Tissue Involvement (2010) (0)
- Salvage Therapy with the Combination of ARA-C and Gemtuzumab Ozogamicin in Post-Allo-SCT High Risk AML Patients Is Feasible and Results in Modest Responses. (2012) (0)
- Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis (2023) (0)
- malignancies relapsing post BMT (letter; comment) Allogeneic cell therapy: the treatment of choice for all hematologic (2011) (0)
- Contribution of echocardiography to cardiac diagnosis. (1986) (0)
- MRD Status Impact on Secondary Acute Myeloid Leukemia Outcomes after Allogeneic Hematopoietic Cell Transplantation. A Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2021) (0)
- Copanlisib treatment in patients with relapsed or refractory indolent B-cell lymphoma: Subgroup analyses from the CHRONOS-1 study (2017) (0)
- COPANLISIB TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA (2019) (0)
- with multiple myeloma immunotherapy after allogeneic stem cell transplantation in patients Low-dose thalidomide and donor lymphocyte infusion as adoptive (2013) (0)
- European Sub-Registry of Chronic Myelogenous Leukemia (CML) Patients (pts) in Failure after Imatinib Therapy (IFP): Rationale, Study Design and Current Enrollment. (2006) (0)
- Prediction of Leukemia-Free Survival Following Haploidentical Stem Cell Transplantation in Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT (2018) (0)
- Fatal acute cardiomyopathy associated with “non‐cardiotoxic” chemotherapy for autologous bone marrow transplantation (1992) (0)
- Nerve Growth Factor and Human Umbilical Cord Blood-Derived Cells Confer Neurovascular Protection in Ischemia (2011) (0)
- The Impact of Cytogenetics on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Survey from the Acute Leukemia Working Party (ALWP) of EBMT (2018) (0)
- Anti-Human T-Lymphocyte Immunoglobulin (ATG)-Induced T Regulatory Cells and Their Soluble Factors Suppress T Cell Proliferation: Potential Role in Allogeneic Stem Cell Transplantation (2015) (0)
- Correction: Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia (2022) (0)
- Tumorigenicity and immunogenicity in a murine model of B-cell leukemia/lymphoma (BCL1). (1998) (0)
- Matching for HLA NK epitopes reduces AGVHD and improves survival in one haplotype matched bone marrow transplants (2003) (0)
- Decreased Iron Overload and Oxidative Stress in Transfusion Dependent Patients with Myelodysplastic Syndromes (MDS) with the Oral Iron Chelator Deferiprone (2018) (0)
- IMPROVED SURVIVAL OUTCOMES FOR PATIENTS WITH EXTRA‐NODAL NK/T LYMPHOMA: DATA FROM 140 PATIENTS PROSPECTIVELY REGISTERED IN THE INTERNATIONAL T‐CELL PROJECT (2017) (0)
- Prospective analysis of prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by allogeneic haematopoietic stem cell transplantation: a study on behalf of the MDS subcommittee of the Chronic Malignancies Working Party of the EBM (2013) (0)
- Two Distinct Populations of Enriched Non Mobilized Peripheral Blood Mononuclear Cells (PBMNCs) with Different Functional Capacities (2008) (0)
- Halofuginone, a Novel Antimyeloma Agent, Upregulates C-Jun, JNK and P-53 Protein in Vitro, and Inhibits Tumor Growth and Improves Survival in in Vivo Multiple Myeloma(MM) Animal Models (2008) (0)
- Inhibition of WIP1 Phosphatase in Multiple Myeloma Overcomes Bortezomib Resistance and Promotes Cell Death Via ER Stress-Induced Apoptotic JNK/c-Jun Signaling and Downregulation of Inhibitors of Apoptosis Proteins (IAPs) (2018) (0)
- Long-Term Survival and Quality of Life Assessment After Allogeneic Stem-Cell Transplantation; Comparable Results Following Myeloablative and Reduced-Intensity Conditioning, (2011) (0)
- Attempt to Discontinue Imatinib Following Interferon Alfa Pre-Treatment In Chronic Phase CML Patients Achieving Stable Complete Cytogentic Responses (CCyR) (2010) (0)
- What Is the Outcome of Patients with Acute Leukemia Who Survive Severe Acute Graft-Versus-Host Disease? (2017) (0)
- The High Affinity CXCR4 Inhibitor, BL-8040, Induces Apoptosis of AML Blasts and Their Terminal Differentiation By Blocking AKT/ERK Survival Signals and Downregulating BCL-2, MCL-1 and Cyclin-D1 through Regulation of Mir-15a/16-1 Expression (2016) (0)
- Quinazolinone-containing drug and methods for their use (1995) (0)
- ERRATA (2005) (0)
- Blocking of WIP1 Phosphatase Overcomes Bortezomib Resistance and Promotes Cell Death via ER Stress-induced Apoptotic JNK/c-Jun Signaling: Novel Therapeutic Target in Multiple Myeloma (2019) (0)
- Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model (2015) (0)
- SAFETY ANALYSIS OF PATIENTS WITH A MEDICAL HISTORY OF RESPIRATORY DISORDERS TREATED WITH COPANLISIB FROM THE CHRONOS‐1 STUDY IN RELAPSED OR REFRACTORY INDOLENT B‐CELL LYMPHOMA (2019) (0)
- Expansion of Hematopoietic Stem Cells (HSC) from Cord-Blood (CB) Derived Mononuclear Cells (MNC) in Cytokine-Free Environment Using Mesenchymal Cells Spatial Co-Culture System. (2006) (0)
- Conditioning Regimen Intensity and Donor Choice Do Not Impact Outcomes of Patients (pts) with Acute Myeloid Leukemia (AML) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in First Complete Remission (CR1): An EBMT Analysis (2022) (0)
- Older Patients with Normal Cytogenetics AML Have a Higher Rate of Genomic Changes Compared to Young Patients as Determined by SNP Chip Analysis (2010) (0)
- Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation A prospective multicenter phase II study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) (2009) (0)
- T cell, B cell and natural killer cell function of patients with chronic hepatitis C virus infection (1996) (0)
- Adoptive Transfer of Immunity to Hepatitis B Through Bone Marrow Transplantation from Immunized Donors (1994) (0)
- TKI discontinuation after allogeneic stem cell transplantation in patients with chronic myeloid leukemia (CML): A retrospective study from the chronic malignances working party (CMWP) (2019) (0)
- [Autologous stem cell transplantation breast cancer with distant metastases]. (1998) (0)
- 8112 POSTER Ethical dilemmas involving family stem cell donors: whose decision is it? (2007) (0)
- CORRELATIONS BETWEEN ELEVATED SERUM FERRITINE LEVEL AND INITIAL CHARACTERISTICS OF HODGKIN ’ S LYMPHOMA PATIENTS (2008) (0)
- Immunotherapy by Allogeneic Lymphocytes and Cytokines Following Autologous and Allogeneic Bone Marrow Stem Cell Transplantation (2020) (0)
- Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia (2022) (0)
- A Pilot Study of Combined Escalated BEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: The Israel Cooperative Lymphoma Group. (2004) (0)
- allogeneic bone marrow transplantation recombinant human interleukin-2 to treat leukemia relapse after Allogeneic cell therapy with donor peripheral blood cells and (2011) (0)
- The Oncoprotein LMO2 Is Expressed in a Germinal Center B-Cell-Associated Pattern and Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma. (2006) (0)
- 145: Reduced Intensity Conditioning (RIC) is Associated with Shorter Duration of Chronic GVHD than Myeloablative Conditioning and Provides Very Good Quality of Life for Long-Term Survivors after Allogeneic Stem Cell Transplantation (2008) (0)
- Post-Transplant Cyclophosphamide in Acute Leukemia Patients Receiving More Than 5/10 HLA-Mismatched Allogeneic Stem Cell Transplantation: A Study on Behalf of the ALWP of the EBMT (2021) (0)
- Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease Is Safe and Effective: 1 Year Follow-up and Mechanism of Action (2015) (0)
- Experimental Double Cord Blood Transplantation (DCBT) of An Expanded Unit Together with a Non-Manipulated Unit in NOD/SCID Mice. (2008) (0)
- Nonmyeloablative Stem Cell Transplantation in the Treatment of Hematologic Malignancies (2006) (0)
- Defining the Prognostic Implications of Recurring Cytogenetic Aberrations and FLT3-ITD in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation: On Behalf of the ALWP of the EBMT (2019) (0)
- Prognostic impact of early‐versus‐late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT (2021) (0)
- Allogeneic : Adult Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome : A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT (2016) (0)
- Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation for LLM: Hype, Reality or Time for a Rethink (2008) (0)
- Risk Factors Influencing Transplant Outcomes of Adults with Acute Lymphoblastic Leukemia in First Complete Remission: A Retrospective Analysis from the ALWP of the EBMT (2022) (0)
- Unrelated cord blood (ECB) transplantation for AML: higher incidence of acute GVHD and lower survival in male patients transplanted with female unrelated cord blood. A report from Eurocord and the ALWP of the EBMT (2015) (0)
- Female Donor Allografts Have a Higher CD3 Content Than Male Donor Allografts: Potential Impact On Transplantation Outcomes in Male Recipients (2012) (0)
- Evaluation of the Impact of Non-Inherited Maternal Antigens on the Outcome of HLA Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Hematological Malignancies on Behalf of the ALWP of the EBMT and the CIBMTR (2015) (0)
- Role of the CXCR4/CXCL12 Axis in Hematopoietic Stem Cell Trafficking (2012) (0)
- Quinazolinenon-containing pharmaceutical compositions for the prevention of neovascularization and for treating malignancies (1998) (0)
- Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2021) (0)
- Impact of response to induction chemotherapy (CT) and prior paclitaxel (TXL)-based CT on the outcome of salvage high-dose chemotherapy (HDCT) for relapsed germ-cell tumors (GCT) in the modern era: An EBMT Solid Tumors Working Party study. (2015) (0)
- Chemotherapy Dose Adjustment For Obese Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): A Survey On Behalf Of The ALWP Of The EBMT (2013) (0)
- Non T–Cell Depleted Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2021) (0)
- Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). (2023) (0)
- [Differentiation and maturation processes of the hematopoietic system in bone marrow using flow cytometry]. (1989) (0)
- High Implementation Adherence to Lenalidomide in Patients with Multiple Myeloma (2022) (0)
- [Regulation of hemopoiesis and immunomodulation by 1,25-dihydroxyvitamin D3]. (1986) (0)
- Allogeneic Stem Cell Transplantation for AML Patients with RUNX1 Mutation in First Complete Remission: A Study on Behalf of the ALWP of the EBMT (2020) (0)
- Determinants for Oral Mucositis in Allogeneic Hematopoietic Stem Cell Transplantation: Prospective Evaluation and Risk Analysis (2017) (0)
- An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia (2022) (0)
- Donor Cell Derived Leukemia: Description Of 38 Cases and a Case Control Study (2013) (0)
- An Alternative Donor Is a Valid Option Compared to a Matched-Unrelated in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in CR2: A Report of 841 Patients from the EBMT Acute Leukemia Working Party (2016) (0)
- Introduction: advances and promise in human umbilical cord blood. (2010) (0)
- Use of halofuginone for treatment of urethralstriktur (1999) (0)
- [Budd-Chiari syndrome in polycythemia following phlebotomy]. (1985) (0)
- Motility, Proliferation and Egress of Human AML Cells in Transplanted NOD/SCID Mice Are Regulated by Membrane Bound and Secreted Elastase. (2004) (0)
- Fludarabine-Based Reduced-Intensity (RIC) or Reduced-Toxicity Conditioning (RTC) May Be Associated with Increased Risk for Secondary Malignancies After Allogeneic Stem-Cell Transplantation (SCT) (2012) (0)
- Copanlisib (COP) in patients with relapsed or refractory indolent B-cell lymphoma: primary results of the pivotal Chronos-1 study (2017) (0)
- BASELINE CLINICAL AND PET‐CT TUMOR BURDEN PARAMETERS DO NOT PREDICT OUTCOME OF RELAPSE/REFRACTORY AGGRESSIVE B CELL LYMPHOMA PATIENTS TREATED WITH ANTI‐CD19 CAR T‐CELLS (2019) (0)
- [Liver damage due to reserpine hypersensitivity]. (1984) (0)
- Allogeneic Hematopoietic Stem-Cell Transplantation in AML and MDS Using Myeloablative Versus Reduced Intensity Conditioning: Long-Term Follow-up. (2008) (0)
- Imatinib long term effects study: three years of follow-up and assessment (2009) (0)
- Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT. (2012) (0)
- STK405759 As a Novel Tubulin Active Agent for Multiple Myeloma Therapy (2015) (0)
- Performance of Prognostic Models in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Comparison (2019) (0)
- Graft-Versus-Leukemia Effect Is Independent from Graft-Versus-Host Disease Following Ptcy-Based HLA-Haploidentical Transplantation (2022) (0)
- Allogeneic Stem Cell Transplantation from Haploidentical Versus Matched Sibling Donors for Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2022) (0)
- Heparanase regulates retention and proliferation of primitive Sca-1 (cid:1) /c-Kit (cid:1) /Lin (cid:2) cells via modulation of the bone marrow microenvironment (2008) (0)
- Anti-3rd party human ctl's generated from autologous or allogeneic t cells are endowed with potent gvl activity in the absence of gvho (2000) (0)
- Inhibition of anastomotic intimal hyperplasia by a synthetic nonsulphated heparin-mimicking compound. (2002) (0)
- Donor Lymphocyte Infusion Vs. Second Allogeneic HCT In Relapsed AML After Allografting: A Landmark Analysis From The Acute Leukemia Working Party Of EBMT (2013) (0)
- Single cell analysis of multiple myeloma. (2018) (0)
- CXCR4 Promotes Bortezomib Resistance and Regulates Metabolic Reprogramming, Activating Both Glycolytic and Oxphos Pathways in Multiple Myeloma (2022) (0)
- Allogeneic Hematopoietic Stem-Cell Transplantation In AML and MDS Using Myeloablative Versus Reduced Intensity Conditioning: 10 Years Later (2013) (0)
- Donor C3435T Polymorphism in the Multidrug Resistance 1 (MDR1) Gene Is Associated with the Incidence of Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. (2006) (0)
- Vivo in Inhibition of a von Hippel-Lindau Pheochromocytoma Treatment with Halofuginone Results in Marked Growth (2003) (0)
- Faculty Opinions recommendation of Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture. (2013) (0)
- Faculty Opinions recommendation of Low-dose melphalan induces favourable responses in elderly patients with high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia. (2007) (0)
- 134 ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN LOWER RISK MDS PATIENTS : A RETROSPECTIVE STUDY ON BEHALF OF THE CMWP OF THE EBMT (2015) (0)
- Modulation of Multiple Myeloma Apoptosis and Adhesion by Seliciclib, A Selective Inhibitor of Cyclin Dependent Kinase (CDK) (2010) (0)
- Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with High-Risk AML in Complete Remission: A Survey from the ALWP of the EBMT (2015) (0)
- Abdominal CT in the clinical evaluation of acute graft-versus-host disease (GVHD) of the gastrointestinal tract: Diffuse small intestine involvement is associated with poor outcome (2005) (0)
- Recurrent episodes of non-A, non-B hepatitis reactivated by chemotherapy. (1985) (0)
- [Adult respiratory distress syndrome complicating acute pyelonephritis in pregnancy]. (1991) (0)
- Interleukin-8 Serum Levels - a Surrogate Marker for Pseudo-Tumor Progression Post Anti-CD19 Chimeric Antigen Receptor T Cells Treatment in Aggressive B-Cell Lymphoma (2021) (0)
- Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation (0)
- HAPLOIDENTICAL VERSUS UNRELATED ALLOGENEIC STEM CELL TRANSPLANTATION FOR ADULTS WITH ACUTE LEUKEMIA (2021) (0)
- Transformation to Myelofibrosis and Blastic Transformation of PV Are Associated with Higher JAK2 Mutation Levels. (2007) (0)
- Human Umbilical Cord Blood Transplantation: A Viable Option for Stem Cell Graft (2006) (0)
- Refined graft-versus-host disease-free/relapse-free survival - a novel outcome endpoint for haploidentical transplantation in adults with acute leukemia: on behalf of ALWP-EBMT (2016) (0)
- Autologous Versus Haploidentical Stem Cell Transplantation in Adult Patients with Intermediate Risk Actue Myelogenous Leukemia in First Complete Remission and Undetectable Minimal Residual Disease: A Global Preliminary Analysis of Chinese Data (2022) (0)
- Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP) (2021) (0)
- Haploidentical Stem Cell Transplantation Attenuates the Prognostic Impact of FLT3-ITD in Acute Myeloid Leukemia (2017) (0)
- Autologous and Allogeneic Stem Cell Transplantation for Richter's Transformation: A Retrospective Analysis From the Chronic Leukaemia Working Party and Lymphoma Working Party of the EBMT. (2009) (0)
- Missing HLA C Group 1 Ligand In Patients With AML and MDS Is Associated With Reduced Risk Of Relapse After Allogeneic Stem Cell Transplantation With Fludarabine and Treosulfan Reduced Toxicity Conditioning (2013) (0)
- INCREASED IMPACT OF ACUTE REJECTION ON CHRONIC ALLOGRAFT FAILURE IN RECENT ERA (2018) (0)
- PS1030 COMPLETE REMISSION WITH INCOMPLETE BLOOD COUNT RECOVERY IS A STRONG PREDICTOR OF NON-RELAPSE MORTALITY IN ACUTE MYELOID LEUKEMIA PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION (2019) (0)
- Comparison of Cyclosporine/ Methotrextae and Cyclosporine/ Mycophenolate Combinations for Prevention of Acute Graft-Versus Host Disease after Allogeneic Stem Cell Transplantation from Unrelated Donors: A Single Center Retrospective Study (2016) (0)
- Extreme Heterogeneity Of Myeloablative Total Body Irradiation (TBI) Techniques Across Europe: A Survey Of Acute Leukemia Working Party Of The EBMT (2013) (0)
- Glucocerebroside Alleviates Chronic Graft-Versus-Host-Disease in a Murine Model. (2004) (0)
- Inflammatory Biomarker Clusters Are Predictive of Response and Toxicity in Large B-Cell Lymphoma Treated with CD19 CAR-T Cell Therapy (2022) (0)
- SP-043 HAPLOIDENTICAL STEM CELL TRANSPLANTATION (2014) (0)
- Frequent Detection of Minimal Residual Disease (MRD) in Autografts from Patients with Multiple Myeloma during Remission Using a New Culture Method. (2004) (0)
- A Novel Inflammatory Index Is Sufficient to Identify Hemophagocytic Lymphohistiocytosis in Adult Patients with Hematologic Malignancies (2020) (0)
- Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2023) (0)
- Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT. (2022) (0)
- thalassemia and sickle cell disease Related umbilical cord blood transplantation in patients with (2012) (0)
- Anti-T Lymphocyte Globulin (ATG) Induces Generation of Regulatory T Cells, at Least Part of Them Express Activated CD44 (2011) (0)
- Favorable Outcome in Patients with Lymphoid Malignancies Following Allogeneic Stem Cell Transplantation Using Fludarabine and Treosulfan As the Preparative Regimen (2012) (0)
- Venetoclax Reverses Metabolic Reprogramming Induced By S1P Modulator FTY720, Suppresses Oxidative Phosphorylation and Synergistically Targets Multiple Myeloma (2021) (0)
- Best allogeneic transplantation approach for AML patients in first CR: is delayed unrelated donor bone marrow transplantation better than immediate unrelated cord blood transplantation? (2016) (0)
- [Role of human hematopoietic growth factors in hematopoiesis and interaction with the immune system]. (1989) (0)
- PF396 HISTONE DEACETYLASE INHIBITOR PANOBINOSTAT TARGETS CALCINEURIN/NFATC1 SIGNALING AND ABROGATES THE RESISTANCE OF PH+ LEUKEMIA CELLS TO DASATINIB (2019) (0)
- Comparison of Matched Sibling, Unrelated and Haploidentical Donor Transplants Using Post-Transplant Cyclophosphamide in Patients with Acute Myeloid Leukemia, a Study of the ALWP EBMT (2020) (0)
- The disappearance of two alleles of JAK2 V617F from peripheral blood of a polycythaemia vera patient correlates with transformation into myelofibrosis (2007) (0)
- Persistent Mixed Chimerism in Plasma Cells Following Allogeneic Stem-Cell Transplantation in Patients with Acute Leukemia Is a Surrogate Marker for Leukemia Relapse. (2005) (0)
- Clustering of Prognostically Important Cytogenetic Aberrations in Multiple Myeloma with Translocation t(11;14)) (q13;q32) (2012) (0)
- Significance of Degree of HLA Disparity When Using Haploidentical Donors with T-Replete PBSC and Post-Transplantation Cyclophosphamide (PTCy) in Acute Myeloid Leukemia (AML) in First Complete Hematologic Remission (CR1) (2021) (0)
- Evaluation of the clinical impact of bone marrow cultures in current medical practice (2022) (0)
- Stem Cells: What Are They and Why Do We Need Them? (2009) (0)
- Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donors (2020) (0)
- Long-Term Survival and Quality of Life (QoL) Assessment After Reduced Intensity Conditioning Allogeneic Stem-Cell Transplantation (SCT) for Hematological Malignancies (2012) (0)
- The novel compound STK 405759 is a microtubule-targeting agent with potent and selective cytotoxicity against multiple myeloma in vitro and in vivo (2017) (0)
- Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation Transplantation and Cellular Therapy (2022) (0)
- Abstract 3556: CXCR4 controls BCL-2 expression and function by regulating miR-15a/16-1 expression in tumor cells (2016) (0)
- The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation. (2019) (0)
- α deletion based mechanism mediated by TNF- Immune regulatory activity of CD34+ progenitor cells: evidence for a (2013) (0)
- High Response Rate and Improved Graft-Versus-Host Disease (GVHD) Following Bortezomib as Salvage Therapy after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC allo-SCT) for Multiple Myeloma (MM). (2007) (0)
- Nonmyeloablative Allogeneic Stem Cell Transplantation: Towards Improving Efficacy of Immunotherapy Instead of Myeloablative Chemoradiotherapy (2000) (0)
- Risk-factors of melphalan/fludarabine dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma (2004) (0)
- Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia with Hyperdiploid Complex Karyotype: A Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2021) (0)
- Engraftment following low dose total body irradiation (Tbi) (200 Cgy)/fludarabine (Flu) Nonmyeloablative conditioning for allogeneic stem cell transplants (alloSCT) (2000) (0)
- Comparison of Outcome after Allogeneic Stem Cell Transplantation in AML Patients in First or Second Complete Remission Following Either Fludarabin/Busulfan, Flamsa-TBI or Flamsa-Bu Conditioning (2017) (0)
- Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT (2023) (0)
- Exploring limiting factors in the prediction of allogeneic HSCT related mortality: an in-silico machine learning analysis of the acute leukemia working party (ALWP) registry of the EBMT (2015) (0)
- Conventional-dose (CDCT) versus high-dose chemotherapy (HDCT) in the salvage management of relapsed pure seminoma: Results from an international database. (2015) (0)
- A new method for subretinal transplantation of human cells as a thin layer in rabbit and porcine eyes (2014) (0)
- P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE (2022) (0)
- 2 amongst patients undergoing autologous transplant for multiple myeloma : a multicentre UK study (2017) (0)
- 28 Infusion of human umbilical cord blood derived ac 133+progenitor cells to treat myocardial infarction (2003) (0)
- Conditioning Intensity In Middle Aged Patients With AML In CR1. No Advantage For Myeloablative Regimens Irrespective Of The Risk Group. An Observational Analysis By The Acute Leukemia Working Party Of The EBMT (2013) (0)
- Thiotepa-Based Conditioning for Allogeneic Stem Cell Transplantation (allo-HSCT) in Acute Lymphoblastic Leukaemia (ALL) - a Survey from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2015) (0)
- Impact of Conditioning Regimen on Outcomes of T-Replete Haplo-Identical Transplantation for Patients Over 45 Years-Old with AML: A Study On Behalf Of the Acute Leukemia Working Party of the EBMT (2017) (0)
- [The role of interleukin-2--based immunotherapy in hematological malignancies]. (1996) (0)
- Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated AML patients: on behalf of the ALWP/EBMT (2022) (0)
- PB1787 OUTCOMES OF PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA AFTER UPFRONT R-DAEPOCH ARE COMPARABLE TO R-VACOPB REGIMEN: A SINGLE CENTER EXPERIENCE WITH RETROSPECTIVE HISTORICAL COHORT COMPARISON. (2019) (0)
- Combination Of Fluorescence In SITU Hybridization (FISH) and Cytogenetic Techniques Optimize The Diagnostic Process Of Patients With Myelodysplastic Syndrome (MDS) (2013) (0)
- 6. NON - M Y E LOA B L A T I V E HEMATOPOIETIC STEM CELL TRANSPLANT ATION (NST) IN THE (2002) (0)
- (CSF) and granulocyte-monocyte CSF between recombinant human granulocyte colony-stimulating factor hematopoiesis in the myelodysplastic syndromes: comparison Impact of marrow cytogenetics and morphology on in vitro (2011) (0)
- Contrasting Factors Determine the Kinetics of Disease Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukaemia (AML): a Survey from the Acute Leukaemia Working Party of the EBMT (2014) (0)
- Induction of tumor dormancy in BALB/C mice against nonimmunogenic b cell leukemia (2017) (0)
- Jewish Immigrants Of Middle Eastern Origin Have a Lower Incidence Of Multiple Myeloma Compared To Both North African and European Jews In a Cohort Of 746,200 Israeli Men Followed From Late Adolescence (2013) (0)
- The Phenotypic, Transcriptional and Functional Properties of CAR T Cells Products May Predict Response of Patients with B Cell Lymphoid Malignancies Treated with CD19 CAR-T Cells (2022) (0)
- The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation. (1999) (0)
- Efficacy of high dose chemotherapy with/without BCNU for autologous bone marrow transplantation (ABMT) in breast cancer (1993) (0)
- Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysis (2022) (0)
- 3D Grown Human Placental-Derived Mesenchymal Stromal Cells (PLX-I) Support and Potentiate the Engraftment of Human Cord Blood Unfractionated (UFCBC) and Fractionated CD34+ Cells (hCD34+) in Irradiated NOD/SCID Mice. (2007) (0)
- The Risk of Sinusoidal Obstruction Syndrome (SOS) in Allogeneic Hematopoietic Stem Cell Transplantation after Prior Gemtuzumab Ozogamicin Treatment : A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (2015) (0)
- Immunotherapy of lymphoma by cytokines and allogeneic cell therapy (1999) (0)
- 192Dose-reduced conditioning with fludarabine/melphalan followed by allogeneic stem cell transplantation for patients with advanced stage II/III multiple myeloma (2003) (0)
- High-Dose Therapy and Autologous Stem-Cel l Transplantat ion Versus (2001) (0)
- Impact of deletion 13q14 detected by fluorescence in situ hybridization on outcome after dose-reduced allogeneic stem transplantation in patients with multiple myeloma. (2004) (0)
- Immunophenotyping and Function of Peripheral Blood Mononuclear Cells in Patients Undergoing Unrelated Allogeneic Transplantation with Post-Transplantation Cyclophosphamide in Combination with ATG Anti-Graft Versus Host Disease Prophylaxis (2019) (0)
- Sequential Chemotherapy Followed by Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation (allo-SCT) in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of EBMT (2012) (0)
- Physicians Abstracts (2015) (0)
- Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT 3-ITD ; a study from the Acute Leukemia Working (2017) (0)
- Impact of CD34+ Cell Dose on Clinical Outcomes after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from Haploidentical Donors in AML Patients. a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2020) (0)
- Autologous stem cell transplantation (ASCT) in patients with POEMS syndrome results in durable symptomatic disease control: A retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancies Working Party of the EBMT (2015) (0)
- The hierarchy of alternative donors for allogeneic hematopoietic stem cell transplantation in poor risk Aml in CR1 revisited (2016) (0)
- The Efficacy and Safety of Anti-CD19 CAR T-Cell Therapy in Young Adults with Relapsed and Refractory Aggressive B-Cell Malignancies—the Experience of a Single Center in Israel (2017) (0)
- Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia Following Total Body Irradiation- the Effect of Anti- Thymocyte Globulin on Transplant Outcome: ALWP of the EBMT Study (2019) (0)
- The anti-angiogenic effect of halofuginone (halo): inhibition of collagen type i tube formation, matrix metalloproteinase-2 (mmp-2) acnvntes and extracellua r matrix (ecm) deposition (2000) (0)
- Use of Post-Transplant Cyclophosphamide in One-Antigen Mismatched Unrelated Donor Transplantation Results in Similar Transplant Outcomes Than Haploidentical Hransplantation: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the EBMT (2020) (0)
- Heparanase expression is prevalent in AML but not in lymphoid malignancies (2000) (0)
- KIR-HLA Interactions Lack Clinical Utility in Matched Unrelated Donor Transplantation for AML: An Analysis of the CIBMTR and DRST Registries (2021) (0)
- Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years-a registry-based study by the Acute Leukemia Working Party of the EBMT. (2023) (0)
- A novel platform for minimally invasive delivery of cells and therapeutics to the posterior segment (2015) (0)
- HLA disparities on unshared haplotype influence outcomes of unmanipulated haploidentical hematopoietic stem cell transplantation (HaploSCT): A Study from the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation (EBMT) (2016) (0)
- No Adverse Impact of 13q14 and P53 Deletion, t(4;14)(p16;q32) or Overrepresentation of CMYC(8q24) as Detected by Fluorescence In Situ Hybridization on Outcome in Patients with Multiple Myeloma Following Dose-Reduced Allogeneic Stem Cell Transplantation. (2006) (0)
- Cyclosporine and Methotrexate (CSA/MTX) Compared With Cyclosporine and Mycophenolate Mofetil (CSA/MMF) as GVHD Prevention Regimens in Allogeneic Stem-Cell Transplantation From Unrelated Donors; Relative Outcomes Are Dependant on Disease Status at Transplantation (2011) (0)
- Attenuated DNA damage responses and increased apoptosis characterize human hematopoietic stem cells exposed to irradiation (2018) (0)
- Sub-Retinal Injection of Human Adult Stem Cells Preserves ERG Response in RCS Rats (2011) (0)
- New Drug In Allogeneic Stem Cell Transplantation Conditioning - I.V. Busulfan (2012) (0)
- Infections Associated with Bendamustine – a Retrospective Multicenter Study (2014) (0)
- Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma (2018) (0)
- Reprogramming human mononuclear cells to express cxcr4 improves homing and engraftment in the infarcted heart (2007) (0)
- Engraftment following mitoxantrone (Mito) based conditioning for allogeneic bone marrow transplantation (allo-BMT). (1998) (0)
- Trends in the Use of Hematopoietic Stem Cell Transplantation in the Management of Relapsed/Refractory Diffuse Large B Cell Lymphoma. a Retrospective Analysis of the Lymphoma Working Party of the EBMT (2022) (0)
- Two-Year Landmark Survival Analysis after Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia: An Analysis from the ALWP of the EBMT (2021) (0)
- Megakaryocyie growth factors in sera of throbocytopenic patients undergoing chemotherapy, radiotherapy or allogeneic bone marrow transplantation (1993) (0)
- Comparable Outcomes after Allogeneic Stem-Cell Transplantation with Intravenous Busulfan or Treosulfan-Based Reduced-Intensity and Reduced Toxicity Regimens in Acute Myeloid Leukemia. a Study on Behalf of the Acute Leukemia Working Party of EBMT (2016) (0)
- Comorbidities in recipients of low transplant conditioning intensity regimens for acute myeloid leukemia: an ALWP EBMT study. (2023) (0)
- Evaluating Outcomes of Adult Patients with Acute Lymphoblastic Leukemia Treated on the GMALL Protocol (2020) (0)
- F04Conventional-dose (CDCT) versus high-dose chemotherapy (HDCT) in the salvage management of relapsed pure seminoma: results from an international database (2015) (0)
- Long-Term Outcome of Second Allogeneic Stem Cell Transplantation (HSCT2) for Primary Graft Failure in Patients with Acute Leukemia in Remission: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2022) (0)
- Amsa/ARA-C Followed By TBI 4 Gy or High Dose Chemotherapy Conditioning Regimens in Primary Refractory AML - Significantly Worse Outcomes in Younger Patients Conditioned with 4 Gy TBI (2022) (0)
- The 48th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Award Winners (O001-O007) (2022) (0)
- Improved Post-Transplant Outcomes in Recent Years for AML Patients with Intermediate Karyotype, FLT3-ITD and Wild Type NPM1: A Report from the EBMT Acute Leukemia Working Party (2022) (0)
- The Optimized HLH Inflammatory Index Is Associated with a Higher Stage of Lymphoma, but an Unexpected High Mortality Associated with Inflammation (2022) (0)
- Post transplant immunotherapy for prevention of relapse after autologous bmt for acute leukemia (1998) (0)
- S1P Modulator FTY720 Targets Multiple Myeloma Cell Proliferation and Stromal Interactions Via CXCR4/CXCL12 and mTOR Pathways (2014) (0)
- Impact of Donor Type in Patients with AML Receiving Allogeneic Hematopoietic Cell Transplantation after Low-Dose TBI Based Conditioning: A Study From the Alwp of the Ebmt and Eurocord (2018) (0)
- Reduced-Intensity Conditioning Is Associated with Shorter Duration of Chronic GVHD Than Myeloablative Conditioning and Provides Very Good Quality of Life for Long-Term Survivors after Allogeneic Stem Cell Transplantation. (2007) (0)
- A new method for subretinal transplantation of human adult stem cells preserves retinal structure along the entire retina and rescues retinal function in a rat model of retinal dystrophies (2013) (0)
- MT1-MMP and RECK Inversely Regulate Hematopoietic Progenitor Cell Egress. (2007) (0)
- Aspergillus quadrilineatus, aNewCausative Agent ofFungal Sinusitis (1992) (0)
- Impact of Higher-Dose Total Body Irradiation Conditioning on Outcome of an Allogeneic Hematopoietic Cell Transplant (HCT) in the Modern Era (2017) (0)
- Postsplenectomy infections in 208 traumatized splenectomized patients from 1971 to 1979 (1985) (0)
- Increased accuracy of leukemia diagnosis by combined analysis of morphology and FISH using the Duet automatic cell scanning system (2002) (0)
- P-Glycoprotein (Pgp) - Dependent Drug Resistance to Imatinib at CML-BC Is Exclusively Developed in Aggressive Minor Blast Subpopulation (MS) and Can Be Reversed by Pgp Modulators (2008) (0)
- Intrathecal prophylaxis following autologous bone marrow transplantation for non-Hodgkin's lymphoma. (1997) (0)
- Cardiovascular toxic factor in patients undergoing cardiopulmonary bypass. (1975) (0)
- Objective Measures of Pre-Transplant Physiologic Fitness Are Strong Predictors of Very-Short Term Transplantation Related Mortality (2016) (0)
- Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome (MDS) Patients at Lower Risk According to International Prognostic Scoring System (IPSS) : A Retrospective Study on Behalf of the Cmwp of the EBMT (2014) (0)
- ASTA-Z 7557 impairs human natural killer (NK) cell activity. (1996) (0)
- Elevated levels of soluble receptors for interleukin-6 (SIL-6R), tissue necrosis factor alpha (STNF-aR) and their respective inflammatory cytokines in bone marrow graft rejection (1996) (0)
- Assessment of proton magnetic resonance spectroscopy of blood serum as a diagnostic tool in bone marrow transplantation (1995) (0)
- Outcome of Soft-Tissue Plasmocytomas in Newly Diagnosed Multiple Myeloma Patients Treated with New Drugs (2018) (0)
- Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome (MDS) Using Treosulfan Based Compared to Standard Reduced-Intensity or Myeloablative Conditioning Regimens. a Report of the Chronic Malignancies Working Party of EBMT (2020) (0)
- An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. (2022) (0)
- Outcomes of Allogeneic Hematopoietic Cell Transplantation with Cord Blood Versus Mismatched Unrelated Donor with Post-Transplant Cyclophosphamide in Acute Myeloid Leukemia: An Analysis from the ALWP of the EBMT (2020) (0)
- Nerve Growth Factor-Responsive Neuronal Progenitors From Human Umbilical Cord Blood. (2009) (0)
- Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMT (2022) (0)
- Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation Is Safe and Effective: 1 Year Follow-up (2014) (0)
- Comparison of Transplant Outcomes in Patients with Acute Lymphoblastic Leukemia after Haploidentical Transplant with Post-Transplant Cyclophosphamide or Matched Unrelated Donor Transplant (2020) (0)
- Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from One Antigen HLA-Mismatched Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT (2018) (0)
- Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT (2022) (0)
- Spontaneous Pregnancy and Fertility Preservation Program in Women Undergoing High Dose Chemotherapy for Hematological Malignancies. (2005) (0)
- [Human CD34+ primitive hematopoietic progenitor cells: their role in the regeneration of the immunohematopoietic system]. (1994) (0)
- Stable Changes in Mesenchymal Stromal Cells from Multiple Myeloma Patients Revealed through Their Responses to Toll-Like Receptor Ligands and Epidermal Growth Factor (2011) (0)
- proliferation, migration, and NOD/SCID repopulation Overexpression of CXCR4 on human CD34+ progenitors increases their (2013) (0)
- PF602 OUTCOME OF EXTRA-MEDULLARY DISEASE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH NEW DRUGS (2019) (0)
- Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No Other (2020) (0)
- interleukin 2-stimulated human T lymphocytes and natural killer cells Selective generation of erythroid burst-promoting activity by recombinant (2010) (0)
- S114 POST-TRANSPLANT CYCLOPHOSPHAMIDE VS ATG FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN T-REPLETE HAPLOIDENTICAL TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT OF THE ALWP/EBMT (2019) (0)
- Second Allogeneic Stem-Cell Transplantation (SCT) From a Different Donor for the Treatment of Relapsed AML and MDS After a Previous Allogeneic SCT (2013) (0)
- Monoclonal antibody defining a myeloid differentiation antigen associated with human sarcomas (1986) (0)
- Prevention of chronic graft versus host disease by oral tolerization of bone marrow transplantation donors (1999) (0)
- Bone Marrow Versus Mobilized Peripheral Blood Stem Cells for Non T Depleted Haploidentical Transplantations with Post Transplantation Cyclophosphamide in Acute Lymphoblastic Leukemia: On Behalf of the ALWP of the EBMT (2019) (0)
- Induction of oral tolerance prior to or following bone marrow transplantation ameliorates chronic graft versus host disease in a murine model (2000) (0)
- Contemporary evaluation of acute myeloid leukemia patients with long‐term survival exceeding 5 years (2022) (0)
- A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk (2022) (0)
- Acute myeloid leukemia with FLT 3 mutation : a therapeutic window for targeted therapy after allogeneic hematopoietic cell transplantation ( alloHCT ) (2017) (0)
- Mast cells modulate lung fibroblasts functional behavior (1997) (0)
- Comparison of haplo-identical versus unrelated allogeneic stem cell transplantation for acute myeloid leukemia with active disease: A report of 1578 patients from Acute Leukemia Working Party of EBMT (2016) (0)
- Expansion of cord blood derived natural killer cells for amplification of the graft versus leukemia effect (1998) (0)
- P1571: EVALUATION OF THE CLINICAL IMPACT OF BONE MARROW CULTURES IN CURRENT MEDICAL PRACTICE (2022) (0)
- Cathecholamines Differently Regulate Human AML and Normal Hematopoietic Progenitor Cell Motility Via miR126 and RGS16 (2013) (0)
- Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party (2022) (0)
- Second Allogeneic Stem Cell Transplantation (allo-SCT) Using Reduced-Intensity Conditioning (RIC) for Acute Myeloid Leukemia (AML) Patients Who Relapsed Following a First RIC Allo-SCT: a Survey From the Acute Leukemia Working Party of EBMT. (2010) (0)
- Donor EBV status has impact on the incidence of acute and chronic GVHD (2015) (0)
- Near-Tetraploidy Can Mask the Presence of Chromosome 13q Deletions in Plasma Cells of Patients with Multiple Myeloma. (2006) (0)
- Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT (2022) (0)
- Minimal Residual Disease Status in Acute Myeloid Leukemia Patients Undergoing T-Cell Replete Haploidentical Transplantation. an Analysis From the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (Ebmt) (2018) (0)
- Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from Different Donor Types in Primary Refractory Acute Myeloid Leukemia: A Report from the ALWP of the EBMT (2022) (0)
- Corrigendum to "P-glycoprotein-dependent resistance of cancer cells toward the extrinsic TRAIL apoptosis signaling pathway" [Biochem. Pharmacol. 86 (2013) 584-596] (2014) (0)
- Autologous Transplant, and Not ATO Alone, Remains the Preferred Therapy for Relapsed APL: A Report from the CIBMTR, EBMT and Two Specialized Centers (2015) (0)
- Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia over 70 Years of Age: On Behalf of the Acute Leukemia Working Party of the EBMT (2018) (0)
- Allogeneic Hematopoietic Stem Cell Transplantation With Reduced-Intensity Conditioning In Patients With Refractory And Relapsing Multiple Myeloma: Long-Term Follow-Up (2010) (0)
- PS1547 LONG-ACTING G-CSF (LIPEGFILGRASTIM, “LONQUEX”) FOR STEM CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) (2019) (0)
- Outcomes of Acute Myelogenous Leukemia Patients Undergoing Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide: Impact of Total Body Irradiation Versus Chemotherapy-Based Myeloablative Conditioning (2020) (0)
- 442 Characteristics of irradiation induced cell death mode of a human salivary cell line (1995) (0)
- Allogeneic Stem-Cell Transplantation in Patients with AML and MDS Using Myeloablative Versus Reduced-Intensity Doses of Intravenous Busulfan : The Role of Dose Intensity. (2004) (0)
- Allogeneic Stem Cell Transplantation for t(3;3)(q21;q26)/inv(3)(q21;q26) Acute Myeloid Leukemia - Report from the Acute Leukemia Working Party of the EBMT (2016) (0)
- siblings with standard-risk leukemia Transplantation of mobilized peripheral blood cells to HLA-identical (2013) (0)
- Acute myeloid leukemia Prognostic signi fi cance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia (2019) (0)
- Allogeneic Stem Cell Transplantation for Elderly Patients with Intermediate-Risk Cytogenetic Acute Myeloid Leukemia and Internal Tandem Duplication of FLT3 (FLT3-ITD); A Study from the Acute Leukemia Working Party (ALWP) of the European Society of Blood and Marrow Transplantation (EBMT) (2015) (0)
- Outcome of Two Loci Mismatched (≤6/8) Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia: ALWP of the EBMT Study (2019) (0)
- Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. (2023) (0)
- Distinct Roles of CHK2 and Cell Death in Suppressing Oncogenic Potential of Tandem DNA Breaks in Human Hematopoietic Stem Cells (2016) (0)
- Role of allogeneic SCT in low risk MDS : A Retrospective Study on Behalf of the CMWP of the EBMT (2015) (0)
- P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (2022) (0)
- S115 IMPACT OF MESURABLE RESIDUAL DISEASE POSITIVITY ON OUTCOMES FOLLOWING UNMBILICAL CORD BLOOD TRANSPLANTATION: A STUDY FROM THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT AND EUROCORD (2019) (0)
- Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm Following Treatment for Lymphoma: A Study of the Chronic Malignancies Working Party of the EBMT (2022) (0)
- 2232 Radiation therapy has a positive inhibitory effect on the growth of fungal infection: In vitro and in vivo results (1999) (0)
- High Risk Advanced Stage Hodgkin Lymphoma Is Well Controlled with 2 Cycles of Escalated Beacopp Followed By 4 Cycles of ABVD in Patients Who Rapidly Achieve Metabolic CR on Interim PET/CT Scan (2014) (0)
- IN VITRO ANALYSIS PREDICTS CLINICAL RESPONSE OF B CELL LYMPHATIC MALIGNANCIES TO CD19 CAR‐T CELLS: PHENOTYPIC, TRANSCRIPTIONAL AND FUNCTIONAL STUDY (2021) (0)
- Reply: Letter to the Editor Regarding "Autologous Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis". (2019) (0)
- Monocyte and neutrophil function in myelodysplastic syndromes (1986) (0)
- [Novel aspects of natural killer cell function: regulation of immune response and hematopoiesis]. (1987) (0)
- Reduced Intensity Conditioning for Allogeneic Stem Cell Transplantation (HSCT) in Acute Myeloid Leukemia (2022) (0)
- Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia (2020) (0)
- Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identical Sibling Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT (2019) (0)
- 326: Donor C3435T polymorphism in the multidrug resistance 1 (MDR1) gene is associated with the incidence of acute and chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic stem-cell transplantation (alloSCT) (2007) (0)
- Human bone marrow-derived CD133+ cells can be expanded ex-vivo in the presence of a polyamine copper chelator (2004) (0)
- Essential Thrombocythemia Patients with CALR Mutations Have Increased Platelet Activation Markers Compared to JAK2V617F Mutated Patients (2014) (0)
- Haploidentical stem cell transplantation abrogates the prognostic impact of FLT3-ITD in acute myeloid leukemia. A report from the Acute Leukemia Working Party of the EBMT (0)
- Bronchiolitis obliterans presenting emphysema and pneumomediastinum: as subcutaneous a case report (1996) (0)
- Long-term follow-up of patients (pts) with relapsed or refractory (r/r) follicular lymphoma (FL) treated with copanlisib. (2019) (0)
- Adding methylprednisone to cyclosporine and methotrexate safely reduces acute graft vs host disease in people receiving sibling-donor bone marrow transplants (2001) (0)
- Umbilical Cord Blood Transplantation for Secondary AML: A Retrospective Study From the Acute Leukemia Working Party of the Ebmt and Eurocord (2018) (0)
- Erratum: Histopathological study of the human submandibular gland in graft versus host disease (Journal of Clinical Biology (May) (395-397)) (1999) (0)
- of chronic myeloid leukemia in first chronic phase Nonmyeloablative allogeneic stem cell transplantation for the treatment (2013) (0)
- Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT. (2023) (0)
- Age, Albumin, and LDH Predict Outcome of Patients with Limited Stage Peripheral T Cell Lymphoma: A Prognostic Model Developed on 244 Cases Enrolled in the T Cell Project 1 By the International T Cell Project Network (2022) (0)
- Influence of Stem Cell Source (Bone Marrow versus Peripheral Blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia—a Report from the Acute Leukemia Working Party of the EBMT (2015) (0)
- Adoptive allogeneic cell-mediated immunotherapy and nonmyeloablative stem-cell transplantation (2000) (0)
- Immune regulatory activity of CD34 (cid:1) progenitor cells: evidence for a deletion-based mechanism mediated by TNF- (cid:2) (2005) (0)
- Allogeneic Stem-Cell Transplantation in Hodgkin Lymphoma; A More Favorable Outcome in Patients With Chemo-Sensitive Disease and With Treosulfan-Based Conditioning (2013) (0)
- Assessment By MRI T2*of Iron Accumulation and Removal in Transfusion Dependent MDS Patients (2019) (0)
- PB2282 REASSESSING THE EFFICACY OF LOW DOSE RASBURICASE FOR MANAGEMENT OF TUMOR LYSIS SYNDROME IN HIGH RISK HEMATOLOGIC MALIGNANCIES (2019) (0)
- Activation of CRLF2/IL7RA Signaling in Normal Human Cord Blood Hematopoietic Progenitors Induces Philadelphia-like B-Cell Precursor Pre-Leukemia and Leukemia In Vivo (2018) (0)
- Comparable survival for poor-risk cytogenetics AML in first complete remission after haploidentical donor or unrelated donor transplantation: a study from the ALWP of EBMT (2016) (0)
- P449 - A mismatch at locus C is A risk factor for unrelated BMT (1996) (0)
- Genetic Variations in Heparanase Gene (HPSE) Are Associated with Increased Risk of Graft Vs. Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: Effect of Discrepancy Between Recipient and Donor. (2009) (0)
- BL-8040, a CXCR4 antagonist, synergizes with the FLT3 inhibitor AC220 inducing apoptosis and reducing minimal residual disease to prolong survival of AML diseased mice (2015) (0)
- Outcomes of Allogeneic Hematopoietic Cell Transplantation for AML with Complex Karyotypes: A Retrospective Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and MD Anderson Cancer Center (2017) (0)
- PF271 USING NEXT-GENERATION SEQUENCING TO PREDICT RESPONSE TO SALVAGE CHEMOTHERAPY WITH HIGH DOSE CYTARABINE AND MITOXANTRONE IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA PATIENTS (2019) (0)
- Comparison of outcomes after unrelated cord blood transplantation and matched unrelated donor reduced-intensity conditioning regimen transplantation for lymphoid malignancies - a Eurocord-Netcord Group/LWP and CLWP of the EBMT Study (2010) (0)
- Incidence, Risk Factors, Treatment and Outcome of Isolated Extramedullary Relapse after Allogeneic Stem Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Arnon Nagler?
Arnon Nagler is affiliated with the following schools:
